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It is generally accepted that there are five basic tastes: salty, sour, sweet, bitter and 
umami [Mouritsen, 2012].1 
While the first four taste modalities have been world-widely accepted for hundreds of 
years, only recently umami has gained widespread recognition in the West. Umami 
came to the fore in 2000 when Chaudari and colleagues identified on the tongue and 
palate the taste receptor for L-glutamate, which is considered to be the prototypical 
umami substance. The protein they described is a new G-protein-coupled receptor that 
corresponds to a truncated form of metabotropic glutamate receptor mGluR4 
[Mouritsen, 2012]. 
Though umami is a term that most consumers do not recognise, they are usually familiar 
with the umami taste sensation. Many foods daily used in both East and West naturally 
contain components that impart an umami taste, and others form umami substances 
during curing, aging or fermentation. Just think of food such as tomatoes and parmesan 
cheese, which can actually be considered the most umami ingredients of the 
Mediterranean diet [Wyers, 2010]. History shows that from a culinary perspective 
umami is not new and was around long before Dr. Ikeda discovered this taste in 1908.  
[referenza]Fermented fish sauces and intense meat and vegetable extracts have been 
valued in world cuisines for more than 2,000 years. For example, Roman garum or 
liquamen, a type of fermented fish stock was regularly added to all dishes of that time 
(Figure 1.1). Although the Greeks and Romans knew that this stock made food to taste 
better, they never identified it as a specific taste. They just enjoyed consuming it. In 
                                                           
1
 A basic taste is an independent taste which cannot be created even through the 
combination of other tastes. 
2 
 
1825 the French gastronome Brillat-Savarin, in The Physiology of Taste, described a 
meaty taste as “toothsome” and predicted that the “future of gastronomy” would have 
belonged “to chemistry”. His description of a meaty taste is similar to the Japanese 
interpretation of umami as “deliciousness” [Marcus, 2009].  
         
Figure 1.1. Ancient Roman fermenting vats, used in the production of garum (left). 
Garum jugs from Pompei (right). 
 
One of the impediments to the recognition of umami as a basic taste may have been the 
lack of traditional words to describe it in Western languages, i.e. consumers are very 
familiar with the umami taste sensation, but not with the term. There is no word in 
Western languages that is synonymous with umami, which it is most often described as 
a "savory" or "meaty" taste. Thus, the term “umami” has been imported from Japanese 
in all our languages [Wyers, 2010]. 
Science is now realizing what great cooks around the world have instinctively known: 
that foods and flavor enhancers with umami can be useful in contributing a savory taste 
and rounding out and heightening the flavor of foods. 
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1.1. Discovery of Umami 
 
Umami was first discovered by the Japanese Professor Kikunae Ikeda of the Imperial 
University of Tokyo in 1908 (Figure 1.2). He noticed that a previously unidentified taste 
quality, quite distinct from the four basic tastes sweet, 
bitter, sour, and salty was present in highly palatable 
foods such as fish and meats. He detected it most clearly 
in soups and broth of flaked katsuobushi, made from 
skipjack fish, and in broth made from kombu, dried sea 
tangle, Laminaria sp., both of which have been used 
traditionally in Japanese cooking (Figure 1.3) 
[Yamaguchi & Ninomiya, 1998, 2000]. In a short paper 
“New Seasonings” written in Japanese and published in 
1909 in Journal of the Chemical Society of Tokyo, Ikeda 
noted down “...physiologists and psychologists recognize 
only the four tastes sour, sweet, salty and bitter. Other tastes are considered to be a 
mixture of these tastes. However, I believe that there is at least one other additional 
taste which is quite distinct from the four tastes. It is the peculiar taste which we feel as 
`UMAI [meaning brothy, meaty, or savory]', arising from fish, meat and so forth. The 
taste is most characteristic of broth prepared from dried bonito and seaweed 
[Laminaria japonica] ... I propose to call this taste `UMAMI' for convenience.  The next 
problem is to identify the chemical substance which produces `UMAMI'. It is difficult to 
prove the existence of a small quantity of unknown taste substance..” [Ikeda, 2002]. 
Subsequently he investigated the constituents of the dried kombu and found it to contain 
2–3 g/100 g dry weight free L-monosodium glutamate (L-MSG, Figure 3) and proposed 
that MSG is for the umami taste what kitchen salt (sodium chloride) is for the salty taste 
or what table sugar (sucrose) is for the sweet taste. 
In 1913, an Ikeda’s disciple, Shintaro Kodama, investigated the constituents of dried 
skipjack, katsuobushi, and reported that inosinate also had umami taste characteristics 
(Figure 3). Many years later, during a study of 5’-ribonucleotide production through 
biochemical degradation of yeast RNA, Akira Kuninaka identified guanylate to be 
another important umami substance. Later, it was shown that guanylate occurs naturally 
Figure 1.2. Prof. Kikunae 
Ikeda, the Umami pioneer. 
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in dried shiitake mushrooms, which are widely used in Japanese and Chinese cooking 
(Figure 1.3) [Yamaguchi & Ninomiya, 1998, 2000]. The discovery of inosinic acid can 
be traced back to Liebig who isolated it from beef broth in 1847. Guanylic acid has been 
known since 1898, when Bang identified it in pancreatic nucleic acid. Once again the 
taste of these substances went unnoticed for decades. At present, MSG (monosodium 
glutamate), IMP (inosine 5’-monophosphate disodium salt) and GMP (guanosine 5’-
monophosphate disodium salt) are widely used as food additives in particular as 
seasonings or condiments to supplement, enhance or round-off the flavor of many 
savory-based processed foods. They are the best flavor enhancers that are in commercial 
use worldwide. 
 
Figure 1.3. Umami substances and their discovery.  
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1.2. Flavor enhancement 
 
The Japanese word umami means “savory”, “delicious” and can denote a really good 
taste of something, a taste or flavor that is an especially appropriate exemplar of the 
flavor of thet thing.  The taste of MSG by itself does not in any sense represent 
deliciousness. Instead, it is often described as unpleasant, and as bitter, salty and soapy. 
Others have described it as a brothy, mouth-watering sensation with a considerable 
increase in salivation.  However, when MSG is added in low concentration to 
appropriate foods, the flavor, pleasantness and acceptability of the food increases 
[Halpern, 2000; Löliger, 2000]. As regards 5’-ribonucleotides, IMP is often described as 
beefy and GMP as oak-mushroom. The use of both compounds was reported to enhance 
flavor notes described as meaty, brothy, mouthfilling, well-rounded, drying or 
astringent. It also seems that 1:1 blends of IMP and GMP can suppress some bitter and 
sour notes, but enhance sweet and salt perceptions [Nagodawithana, 1995; Löliger, 
2000].  
These compounds not only have their own characteristic taste at a level higher than their 
threshold levels but also enhance or potentiate the flavor of the food even at a level 
lower that their threshold levels.  In any case, MSG, IMP and GMP can favourably alter 
the preference for foods. Thus, they are called flavor enhancers, flavor potentiators or 
sometimes flavor modifiers [Yamaguchi, 1998], that is to have the ability to 
significantly influence the taste perception of other substances, e.g. the components of 
certain types of food so that these foods become organoleptically attractive to the 
human palate.  According to Kuninaka, “umami” may be defined as a taste of a flavor 
enhancer at a concentration higher than its threshold level [Kuninaka et al., 1980]. 
Results of taste panel studies on processed foods indicate that an MSG level of 
0.2-0.8% of food by weight optimally enhances the natural food flavor; similarly, the 
corresponding level of 5’-ribonucleotides required to generate the equivalent taste 
intensity may be in the 0.02-0.04% range (Nagodawithana, 1995).  However, 
sometimes, the flavor-enhancing activity of a potentiator is noticeable even at 
concentration which are in the order of its detection threshold.  It should be noted that 
the threshold values reported in the literature for sodium glutamate and 
6 
 
monoribonucleotides show considerable variation, depending on the method of 
measurement and the sensitivity of the panelists to umami taste [Yamaguchi, 1998]. 
 
 
1.3. Synergistic action between flavor enhancers 
 
What is perhaps the most interesting property about MSG and 5’-ribonucleotides is their 
capacity to interact synergistically.  This remarkable property between the two types of 
flavor enhancers was first identified by Kuninaka in 1960 [Kuninaka, 1960].  He found 
that the detection threshold of MSG was markedly lowered in the presence of IMP (or 
GMP) and vice versa [Sugita, 2002]. 
For example, the threshold of MSG in water decreased a hundred times when estimated 
in 0.25% solution of IMP, that is the flavor or MSG is potentiated by the presence of 
small concentration of nucleotides.  In a complementary experiment, the taste threshold 
of a 1.1 blend of IMP and GMP was found to be about a hundred times lower when the 
mixture was dissolved into an aqueous solution of 0.8% MSG (see Table 1.1).  These 
data clearly indicate that both GMP and IMP can significantly reduce the glutamate 
requirement and still maintain the desired flavor enhancing properties in food 
formulation. 
 
Table 1.1. Taste Threshold of Umami Substances 
  
Detection Threshold 
(g/dl) 
  
 
MSG alone 1.20 x 10–2  
IMP alone 2.50 x 10–2  
GMP alone 1.25 x 10–2  
  
MSG in 0.25% IMP  1.50 x 10–4  
IMP + GMP (1 : 1 blend)  6.30 x 10–3  
IMP + GMP (1 : 1 blend) in 0.8% MSG  1.30 x 10–5  
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It is noteworthy that the synergistic interactions of MSG with IMP and/or GMP also 
occur in certain savory foods bringing about a flavor effect which is greater than the 
sum of the individual flavor-enhancing effects.  
This phenomenon of synergism is of the utmost importance, because it provides an 
opportunity for the food processor to use less MSG in the formulation without affecting 
flavor quality.  For instance, it has been found that food processors who use 100 g of 
MSG can reduce usage levels to 17 g in the presence of 0.9 g of 50:50 blends of IMP 
and GMP with a substantial (25-30%) cost reduction and without an adverse effect on 
the organoleptic properties of the processed food [Löliger, 2000]. 
Several combinations of MSG and GMP and/or IMP are now commercially available 
for use in the food industry.  Most popular blend have MSG:5’-ribonucleotides ratio of 
about 95:5. Because of the improved efficacy of these blends due to the phenomenon of 
synergism, these flavor enhancers will be used at relatively low concentration in food 
formulations thereby providing a cost advantage to the food processor. The lower usage 
level of blends automatically eliminates the possibility of any flavor contributions by 
5’-nucleotides because these compounds are, most likely, introduced to the food 
formulation at sub-threshold concentrations with respect to taste only to exert the 
synergistic flavor enhancement.  Such low concentrations of 5’-ribonucleotides are 
capable of providing an impression of a much greater concentration of glutamate than is 
actually present in the food system [Nagodawithana, 1995].  
Umami substances generally improve the intensity and pleasantness of foods only at a 
certain range of concentrations.  Any excess can cause an unpleasant sensation in the 
palate.  Thus the concentration of flavor enhancer intake by humans can be regarded as 
self-limiting.  For example, an optimum amount of MSG appears to be around the 
concentration found in many natural foods, typically 0.1–0.8% by weight [Mouritsen, 
2012]. 
It must be noted that certain yeast extracts that contain all three of these flavor 
enhancers (MSG, IMP and GMP) in natural form, are of particular interest to food 
processors not only because of the effect of synergism but also due to the background 
flavor these natural extracts elicit in savory food systems. 
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Yamaguchi investigated the synergistic effect in detail [Yamaguchi, 1998]. The 
relationship between the proportion of IMP in a mixture of MSG and IMP and the taste 
intensity of the mixture is shown in Figure 1.4. 
 
Figure 1.4. Relationship between umami intensity at different ratios of MSG and IMP 
 
In addition Yamaguchi proposed a mathematical model to correlate the taste 
enhancement of MSG with its concentration and that of the enhancer present in the 
same aqueous solution.  The relationship between the degree of taste enhancement and 
the two concentrations is expressed by equation 1.1, where u is the concentration of 
MSG, v is the concentration of the nucleotide, y is the concentration of MSG alone in a 
solution equivalent in taste intensity to the mixture (u + v), and γ is a constant. 
 
y = u + γ • v • u                  (eq. 1.1) 
 
Equation 1 is now generally accepted (providing that u is not too far from the subjective 
threshold value of MSG and v is in the range 2-14% u) and has been validated by 
studies on the flavor enhancing activity of compounds related to inosine 5’-phosphate.  
It must be noted that γ (conc-1) is specific to the enhancer and is indicative of its 
synergistic capacity to increase the umami taste of MSG. 
 
The synergistic action between MSG and flavor nucleotides was also demonstrated 
neurophysiologically. For example, the response of rat chorda tympani to IMP or GMP 
is greater than that to UMP or CMP, and the response to MSG was synergistically 
enhanced by addition of GMP (Figure 1.5) [Kuninaka, 1981]. 
9 
 
 
Figure 1.5. Integrated chorda tympani response to stimulation of the rat tongue by 0.3% 
MSG solution, 0.0003% - 0.3% GMP solutions, and 0.3% MSG solutions containing 
0.0003% - 0.3% GMP. 
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1.4. Natural Occurrence of Umami 
 
Umami compounds make a variety of foods palatable, although umami taste by itself is 
not particularly palatable. For example, a solution of MSG is not very palatable, but 
MSG added to soup greatly enhances its palatability. The effect of adding MSG to 
various foods has been investigated by a number of researchers [Yamaguchi & 
Ninomiya, 2000]. Think about biting into a cheddar cheeseburger with ketchup, 
spaghetti with marinara sauce and a dusting of Parmesan cheese or a salt-kissed slice of 
Jambon de Bayonne – the saliva-inducing, mouth-filling, deep, satiating taste – that is 
umami. In addition to being a unique standalone taste, umami seems to enhance the 
taste of foods it is combined with, intensifying other flavors as well.  
Since umami flavor is imparted by a combination of substances that interact 
synergistically, the evaluation of the amount of both MSG and 5' riboucleotides (GMP 
and IMP) is necessary. 
Free glutamic acid is naturally present in most foods, such as meat, poultry, seafood and 
vegetables [Yamaguchi & Ninomiya, 2000]. In addition, L-glutamic acid is one of the 
most abundant amino acid of food proteins (plant and animal), where it constitutes 
about 40% and 10-20% of the protein mass in animal and plant tissues, respectively. 
Therefore, the “bound glutamic acid” found in many common foods needs to be 
released to produce umami taste. Similarly, most nucleotides in living organisms are 
bound in nucleic acids, such as DNA, RNA and ATP. Thus, these nucleic acids have to 
be degraded and free nucleotides have to be released to produce umami flavor. 
Consequently, most raw foodstuff materials need to be processed in order to break 
down the proteins into free amino acids and the nucleic acids into free nucleotides to 
provide umami [Mouritsen, 2012]. Processes such as cooking, boiling, steaming, 
simmering, roasting, braising, broiling, smoking, drying, maturing, marinating, salting, 
ageing and fermenting contributes to the degradation of the cells and the 
macromolecules of which the foodstuff is made. Among them, fermenting, by microbes 
such as yeast and bacteria or by enzymes, is by far the most potent method of freeing 
umami compounds  [Mouritsen, 2012]. 
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Table 1.2 and 1.3 provide a selection of foodstuffs, some raw and some processed, 
along with their concentration of free glutamate and nucleotides as determined in the 
international literature [Kuninaka, 1981; Sugita, 2002; Behrens et al., 2011]. 
 
Table 1.2. Umami compounds occurring naturally in several raw and processed animal 
foods (mg/100g). 
Food   Nucleotides 
 MSG  IMP  GMP  AMP  
Beef meat 33 
 
90 
 
4 
 
8 
Pork meat 23  200  2.5  9 
Chicken meat 44  115  2.2  13.1 
Cured ham 340   -   -   -   
Clam 150-250   -  -  12 
Eel 10  165  -  20.1 
Mackerel 40-60 
 
150-190 
 
- 
 
6.4 
Oyster 265  -  -  - 
Sardine 288  188  -  0.8 
Scallop 140 
 
- 
 
- 
 
172 
Sea urchin 300-400  2  2  - 
Tuna (katsuobushi) 268  630-1310  -  trace 
Yellow fin tuna 4-9   286   -   5.9   
Cow's milk 1,9   - 
 
- 
 
- 
Human breast milk 22  -  -  - 
Parmesan cheese 1680  -  -  - 
Emmentaler cheese 308 
 
- 
 
- 
 
- 
Cheddar cheese 182   -   -   -   
Sources: Kuninaka, 1981; Sugita, 2002; Behrens, 2011. 
 
The data in Tables 1.2 and 1.3 show that among ribonucleotides that mostly contribute 
to the umami taste, GMP and IMP are present in many foods. Inosinate is found 
primarily in animal foods, whereas guanylate is more abundant in vegetable foods. 
Another ribonucleotide, 5’-adenylate, is abundant in fish and shellfish [Yamaguchi & 
Ninomiya, 2000]. However, its umami threshold concentration is lower than those of 
GMP and IMP. It appears from the Table 1.2 and 1.3 that umami is not a flavor that is 
found only in the Japanese cuisine, in fact it is associated with well-known and common 
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foods and food ingredients in western cuisine [Mouritsen, 2011]. For example, meats, 
ham, sea urchin, mackerel, katsuobushi and clams are the most taste active animal foods 
(Table 1.2). 
 
Table 1.3. Umami compounds occurring naturally in several raw and processed 
vegetable foods (mg/100g). 
Food   Nucleotides 
 MSG  IMP  GMP  AMP  
Asparagus 106 
 
- 
 
trace 
 
4 
 
Beans  39  -  -  - 
Broccoli 30  -  -  - 
Cabbage  50 
 
- 
 
- 
 
- 
 
Carrots 33  -  1.5  - 
Cauliflower 46  -  -  - 
Celery  51 
 
- 
 
4-5 
 
- 
Eggplant 1-2  -  3  - 
Green peas 106  -  -  2 
Onion 102 
 
trace 
 
- 
 
1 
Potato 180  -  2,3  - 
Spinach 48  -  -  - 
Sweet corn 100 
 
- 
 
- 
 
- 
 
Tomato 256  -  10  21 
Zucchini 16  -  7.5  - 
Porcini mushroom  77 
 
- 
 
10 
 
- 
Shiitake mushroom  1060  - 
 
216 
 
321 
Nori (seaweed) 1608   -   13   -   
Sources: Kuninaka, 1981; Sugita, 2002; Behrens, 2011. 
 
During the ripening of cheese, proteins are broken down progressively into smaller 
polypeptides and individual amino acids. In particular, significant increases in leucine, 
glutamate, lysine, phenylalanine and valine are noted [Weaver & Kroger, 1978]. 
Increases in the amount of these amino acids are generally recognized to be a reliable 
indicator of cheese ripening [Puchades et al., 1989; Weaver & Kroger, 1978], and 
contribute to the taste and texture of the cheese [Ramos et al., 1987]. For example, 
Parmesan cheese has the highest level of free glutamate. 
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Large increases in free amino acid content also occur during the curing of ham; 
glutamate is the most abundant free amino acid found in the final product [Cordaba et 
al., 1994]. 
It is interesting to note that the glutamate content of human breast milk is up to 10 times 
higher than that in cow milk. Moreover, among the 20 free amino acids in human breast 
milk glutamate is the most abundant; it accounts for more than 50% of the total free 
amino acid content [Rassin et al., 1978]. Glutamate presence may influence the taste 
acceptability to nursing infants (Figure 1.6). A series of studies on facial expressions of 
infants responding to different tastes showed that they display a happy expression after 
tasting something sweet, while they screw up their faces after consuming sour and bitter 
tasting foods. Interestingly, after consuming umami, in the form of vegetable soup with 
monosodium glutamate added, they display a calm face similar to that when having 
consumed something sweet [Steiner et al., 1978; Steiner, 1993]. These results suggest 
that umami is a palatable taste for humans infants; by virtue of its presence in breast 
milk, it might conceivably contribute to the taste acceptability of this liquid. 
       
umami    sweet    sour   bitter 
Figure 1.6. The four images show the reactions of infants after tasting umami, sweet, sour and 
bitter.  
 
 
Among vegetable foods that provide umami in Western tradition, asparagus, potatoes 
and peas have the highest levels of free MSG. Furthermore, the tomato is the “most 
umami” vegetable in the Mediterranean diet (Table 1.3). Its attractive, full, rounded 
“meaty” flavor comes from its heavy load of glutamates, and this flavor is reinforced by 
its unique crimson color. For these reasons the tomato is widely used throughout the 
world to impart the taste of umami in a wide variety of dishes. 
The ripening of vegetables generally makes them more flavorful. For example, flavor 
maturation in ripening tomatoes has been related to the increase in their natural contents 
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of free amino acids, i.e. glutamate, sugars and organic acids (Figure 1.7) [Yamaguchi & 
Ninomiya, 2000].  
 
Figure 1.7.  Level of free MSG in tomato during ripening 
 
Okumura et al. [1968] prepared synthetic extracts of tomato containing citric acid, 
glucose, potassium hydrogen phosphate, magnesium sulfate, calcium chloride, 
glutamate and aspartate. The taste of the synthetic extract was greatly affected by the 
ratio of glutamate to aspartate. The ratio and the coexistence of both amino acids were 
the most important factors in reproducing tomato taste. When no glutamate was added 
to the extract, the taste was similar to green tomato or citrus. It is difficult to perceive a 
clear umami taste in tomatoes, but it is one of the most important taste components.  
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1.5. Manufacture of flavor enhancers 
 
1.5.1. Production of glutamate 
 
When Ikeda discovered MSG as the compound behind umami, he immediately realised 
the technological importance of his discovery and filed a patent (Figure 1.8) [Ikeda, 
1908] for the production of pure MSG to be used as an artificial flavoring agent in 
foodstuffs [Sano, 2009; Wyers, 2010]. 
 
Figure 1.8. Patent on manufacturing seasoning (L-glutamate) 
filed by K. Ikeda [http://www.ajinomoto.com/features/aji-no-
moto/en/basic/history.html]. 
 
 
 
 
 
 
 
In 1909 Saburosuke Suzuki, an entrepreneur, and Ikeda began the industrial production 
of monosodium L-glutamate (MSG). 
The first industrial production process was an extraction from hydrolysates of vegetable 
proteins. The main raw material was wheat gluten, which contained up to 25% glutamic 
acid by weight. The gluten was subjected to hydrolysis by aqueous HCl. Glutamic acid 
hydrochloride was then isolated from the hydrolysate and purified by crystallization as 
MSG. Initial production of MSG was limited because of the technical drawbacks of this 
method. Better methods did not emerge until the 1950s. One of these was direct 
chemical synthesis, which was used from 1962 to 1973. In this procedure, acrylonitrile 
was the starting material, and optical resolution of DL-glutamic acid was achieved by 
preferential crystallization. 
In the 1950s Corynebacterium glutamicum was found to be a very efficient producer of 
L-glutamic acid. Since then fermentation processes with bacteria of the species 
Corynebacterium became among the most important manufacturing methods in terms of 
tonnage and economical value.  
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The selected microorganism is cultured with carbohydrates and ammonia and releases 
the L-form of the amino acid into the culture medium. The cell produces glutamate from 
2-oxo-glutarate (2-oxo-pentanedioic acid) by reductive ammonia fixation that uses the 
enzyme glutamate dehydrogenase, a normal cellular constituent. 
The advantages of the fermentation method (e.g., reduction of production costs and 
environmental load) were large enough to cause all glutamate manufacturers to shift to 
fermentation [Hermann, 2003].  
In 2010, total world production of monosodium glutamate (MSG) was estimated to be  
2.1 million MT (metric tonnes) and that of nucleotides 22,000 MT.2 Ajinomoto, 
currently an international company, established by Ikeda itself owns about one third of 
the market for glutamate and 40% of the market for nucleotides.  
“To create good, affordable seasonings and turn simple but nutritious fare into 
delicaciaes” was the motivation of Ikeda for inventing Ajinomoto and this is still the 
aspiration of Ajiinomoto group (Figure 1.9). 
 
Figure 1.9. [http://www.ajinomoto.com/en/aboutus/principles/#page]. 
 
 
                                                           
2
 http://foodingredientsfirst.com/news/Ajinomoto-Increases-MSG-Prices-in-US.html 
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1.5.2. Production of 5’-nucleotides 
 
As in the early days, when MSG was produced from proteins such as gluten, rich in 
glutamic acids, 5’-nucleotides were also initially from natural sources. In 1950s, 
production techniques that involve microbial fermentations with a higher level of 
productivity came into widespread use for both 5’-inosinic and guanylic acids. Today, 
the most used processes for the production of these flavor enhancers are: 
- Fermentation methods  
Various microbial sources such as Candida utilis, Penicillium citrinum, Saccharomyces 
cerevisiae, Kluyveromyces marxianus, Brevibacterium ammoniagenes, Streptomyces 
aureus, Bacillus subtilis, B. megaterium, Micrococcus glutamicus, Methylobacter 
acidophilus, and Escherichia coli have been reported to produce ribonucleotides and 
their derivatives [Kim et al., 2002]. Mutants of Brevibacterium ammoniagenes are 
currently used because of their ability to overproduce 5’-GMP and 5’-IMP 
[Nagodawithana, 1995; Sugita, 2002].  
- Degradation of microbial RNA using 5’-phosphodiesterase to form 5’-nucleotides. 
Subsequent conversion of 5’-AMP to 5’-IMP with adenylic deaminase enzyme. 
Among the recent advances that were of benefit to food processing industry, production 
of yeast extracts high in flavor enhancing 5’-nucleotides was clearly a major 
development. Yeast is especially selected as a potential source of RNA because of its 
high RNA content (2.5-15%). It is Generally Recognized As Safe (GRAS) and can be 
grown economically to produce large quantities of biomass, rich in ribonucleic acid.  
Since nucleotides are the building blocks of RNA, one could expect the release of 
desired 5’-nucleotides, when RNA is hydrolyzed under controlled conditions in the 
presence of appropriate enzymes [Sugita, 2002]. 
MSG, IMP and GMP occur as colorless or white crystals or as white crystalline 
powders.  They are odourless and dissolve in water readily. 
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1.6. New developments in umami molecules 
 
In recent years, interest for taste (taste-active molecules, taste receptors, taste 
perception, etc.) is growing rapidly both in academia and in industry. In particular, in 
industrial field the aim is to find molecules that influence taste properties in a desired 
direction. Examples are increasing the sweetness of conventional carbohydrate sugars to 
maintain the positive taste properties of these sugars, while reducing the negative 
properties like high energy content and caries induction, or increasing the taste 
perception of salt (NaCl) so that less salt can be added to foods. It is well known that 
many people consume more salt than their bodies need, since the taste of salt added in 
foods is undoubtedly appealing. This behavior is especially pronounced in elderly 
people as we lose some of our sense of taste with age. On the other hand, nutritionists 
recommend a reduction of sodium chloride in the diet considering its correlation with 
coronary heart disease and hypertension [Winkel et al., 2008].  
In this regard, umami substances can be very useful when added in small amounts to 
foods with low level of salt by making them more acceptable and appetizing. It has been 
proven that up to 40% reduction in the NaCl content can be afforded without affecting 
palatability, provided that 0.6-0.8% MSG is added [Mouritsen, 2012].  
Also for umami-tasting molecules there have been raised health concerns. In particular, 
MSG is accused of causing the so-called Chinese restaurant syndrome which was 
associated with the reporting of certain physiological effects following the intake of 
Chinese meals in which MSG was used as a flavor enhancer. The syndrome includes an 
ill-defined set of symptoms, such as numbness and tingling, flushing, muscle tightness, 
migraine headache and bronchoconstriction in some asthmatics.  
Although the scientific evidence for any harmful effects of MSG and for a link between 
MSG and the symptoms are lacking, there is a slow but steadily growing negative 
public perception towards this flavor enhancer [Mouritsen, 2012]. 
It has been reported that the average person consumes between 10 and 20 grams of 
glutamate from their diet each day, with most coming from the protein-containing foods 
we eat as part of our normal diet. The body does not distinguish between the glutamate 
occurring naturally in food and the glutamate added as seasoning, so MSG brings 
nothing new to the diet. But the negative aura around this chemically sounding 
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ingredient has strongly stimulated research for more natural and clean-label sounding 
alternatives [Wyers, 2010].  
It is not surprising that most of the research to find other umami-tasting molecules was 
carried out in Japan. Dozens of articles have been published on this topic. In particular, 
most of investigations have been focused on the constituents of materials commonly 
used as tasty ingredients in savory dishes because of their umami-like taste attributes 
and taste-enhancing activity. 
Among them, of particular interest are Hydrolyzed Vegetable Proteins (HVPs) and 
yeast extracts. 
 
 
1.6.1. Hydrolyzed Vegetable Proteins (HVPs) 
 
Hydrolyzed vegetable proteins (HVPs) have been known for a long time in the food 
industry but only since the 1930s this product gained prominence as a flavoring agent to 
improve the flavor of processed foods. It is also used worldwide as a savory ingredient 
or a seasoning. 
HVPs are generally described as either flavor donors, flavor enhancers or flavor 
donor/enhancer combination products. Flavor donors contribute a taste which becomes 
a definite feature of the final product. Additionally, the high concentration of glutamates 
in the product makes it a flavor enhancer enriching the naturally occurring flavor of the 
savory based foods. HVPs are known to contribute meatiness to foods, enhance and 
intensify naturally occurring savory flavors and generally round-off and balance the 
savory characteristics in the food material. It is thus used in soups, gravies, savory 
snacks, sauces, ready-to-eat meals and other meat-based products. These hydrolysates, 
like yeast extract, are known for their versatility and ease of application in food 
systems. Due to the high salt concentration (40-45%), these protein hydrolysates have 
an excellent shelf-life by normal standards. They contain strong flavor intensities 
offering low usage levels and thus lower costs in formulating wide range of finished 
food products. A major advantage of HVPs is its stability under varying process 
conditions. Hence, it can be used in canning and freezing processes without any 
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breakdown or change in flavor and also been used successfully in baking flavored 
snacks and crackers at around 180 °C [Nagodawithana, 1995; Loliger, 2000]. 
In a typical process for the production of HVPs, the raw materials include proteinaceous 
materials of plant origin mainly what gluten, corn gluten, defatted soy flour, defatted 
peanut flour, defatted cottonseed flour, etc. During the early 1950s the major raw 
material for making HVPs was wheat gluten because of the low cleavage cost, high 
glutamic acid concentration in this protein and relative abundance of the product. This 
has been largely replaced lately with 70% soy bean protein concentrates or a blend of 
these vegetable proteins. 
HVPs are mainly prepared by enzymatic and/or acid hydrolysis of proteinaceous 
materials. The taste of HVPs is rigidly controlled by proper selection and blending of 
raw materials and appropriate selection of hydrolytic conditions. The large protein 
molecules are degraded by the acid due to the cleavage of the peptide bonds first into 
the short chain polypeptides and then to peptides and eventually to amino acids. Parallel 
to this sequence of reactions are other reactions that break down carbohydrates into 
flavor or flavors precursors such as 5-hydroxyfurfural, hydroxymethylfurfural and 
others which further undergo Maillard type reactions to produce other flavor 
compounds. A high ratio of acid to protein is generally employed to lower the extent of 
amino acid destruction and to improve the characteristics HVPs flavor. However, 
excessive usage of acid is generally avoided because of the high salt levels that would 
result following neutralization with the appropriate base. 
Following hydrolysis, the reaction mixture is cooled and neutralized with 13% of pure 
caustic soda of food grade quality or a mixture of soda ash and caustic soda. The 
proportion of HCl and NaOH can vary within limits to achieve HVPs of different flavor 
profiles with definite salt concentrations. Furthermore, the pH after neutralization may 
vary between 5 and 6 depending on the nature of the original protein that was 
hydrolyzed or the type of flavor profile that the consumer is looking for in the final 
product. The salt formed by the acid neutralization contributes to the taste of the 
product.  
To meet individual customer demands for savory flavor and to expand the application 
capabilities, development and refinement of the hydrolysis techniques have progressed 
considerably during the past years. The color, taste and salt content have been varied in 
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the final product by making minor adjustment in process condition and/or by varying 
the protein blend used in the process. The salt content, typically 40-45%, is directly 
linked to the level of HCl used in the process. 
HVPs serve three important functions when incorporated in savory products such as 
meat: they contribute taste which becomes a special sensory feature of the food product, 
they serve as a precursor to develop other desirable flavor during subsequent processing 
and they also serve as a flavor enhancer thus intensifying the already existing savory 
notes in the food product. 
The overall composition of the HVPs and their possible taste effects have been 
extensively investigated. Monosodium glutamate and salt (NaCl) are two major water 
soluble components that are capable of enhancing or “stretching” the flavor effect of 
other non-volatile taste compounds already existing in the food. HVP blends generally 
contain 9-12% naturally occurring MSG. Other non-volatile components of HVP with 
taste properties include amino acids and peptides (particularly dipeptides). 
Several glutamyl oligopeptides have been shown to exhibit brothly taste. Other best 
known short peptides among the products tested with strong savory properties were 
Glu-Asp, Glu-Gly-Ser, Glu-Glu, Glu-Thr and Glu-Ser with weak brothy character. 
Analysis of the peptides in an enzymatic hydrolysate of deamidated wheat gluten 
revealed pyroglutamyl peptides such as pGlu-Pro-Ser, pGlu-Pro, pGlu-Pro-Glu, and 
pGlu-Pro-Gln as important umami-like-tasting molecules in this liquid seasoning 
[Schlichtherle-Cerny & Amado, 2002]. Moreover, enzymatic hydrolysis of fish proteins 
was reported to lead to savory products which are rich in acidic peptides such as 
Asp-Glu-Ser, Glu-Asp-Glu, Thr-Glu, and Ser-Glu-Glu. Such acidic di- and tripeptides 
were found to express weak umami activity by themselves but have been demonstrated 
to be significantly enhanced in the presence of IMP [Behrens et al., 2011].  
Brothy tasting compounds were shown to be more acidic, polar and hydrophilic than 
other flat tasting peptides [Arai et al., 1973]. 
It must be pointed out that savory peptides are discussed controversially in the 
literature. For examples, recent work from an Indonesian group stated that the single 
amino acids L-glutamate and L-aspartate were the main contributors to umami taste in 
fermented soy sauce [Winkel et al., 2008]. On the other hand, mixtures of amino acids 
in the proportion found in HVPs do not give the same flavor as the original 
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hydrolysates. It is thus clear that components of the hydrolysates other than amino acids 
play an important role in the flavor generation. 
For example, chemical analysis of the most intense glutamate-like fraction of the 
enzymatic hydrolysate of acid-deaminated wheat gluten revealed the presence of 
different glycoconjugates of glutamate, glutamine and lysine. The most abundant 
Amadori compound, N-(1-deoxy-D-fructos-1-yl)-L-glutamate 1.1 (Figure 1.10) was 
identified as eliciting an intense umami taste [Schlichtherle-Cerny et al., 2004].  
 
 
Figure 1.10. 
 
Moreover, food additives, caramel, salt and MSG are often added to HPVs to generate 
flavor profiles that meet the specific flavor requirements of food processors. Food 
flavorists active in the field have been able to formulate several authentic, meat-like 
savory flavors by the direct controlled reaction between HPVs and reducing sugars such 
as glucose and xylose in the presence of other ingredients such as fatty acids, salt, 
spices, certain vitamins, esters of amino acids and sulfides. Such flavorings do play an 
important role in providing a distinct cooked top notes to savory-based products. 
Hydrolyzed vegetable proteins provide significant saving other flavorings such as beef 
extract while maintaining a similar or sometimes even a better flavor profile 
[Nagodawithana, 1995].  
 
 
1.6.2. Yeast Extracts 
 
Yeast extract is a concentrate of soluble material derived from yeast following 
hydrolysis of the cell material, particularly the proteins, soluble carbohydrates and 
nucleic acids (yeast is generally known for its high RNA content). This is generally 
carried out by use of its own hydrolytic enzymes (autolysis) or by other methods 
(plasmolysis or hydrolysis) in order to release the cell content in a highly degraded 
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form. It is commercially available most commonly as powders of different particle sizes 
but also as concentrated pastes of varying color, composition and flavor. Yeast extracts 
have become popular during the last few decades in part due to their usefulness as a 
natural flavoring agent and also for their ability to promote growth of microorganism in 
industrial fermentations. A major consideration in their use as a flavoring agent is their 
cost effectiveness compared to other flavoring agents on the basis of equivalent flavor 
intensity [Nagodawithana, 1995]. 
In contrast to MSG, yeast extracts have not shown any adverse reaction in humans and 
hence have, thus far, received the clean label status by virtue of being natural. They can 
be used as a natural flavoring or a flavor enhancer in a wide variety of savory food 
products. In addition, their background flavor characteristics are complementary to beef, 
pork, poultry and cheese flavor systems. Hence these ingredients provide an added 
advantage to the food processor. 
Although both extracts and autolysates can be produced commercially from both 
brewers and baker’s yeast, they can also be made from other species of yeast such as 
Candida utilis (torula yest) grown on ethanol or other carbohydrates substrates or 
Kluyveromyces marxianus grown on whey. These extracts or autolysates have their 
unique flavor characteristics different from one another and they are widely used as 
flavoring agents throughout the food industry. 
The choice of the starting material for the production of yeast extracts is directly 
dictated by the cost and availability of the yeast and the quality expected in the final 
product. These extracts are commonly used in soups, gravies, broths, sauces etc., as in 
the case of MSG or 5’-nucleotides. The delivery of similar, if not better, flavor 
characteristics is primarily due to the background flavor of the yeast extracts, blending 
well with the flavor notes of the food to which they added. Many types of cheese 
flavored products such as crackers and fried snacks are commonly improved by the 
incorporation of yeast extracts. They increase the flavor impact and provide a sharper 
and more aged cheesy character. Food processors have often been able to reduce their 
ingredient costs by reducing the level of more expensive ingredients such as natural 
flavors, cheese and meat extracts. The natural 5’-nucleotides of some of these yeast 
extracts consistently demonstrate synergistic potentiating effects by interacting with the 
low levels of natural glutamate present in the extracts as well as in the food substrates to 
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provide the overall delicious character and enhanced savory attributes of processed 
foods. 
Although a series of studies have been performed on the odor active volatile fraction of 
yeast extract, knowledge on the taste-active and/or taste-modulating nonvolatiles is 
rather limited. 
Sensory-guided fractionation of a commercial yeast extract led to the discovery of the 
previously not reported umami-enhancing nucleotide diastereomers (R)- and (S)-N2-(1-
carboxyethyl)guanosine 5’-monophosphate (1.2a and 1.2b Figure 1.11). Model 
experiments confirmed the formation of these diastereomers by a Maillard-type 
glycation of guanosine 5’-monophosphate with dihydroxyacetone and glyceraldehyde, 
respectively [Festring & Hofmann, 2010]. Sensory studies revealed umami recognition 
threshold concentrations comparable to that of 5’-GMP, especially for the (S)-isomer, 
and demonstrated the taste-enhancing activity of these nucleotides on MSG solutions. 
 
Figure 1.11. Chemical structure of (R)-N2-(1-carboxyethyl)guanosine 5’-
monophosphate 1.2a and (S)-N2-(1-carboxyethyl)guanosine 5’-monophosphate 1.2b. 
 
 
1.6.3.  Natural Umami Compounds 
 
Besides L-glutamate and ribonucleotides, additional umami-tasting molecules have been 
identified in various natural sources. 
In 1998 Shima et al., working at the Ajinomoto, isolated from a beef bouillon a 
condensation product of L-alanine and creatinine, N-(1-methyl-4-hydroxy-3-imidazolin-
2,2-ylidene)alanine 1.3 (Figure 1.12), which imparted the favorable “brothy taste”. This 
product was the first of a series of new types of umami molecules [Shima et al., 1998]. 
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Figure 1.12. Chemical structure of N-(1-methyl-4-hydroxy-3-imidazolin-2,2-
ylidene)alanine. 
 
More recently, Kaneko et al. [2006] investigated the key compounds imparting the 
umami taste sensation induced by the consumption of so-called “mat-cha”, a Japanese 
green tea, and identified - besides L-glutamate and succinic acid 1.4 - gallic acid 1.5, 
(1R,2R,3R,5S)-5-carboxy-2,3,5-trihydroxycyclohexyl-3,4,5-trihydroxybenzoate 1.6  
(known as theogallin) as well as N-ethylglutamine 1.7 (known as L-theanine) as 
important umami taste enhancing molecules (Figure 1.13). 
 
Figure 1.13 Chemical structure of some umami-tasting molecules identified in “mat-
cha”: succinic acid 1.4; gallic acid 1.5; (1R,2R,3R,5S)-5-carboxy-2,3,5-
trihydroxycyclohexyl-3,4,5-trihydroxybenzoate 1.6 (known as theogallin); N-
ethylglutamine 1.7. 
 
Thermal processing including drying has long been known to enhance umami and 
savory tastes of food products such as, for example, sun-dried tomatoes and 
mushrooms, respectively. 
A so-called “sensomics” approach was developed to enable the targeted discovery of 
taste compounds and taste enhancing molecules in complex processed foods. This 
approach combines techniques of advanced natural product analysis and analytical 
psychophysical tools, and was used to systematically and comprehensively identify, 
catalog, and quantify the taste-active key metabolites produced upon food processing. 
Application of this sensomics approach revealed that the attractive savory taste of air-
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dried Morel mushrooms is due to the enhancement of the umami taste of L-glutamate by 
(S)-malic acid 1-O-β-D-glucopyranoside 1.8. This so-called (S)-morelid 1.8 is generated 
by the non-enzymatic glucosylation of L-malic acid upon drying the mushrooms 
[Rotzoll et al., 2005]. A drawback of these condensation products is that they are quite 
instable and difficult to synthesize. Furthermore, N-(1-deoxy- D-fructos-1-yl)-L-
glutamic acid 1.9 was identified in sun-dried tomatos in yields of up to 1.5% (on a 
weight basis), and confirmed to be generated by the Maillard reaction of L-glutamic acid 
and glucose upon the drying of foods (figure 1.14) [Behrens et al., 2011].  
 
Figure 1.14 Chemical structure of umami-tasting molecules generated by thermal 
processing: (S)-malic acid 1-O-β-d-glucopyranoside 1.8 (known as (S)-morelid) and N-
(1-deoxy- d-fructos-1-yl)- L-glutamic acid 1.9. 
 
Moreover, N-(1-carboxymethyl)-6-hydroxymethylpyridinium-3-ol inner salt, named 
alapyridaine 1.10 (Figure 1.15), was discovered as a taste enhancer in beef bouillon by 
means of the sensomics approach [Ottinger & Hofmann, 2003]. 
 
Figure 1.15. Chemical structure of N-(1-carboxymethyl)-6-hydroxymethylpyridinium-
3-ol inner salt 1.10 (known as alapyridaine). 
 
Model experiments demonstrated that this pyridinium salt is generated as a racemic 
mixture by the Maillard reaction of L-alanine and glucose from beef broth (Scheme 1.1) 
[Winkel et al., 2008]. 
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Scheme 1.1. Maillard reaction product of alanine and glucose from beef broth [Winkel 
et al., 2008]. 
 
Although being tasteless on its own, the enantiomer (+)-(S)-alapyridaine was confirmed 
to significantly decrease the human recognition threshold of umami as well as sweet 
stimuli, whereas (-)-(R)-alapyridaine was physiologically not active [Soldo et al., 2003]. 
A disadvantage of alapyridaine was the fact that it was required at equimolar quantities 
compared with the other umami-taste active compounds . Additional structure-activity 
relationship studies revealed that substitution of the alanine moiety in 1.10 by a glycine 
moiety converted the sweetness-enhancing alapyridaine into a bitter taste inhibitor 
[Soldo et al., 2004]. 
 
Frerot and Escher (Firmenich) reported in a patent that also succinoyl amides of amino 
acids had umami-taste properties, such as N-succinoyl-S-methyl cysteine 1.11 (Figure 
1.16) [Frerot & Escher, 2004]. 
 
Figure 1.16. Chemical structure of N-succinoyl-S-methyl cysteine 1.11. 
 
In 2004 Schlichtherle-Cerny et al. (Nestle) claimed Amadori-rearrangement products, 
the first condensation step in the Maillard reaction, and other N-glycosides, 
pyroglutamyl-peptides and N-acetylglycine to have umami taste [Schlichtherle-Cerny et 
al., 2004].  
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It is hard to say whether this series of molecules could bind to the glutamate or 
GMP/IMP binding side of an umami receptor. The structures are not similar but they are 
also not very different.  
A quite different type of umami-tasting molecules came from the screening of a large 
set of molecules (>10,000) to find a series of very strong umami-tasting molecules 
[Tachdjian et al., 2006]. As the used libraries had pharmaceutical origin, their molecular 
structures were very new to foods (Figure 1.17). These molecules have a much lower 
taste threshold value that is in the low µm to even nm range, and are the strongest 
umami-tasting molecules found so far. Moreover, since these compounds are very 
different in structure and hydrophobicity from MSG and IMP/GMP, it is likely that they 
bind to a different binding site on an umami receptor. The taste profile tests of these 
molecules are different as well. Probably due to their high affinity for the receptor, the 
taste is quite long-lasting and reminds a bit of the very strong artificial sweeteners.  
 
Figure 1.17. Different type of umami-tasting molecules 
 
Among the umami molecules resembling ribonucleotides, the specific taste modulating 
flavor ingredient N-lactoylguanosine 5’-monophosphate 1.14 (N-lactoyl GMP, Figure 
1.18) was identified in bonito, dried and fermentated skipjack, that is used to make 
dashi, a broth that is the basis for many Japanese foods [de Rijke et al., 2007]. The 
organic synthesis of this compound showed that other amides of GMP had umami taste 
as well. For example, acetyl GMP 1.15 has a similar taste as lactoyl GMP but it 
enhances the salty taste as well [Winkel et al., 2008]. These molecules had proved to be 
ca. 10 to 50 times stronger than GMP itself and therefore their strength is in between the 
common natural umami molecules and the artificial extremely strong umami molecules. 
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Figure 1.18. Chemical structure of N-lactoylguanosine 5’-monophosphate 1.14 and 
N-acetylguanosine 1.15. 
 
 
 
1.7. Ribonucleotides as Flavor Enhancers 
 
 
As stated already, several 5’-nucleotides, in particular IMP, GMP, XMP (xanthosine 5’-
monophosphate) and AMP (adenosine 5’-monophoshate), have particular flavor 
activity, and IMP and GMP have been used as flavor enhancer since 1961. 
It is important to note that 5’-XMP, which has OH groups at C-2 of the purine ring has 
the weakest taste intensity of the three naturally occurring 6-oxo-purine flavor 
nucleotides. Hence it is the least important nucleotide of the three, from a commercial 
standpoint. Of the other two (5’-GMP and 5’-IMP), 5’-GMP in generally perceived as 
having a higher flavor enhancing intensity than 5’-IMP. 
Although the taste intensity is not as strong as IMP or GMP, 5’-adenylic acid (AMP) is 
another important umami substance which is widely distributed in natural food, 
especially seafood. 
Extensive investigations of the synergistic activity of inosinic acid derivatives were 
made in the seventies by Japanese researchers and are summarized in Table 1.4 [Imai et 
al., 1971; Mizuta et al.,1972; Yamaguchi et al., 1971; Kuninaka et al., 1980]. 
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Table 1. 4.  Relative Flavor-Enhancing Activities of Naturally Occurring Flavor Nucleotides 
and Their Derivatives 
 
 
Nucleotide or derivate Relative flavor activity 
5’- IMP · 7.5H2O 1 
5’- GMP · 7H2O 2.3 ± 0.07 
5’- XMP · 3H2O 0.61 ± 0.04 
5’- AMP 0.18 ± 0.03 
2-Methyl-5’- IMP · 6H2O 2.3 ± 0.16 
2-Ethyl-5’- IMP · 1.5H2O 2.3 ± 0.14 
2-Methylthio-5’- IMP · 6H2O 8.0 ± 0.97 
2-Ethylthio-5’- IMP · 2H2O 7.5 ± 0.75 
2-Methoxy-5’- IMP · H2O 4.2 ± 0.33 
2-Chloro-5’- IMP · 1.5H2O 3.1 ± 0.25 
2-N-Methyl-5’- GMP · 5.5H2O 2.3 ± 0.15 
2-N-Dimethyl-5’- GMP · 2.5H2O 2.4 ± 0.13 
2’,3’-O-Isopropylidene 5’-IMP 0.21 ± 0.06 
2’,3’-O-Isopropylidene 5’-GMP 0.35 ± 0.06 
 
Data from such investigations indicated that the structural requirements for MSG-
enhancing activity by nucleotide molecules are:  
(a) a purine nucleus as the base moiety; 
(b) a free phosphate group at 5’-position (2’- or 3’-ribonucleotides have no flavor 
activity); 
(c) an electron withdrawing group at the 6-position of the purine nucleus [Yamaguchi et 
al., 1971; Kuninaka et al., 1981]; 
(d) an unaltered ribose moiety (purine/pyrimidine base as well as their nucleosides have 
no flavor activity. In addition a strongly reduced activity occurs if the 2’-OH is replaced 
by H or the 2’- and 3’-positions are protected as in isopropylidene derivatives of IMP 
and GMP) [Yamaguchi et al., 1971]. 
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By contrast, a large variability of the synergistic effect between 5’-nucleotides and 
MSG was observed in 2-substituted inosinic acids [Kuninaka et al., 1981; Imai et al., 
1971].  In particular, 2-alkylthio-IMPs (inosine 5’-monophosphatederivatives) showed 
pronounced activities when compared with IMP and GMP [Imai et al., 1971] (Table 
1.4). 
It must be noted that, regardless of the structure/activity relationships (SAR) observed 
[Mizuta et al.,1972] only two N2-substituted GMPs, i.e., methyl- and dimethyl-
guanosine were submitted to sensory analyses indicating an activity comparable to that 
of GMP [Kuninaka et al., 1981]. For this reason, recently our research group 
investigated the synthesis and the MSG enhancing activity of N2-substituted 5’-guanylic 
acids [Cairoli et al., 2008]. 
 
 
1.7.1. Synthesis of N2-alkyl and N2-acyl derivatives of 5’-guanylic acid 
 
The synthesis of guanosine 5’-phosphates alkylated or acylated at the exocyclic amino 
group is reported in the Schemes 1.2 and 1.3. Proper reaction conditions were 
developed to optimize the yields of the desired products. In all cases 
2’,3’-O-isopropylidene protected guanosine was used as starting material. 
 
Scheme 1.2. Synthesis of N2-alkyl derivatives of 5’-guanylic acid 
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Alkylation was carried out in two steps by reaction of the protected nucleoside 1.17 
with an aldehyde and p-thiocresol, followed by reduction of the resulting thioadduct 
[N2-[1-(p-tolylthio)alkyl]-guanosine] 1.18 with NaBH4 in ethanol. The intermediate 
nucleosides 1.19, obtained in satisfactory yields, were finally treated with phosphorus 
oxychloride in triethyl phosphate. 
The early introduced protecting group, which was suitable for the next phosphorylation, 
was then removed in the working up of the last reaction mixture giving rise to 
nucleotides. 
 
The N2-alkyl derivatives of 5’-guanylic acid we synthesized and tested for their 
synergistic effect with MSG are depicted in Figure 1.20. The replacement of the 
methylene group by a sulfur atom in the aliphatic chain linked to the exocyclic amino 
group (compounds 1.20b and 1.20c) was suggested by the SAR data previously 
observed for 2-alkylthio inosinic acids [Kuninaka et al., 1981; Imai et al., 1971] as well 
as taking into account the large variety of sulfur containing compounds which 
contribute to the flavor of many umami foods (meat, mushroom, onion, garlic and so 
on) [Kuninaka et al., 1980; Widder et al., 2000]. 
 
Figure 1.20. N2-alkyl derivatives of 5’-guanylic acid synthesized. 
 
Acylation of guanosine amino group, performed as reported in Scheme 1.3, was based 
on a preliminary silylation of 2’,3’-O-isopropylidene guanosine (1.17), followed by 
treatment of the reaction mixture with the specific acyl chloride at room temperature in 
one-pot procedure. Such a method is known as transient persilylation and allows to 
overcome the very low reactivity of the amino group of guanosine and the competition 
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of the nucleophilic oxygen atom in 6-position in the acylation reaction [Cairoli et al., 
2008]. In this way 2’,3’-O-isopropylidene-N2-acylated guanosines (1.22) were obtained 
in good yields and used for the final phosphorylation step which was carried out as 
previously allowing the simultaneous removal of the protecting group. 
 
Scheme 1.3. Synthesis of N2-acyl derivatives of 5’-guanylic acid. 
 
The guanylic acid derivatives we obtained by acylation of the amino group of guanosine 
are depicted in Figure 1.21. 
 
Figure 1.21. N2-acyl derivatives of 5’-guanylic acid synthesized. 
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1.7.2. Sensory testing 
 
The umami potential of the synthetic 5’-ribonucleotides 1.20a-e and 1.23a-f was 
estimated for their ability to enhance the taste intensity of MSG [Yamaguchi, 1998; 
Nagodawithana, 1995; Toyono et al., 2003]. For aqueous solutions containing MSG and 
a given purine 5’-ribonucleotide disodium salt a general equation (1.2) was proposed by 
Yamaguchi [1967]: 
y = u + γuv                    (eq. 1.2) 
where 
u is the concentration of MSG, 
v is the concentration of the purine 5’-nucleotide, 
y is the concentration of MSG alone in a solution equivalent in taste intensity to the 
mixture (u + v), and 
γ (conc-1) is a constant specific to the 5’-ribonucleotide present in the mixture which can 
be assumed to be indicative of the synergistic capacity of the nucleotide to increase the 
umami taste of MSG. 
We performed quantitative measurements of such taste enhancement using a panel of 
trained tasters and the “Probit method” to make the responses of panelists statistically 
valid. 
A solution named “fixed sample” containing MSG (u, 10.0 mM) plus the test compound 
(v, 0.4 mM) (pH 7.3) was compared, by the “sip and spit” procedure, with single 
solutions of MSG (five “reference samples” having concentrations determined in 
logarithmic equal steps at 40% intervals). 
Five pairs of the fixed sample and one of the 5 reference samples (40 mL in randomly-
coded glasses) were presented to each taster. Panelists were asked to indicate which in 
each pair had the stronger umami taste. The response for each reference sample was 
considered as positive when the fixed sample had the stronger taste. Replications were 5 
for each panelist, 
According to the Probit method, every percentage of positive responses was plotted as 
ordinate against the logarithm of the MSG concentration of the corresponding reference 
sample (plotted as abscissa) (Figure 1.22). The best straight line fitting the five points 
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on the coordinate plane was then calculated. For the percentage value of 50 read as 
ordinate, the abscissa of the line afforded the logarithm of the MSG concentration of a 
solution equivalent in taste to the fixed sample. Such concentration (y) allowed the γ 
value to be estimated from equation 1.2. 
 
Figure 1.22. Probit analysis carried out. 
 
 
The γ value of each N2-alkyl and N2-acyl derivative of 5’-guanylic acid was then 
referred to the γ value of IMP (measured with the same procedure), thus expressing the 
synergistic capacity as β [β being equal to γ (nucleotide) divided b γ (IMP)].  β values of 
the nucleotides we tested are reported in Figure 1.23. 
In the diagram shown in Figure 1.23 the capacities β of N2-substituted guanylic acids 
are plotted against the chain length of the substituent. At first glance a dependence of 
the glutamate taste enhancing activity on the chain length of both the alkyl and acyl 
substituent appears to be evident. In the range of 1 to 8 terms of the chain, including the 
sulfur atom, such an activity was found to be higher than that of GMP, reaching a 
maximum corresponding to about 6 times that of IMP for a number of terms equal to 5. 
Two additional features of SAR type may be noticed : the synergistic efficacy decreases 
slightly when an alkyl chain is replaced by the corresponding acyl substituent; on the 
contrary, it increases if a sulfur atom is inserted in the methylene chain. Such an 
increase results to be larger if the replaced methylene group is in δ rather than in 
γ position. 
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Figure 1.23. MSG-enhancing capacities of N2-substituted 5’-guanylic acids referred to IMP. n 
indicates the chain length of the substituent in the 2-position of the purine nucleus. 
 
It is well known that many flavoring and odoriferous natural compunds contain the 
sulfoxide function [Mithen, 2006]. For instance, some sulfides and the corresponding 
sulfoxides occur in plants of the genus Allium.  S-alkyl and S-alkenyl cysteines, their 
sulfoxides, and other derivatives from enzymatic degradations are responsible for the 
characteristic pungent odor of garlic and onion both in intact and crushed bulbs. 
 
 
Scheme 1.4. Sulfur compounds occurring in garlic and onion. 
 
Considering this fact, we prepared the sulfoxides of the guanylic acids bearing a sulfur 
atom inserted into the carbon chain of their N2-alkyl or N2-acyl substituents with the aim 
of comparing them to the corresponding sulfides for the ability to enhance the intensity 
of MSG taste [Morelli et al., 2010]. 
These componds were prepared using the same synthetic strategies of alkylation and 
acylation of the exocyclic amino group of guanosine described above. 
β = γ (nucleotide) / γ (IMP) 
R =
β n = 1
n = 4
n = 5
n = 6
n = 7 n = 8
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Oxidation of sulfides 1.28 to sulfoxides 1.29 was carried out as the last step, using 
hydrogen peroxide as reagent under neutral condition to give the desired product in 
quantitative yield (Scheme 1.5).  
If not commercially available, the sulfur-containing aldehydes 1.26 were prepared by 
reaction of the proper ω-bromo diethylacetal 1.24 with a thiol 1.25 followed by 
hydrolysis of the acetal function in the presence of the resin Amberlyst-15.   
 
Scheme 1.5. Synthesis of sulfoxides of N2-alkyl substituted 5’-guanylic acid. 
 
In the case of acyl derivatives, the sequence of reactions was similar to that previously 
described (Scheme 1.6). 
If not commercially available, the sulfur-containing carboxylic acids 1.32 were prepared 
by reaction of the proper omega-bromo ester 1.30 with a thiol followed by hydrolysis of 
the ester function as reported here.   
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Scheme 1.6. Synthesis sulfoxides of N2-acyl substituted 5’-guanylic acid. 
 
 
The sulfides and sulfoxides we prepared by using these strategies are shown in 
Figure 1.24. At present, only the first three sulfoxides of this list have been tested using 
the same sensory procedure as described before. 
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Figure 1.24. Sulfides and sulfoxides derivatives of 5’-guanylic acid synthesized. 
 
 
As shown in Figure 25, the synergistic activity of each sulfoxide toward MSG when 
expressed by its β value, resulted to be lower than that of the corresponding sulfide.  
However,  we noticed that in all cases, the perception of the glutamate taste appeared to 
be affected by some additional, but pleasant, sensory effect. 
A possible explanation of the lower β-values observed is that sensory analyses were 
carried out on the diastereoisomeric mixture of each sulfoxide (1.29a, 1.29b, 1.35a). In 
fact, it has been recently reported that the stereochemistry of the N2-substituent strongly 
influences the umami enhancing activity of a series of Maillard-modified guanosine 5’-
monophosphates [Festring et al., 2011a and 2011b].  
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Figure 1.25. MSG-enhancing capacities of sulfides and sulfoxides synthesized. 
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1.8. Functional Anatomy of the Taste System 
 
The organ primarily involved in taste perception is the tongue. Similar to stimuli of the 
other basic tastes, umami molecules interact with the apical membrane of specific 
sensor cells, namely, the taste receptor cells (TRCs) in the oral cavity. TRCs are not of 
neuronal origin, but are specialized epithelial cells [Behrens et al., 2011]. They are 
innervated by afferent nerves (transmitting towards the control nervous system) to 
transduce gustatory signals to the brain [Witt et al., 2003].  
TRCs are found together with other cells in small aggregates called taste buds which are 
the proximate sensory organs of taste. These onion-shaped structures contain about 50–
150 cells, including sensory neurons, that are embedded in the non-sensory epithelium. 
Fingerlike projections called microvilli, which are rich in taste receptors, project from 
one end of each sensory neuron to the surface of the tongue. Nerve fibers at the opposite 
end of each neuron carry electrical impulses to the brain in response to stimulation by 
tastants.  
Structures called papillae contain numerous taste buds. Taste buds are found in the 
three types of chemosensory papillae on the tongue: the fungiform papillae of the 
anterior tongue, the foliate papillae of the posterior tongue edges, and the circumvallate 
papillae of the posterior tongue (Figure 1.26) [Miller, 1995].  
Taste buds also occur numerously in the soft palate and are present in the pharynx, 
larynx, and epiglottis. Extralingual taste buds, however, are not organized in papillae 
[Sbarbati et al., 2004].  
 
Figure 1.26. Taste buds (left) are composed of 50–150 TRCs, distributed across different 
papillae [Chandrashekar et al., 2006] 
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Recent molecular and functional data have revealed that, contrary to popular belief, 
there is no tongue ‘map’ (Figure 1.27); indeed, responsiveness to the five basic 
modalities (bitter, sour, sweet, salty and umami) is present in all areas of the tongue 
[Chandrashekar et al., 2006] even if with slight differences in the local sensitivity. 
 
Figure 1.27. Classical tongue ‘map’ [Chandrashekar et al., 2006] 
 
The perception of taste begins with the interaction of “tasty” molecules with specific 
receptors present on the membrane of cells (TRCs) constituting the taste buds. This 
interaction causes electrical changes in taste cells that are transformed into chemical 
signals and converted to impulses to the brain. 
Detection of the gustatory world is mediated by several distinct classes of taste 
receptors and taste receptor cells (Figure 1.28). 
 
Figure 1.28. Mammalian Taste Receptors, Cells, and Ligands [Yarmolinsky et al., 2009] 
Interestingly, both sweet and umami tastes are sensed by heterodimeric G protein-
coupled receptors (GPCRs) assembled by the combinatorial arrangement of T1R1, 
T1R2, and T1R3 subunits [Nelson et al., 2001, 2002; Li et al., 2002]. 
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1.9. Umami taste receptors 
 
1.9.1. Taste-mGluR4 and mGluR1tr 
 
The discovery of umami receptors using methods of molecular biology is one of the 
recent highlights of taste research [Lindemann et al., 2002]. In 2000, a metabotropic 
glutamate receptor, similar to the mGluR4 receptor usually present in the brain, was 
found on the tongue, specifically in the taste buds. It is a G protein-coupled 
metabotropic receptor. The taste variety of mGluR4 has a truncated N-terminal region to 
which L-glutamate still binds, even if with reduced affinity (Figures 1.29A-1.29B). 
Presumably, the truncation adapted the receptor to the high glutamate concentration in 
food [Chaudari et al., 2000]. 
 
           
Figure 1.29. A) Structure of the metabotropic receptor of glutamate (GPCR). B) Predicted 
transmembrane topology of brain- and taste-mGluR4 showing the truncated extracellular N 
terminal domain followed by seven putative transmembrane helices [Chaudari et al., 2000]. 
 
Figure 1.30 shows the 5’ end of mGluR4 cDNA from taste papillae (lower lines) 
aligned with the corresponding region of mGluR4 cDNA from brain (upper lines). 
Amino acid (bold) and translated nucleotides (regular text) for each sequence are 
numbered. A stop codon (∆), in frame with the long open reading frame, is found within 
the novel region of the cDNA from taste tissue. Sequence identity between the two 
cDNAs begins abruptly at the codon for R291. 
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Figure 1.30. Alignment of mGluR4 cDNA 5' ends from taste papillae (lower lines) and 
brain (upper lines) [Chaudari et al., 2000]. 
 
Glutamate activates also a mGlu receptor related to the brain mGluR1 receptor 
(Figure 1.31). Taste mGluR stimulates maximal inward current at a higher L-glutamate 
concentration (25 mM) than that required by the brain type (0.1 mM) [San Gabriel, 
2007]. 
 
Figure 1.31. Glutamate in the binding site of mGluR1 receptor. Residues in contact with the 
L-glutamate side chain carboxylate are shown in red, and residues that contact the L-glutamate 
α-amino acid moiety are shown in green. [Figure from Li et al. 2002]. 
 
 
1.9.2. Umami receptor T1R1 - T1R3 
 
More recently, another umami receptor was discovered. Interestingly, this is a 
heterodimer built of the G protein coupled receptors T1R1 and T1R3 [Li et al., 2002; 
Nelson et al., 2002]. It is related to the sweet taste receptor, which belongs to the same 
family, being a heterodimer T1R2-T1R3 [Li et al., 2002; Nelson et al., 2001]. 
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Therefore, sweet and umami receptors have the subunit T1R3 in common. In mice the 
heterodimer T1R1-T1R3 responds to many amino acids contained in food, but in 
humans its response is preferentially to L-glutamate and it is the only known umami 
receptor sensitive to both glutamate and nucleotides [Nelson et al., 2002]. The T1R1-
T1R3 umami receptor is therefore a strong candidate for the synergistic effect between 
glutamate and guanosine or inosine described previously. As the T1R3 subunit of the 
dimeric receptor is in common with the umami and the sweet repeceptor, glutamate 
binding site should be on the T1R1 subunit of the umami receptor. Molecular dynamics 
calculations strongly support this hypothesis, revealing that glutamate binding to the 
T1R1 subunit is strongly favored, whereas glutamate binding on the T1R3 subunit 
occurs only transiently [Lopez Cascales et al., 2010]. Key ligand-binding residues of the 
mGluR1 metabotropic glutamate receptor (Figure 1.32) are conserved in T1R1 [Li et al, 
2002]. 
 
Figure 1.32. Sequence alignment of human and rat TRs with rat mGluR1. Potential 
transmembrane segments are boxed in blue. Glutamate-binding residues are highlighted 
following the color scheme of Fig. 3. [Figure from Li et al., 2002]. 
 
T1R receptors belong to the class C of GPCRs, along with metabotropic 
glutamatereceptors (mGluRs). The defining motif in all these receptors is an outer 
membrane N-terminal Venus flytrap (VFT) domain The VFT is connected to the 
transmembrane helical region through a cysteine-rich domain (Figure 1.33). The VFT 
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domain of C-GPCRs contains the ligand
subdomains, the N-terminal upper lobe and the lower lobe, that are connected by a 
3-stranded flexible hinge. 
Figure 1.33. General architecture of the mGluRs. EC, extra
intra-cellular [Modified from Tekanori 
 
The crystal structures of mGluR1 VFT domains (Figure 1.34) revealed that the bi
architecture can be in an open or in a closed conformation. Glutamate binding stabilizes 
both the active dimer and the closed conformation [Kunishima 
Figure 1.34. Structure of the Venus flytrap domain of mGluR1 receptor (PDB ID 1EWK) in the 
open (A) and closed (B) form [Kunishima 
Figure prepared with Chimera [Pettersen 
 
Zhang et al. [2008] built homology models of the T1R1 VFT domain in open and 
closed forms using available structures of mGluR1, mGluR3, mGluR7 from the Protein 
Databank. Despite low overall sequence identity (
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respect to mGluR1, residues near the hinge of the VFT domain that connect the 2 lobes 
and that coordinate the bound glutamate in the mGluR family of proteins are conserved 
(cfr Figure 1.32). Their assumption is therefore that the glutamate binding mode in 
T1R1 closely resembles that in the mGluR family of proteins. In their T1R1 model, the 
α-carboxylate group of glutamate makes hydrogen bonds with a group of residues close 
to the hinge of the flytrap and conserved in mGluRs, specifically to the backbone 
nitrogens of S172 and T149 and to the serine side-chain of S172 (Figure 1.35). The 
α-amino group of L-glutamate is coordinated by upper lobe S172 and lower lobe E301. 
The ring of Y220 in the lower lobe makes cation-π interactions with the amino group of 
L-glutamate. Results from mutagenesis analysis confirmed that residues S172, D192, 
Y220 and E301 are essential for glutamate binding, whereas the mutant T149A showed 
only a partially reduced activity [Zhang et al., 2008]. Notably, the charged residues that 
form both direct contacts to the side chain of L-glutamate and stabilizing contacts 
between the lobes in the closed form of mGluR1 are largely absent in T1R1, which 
could help to explain T1R1's lower affinity for L-glutamate than mGluRs [Zhang et al., 
2008]. 
 
Figure 1.35. Molecular model of T1R1 VFT domain. Key residues for L-glutamate (blue) and 
for IMP (red) binding. The VFT domain is oriented so that the opening to solvent is horizontal, 
with the upper lobe on the top and the lower lobe on the bottom. The flytrap hinge region is to 
the right, and the flytrap opening is to the left. L-glutamate (golden) is located deep inside the 
VFT domain near the hinge region, while IMP (green) is located close to the opening of the 
VFT domain [Zhang et al., 2008]. 
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The same authors mapped also the IMP binding site into the VFT domain of T1R1 
(Figure 1.35). In the proposed model, the phosphate group of IMP coordinate the 
positively charged residues that are on the two lobes of the VFT and are brought in 
proximity to each other when the VFT assumes the closed form. The identity of the 
involved residues was confirmed by site-directed mutagenesis analysis.  
The position and orientation of IMP relative to L-glutamate are further constrained by 
the shape of the active-site cleft of the flytrap domain and by the nature of residues 
lining the active-site cleft. In this model, L-glutamate is positioned deeper in the active-
site cleft, whereas IMP binds near the opening of the VFT vestibule between the two 
lobes (Figure 1.35), providing additional stabilizing interactions between the upper and 
lower lobes. The enhancement activity of IMP may be sufficiently explained by the 
binding of IMP adjacent to glutamate, stabilizing the closed form of the T1R1 VFT 
domain through electrostatic interactions [Zhang et al., 2008]. 
Insights into the energetics of VFT movements are available for an ionotropic glutamate 
receptor. Indeed, crystal structures exist for the mGluR1 VFT domain in the open 
conformation, showing glutamate bound to one lobe only (Figure 1.34A). The 
thermodynamic contributions of flytrap closure have been measured for the VFT 
domain of ionotropic glutamate receptor iGluR2, revealing fast (≈µs) binding of 
glutamate (docking) followed by slow (≈ms) stabilization of the closed form (locking) 
[Lau & Roux, 2011]. A two-step mechanism for flytrap closure was therefore proposed. 
In the first step, glutamate binds to one lobe and lowers the entropic barrier to form the 
closed conformation. In a second step, the lobes close up and facilitate interactions 
between glutamate and the lower lobe, as well as interactions between the upper lobe 
and the lower lobe. A dynamic picture of the synergic action of glutamate and purine 
ribonucleotides towards the T1R1 receptor is due to Mouritsen et al. [2012]. Analysis of 
the trajectories of molecular dynamic simulations up to 150 ns showed that the receptor 
assumes the closed conformations upon binding with glutamate, and the aperture of the 
VFT is further closed when GMP is present, confirming the stabilization of the closed 
(active) conformation due to the binding of GMP (Figure 1.36). 
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Figure 1.36. The vestibule leading to the GMP-binding site and thereafter the L-glutamate-
binding site is color-coded based on to the radius of the largest fitting spherical probe (blue, 
wide; green, medium; red narrow), calculated using the program HOLE. The simulation 
snapshots are taken from the final conformations of the Glu and GMPGlu simulations. The 
radius of the vestibule is significantly reduced (red) in GMPGlu close to the GMP-binding site 
[Mouritsen et al., 2012]. 
 
It is further interesting to note that, in some simulations with GMP, the first principal 
mode of protein motion is not closure and opening of the VFTD, but a twisting motion 
around an axis different from the VFTD hinge axis, suggesting that the movement of the 
VFTD that switches the protein between active and inactive conformations is 
significantly dampened by addition of GMP. In simulations without any bound ligand, 
the protein accesses conformations where the two lobes of the VFTD are separated even 
further than observed in crystal structures of mGluR1s, although it cannot be exclude 
the possibility that the excess conformational freedom may be a consequence of the 
simulation. On the other hand, it is possible that the VFTD of the full umami receptor is 
very flexible, perhaps more so than the mGluR1 family of proteins. The single most 
important phenomenon explained by the simulations is that the presence of nucleotides 
enhances the sensation of the umami taste. The simulations show that the presence of 
GMP further stabilizes the closed (active) state of the protein once glutamate is bound. 
An inherent assumption in this analysis is that GMP binds after glutamate. As GMP 
binds at the entrance of the binding cleft, it is very likely that binding of GMP will be 
enhanced if glutamate is already bound, because the upper and lower lobes of the VFTD 
will be closer, and will be optimally positioned for GMP to bind. Furthermore, if GMP 
bound first, it would sterically block the entrance to the VFTD vestibule, and prevent 
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access of glutamate to the glutamate-binding site. Thus, it may be that, when both 
ligands are available, GMP binding after L-glutamate is more likely than the other way 
around. 
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2. AIMS 
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Aims of this PhD thesis are: 
 
1. Valorization of agri-food industry waste rich in proteins as starting 
material to produce HVPs 
 
Proteins are key ingredients in many foods as they contribute to the nutritional value, 
flavor and other important functional properties of food systems [Giese, 1994]. Protein 
hydrolysates constitute an alternative to intact proteins in the development of special 
formulations designed to provide nutritional support to individuals with different needs, 
such as patients with particular physiological and nutritional needs or unable to ingest 
adequate amounts of food in a conventional form. Protein hydrolysates are also utilized 
extensively as a source of nutrition to the elderly, young children and 
immunocompromised people. These products have an added advantage in having 
peptides that are small enough to circumvent possible allergenic reactions occurring 
with the consumption of larger size peptides or proteins [Nagodawithana, 2010]. 
For these reasons, there is a growing interest for Hydrolyzed Vegetable Proteins (HVPs) 
containing bioactive peptides because of their nutritional and therapeutic properties.  
HVPs are produced by chemical and/or enzymatic hydrolysis of vegetable raw materials 
rich in proteins, such as wheat, corn, soybean, peanut, sunflower. The most effective 
way to obtain protein hydrolysates with defined characteristics is the use of different 
proteases (endopeptidases and exopeptidases) coupled with the development of post-
hydrolysis procedures [Clemente, 2000]. The origin of the starting material and 
conditions of hydrolysis determine the biological as well as organoleptic properties of 
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the end product. In fact, these products have been widely used for centuries as flavor 
enhancers for their glutamate-like “umami” taste, particularly in typical Eastern 
vegetarian cuisine, as an alternative to glutamate. Other peculiarities of HVPs, such as 
antioxidant and antiinflammatory properties [De Carvalho-Silva et al., 2012], 
antihypertensive effect [Li et al., 2007], and antifungal activity [Joo et al., 2004], are 
rigidly controlled by proper selection and blending of the protein source and appropriate 
selection of hydrolytic conditions.  
 
Substantial amounts of protein-containing waste are generated in the production of 
foods and beverages. Examples include vinasse (from sugar beet or cane), distiller’s 
grains with solubles (from wheat or maize), press cakes (from oil seeds), fish silage, 
proteins from coffee and tea production, and agricultural residues from various crops. 
Much of this protein material is currently processed as animal feed although it could be 
valorised as a feedstock for production of high value added chemicals. 
Since the early 1990s, attention has been diverted from waste remediation to waste 
prevention, with the emphasis on applying the principles of “green chemistry” 
(“prevention is better than cure”) [Tuck et al., 2012]. 
In recent years great attention has been focused on the exploitation of those wastes that 
are largely unavoidable i.e. on ways of getting higher value from the waste using proper 
“waste valorization” strategies. Because the sources of waste are so diverse, it is 
convenient to consider the chemistry in terms of four source-independent categories: 
polysaccharides, lignin, triglycerides (from fats and oils), and proteins. Lignin is 
challenging to break down into chemically useful fragments. By contrast, pretreatment 
of polysaccharides, triglycerides, and proteins can lead to their constituent building 
blocks: monosaccharides, fatty acids plus glycerol, and amino acids, respectively. 
Among wastes from agri-food industry rich in proteins, rice middlings (a by-product of 
the conversion of raw rice into white rice) as well as the seeds of hemp and flax (after 
the extraction of the oil) have not yet been exploited and deserve further valorization 
according to the concept of biorefinery. 
IEA Bioenergy Task 42 [IEA, 2008] defines biorefineries as the sustainable processing 
of biomass into a spectrum of marketable products and energy. The biorefinery concept 
embodies the concepts of system integration, multiple products, and sustainability. It 
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includes a wide range of technologies able to separate biomass3 resources (wood, 
grasses, corn, …) into their building blocks (carbohydrates, proteins, triglycerides, …) 
which can be converted to value added products, biofuels and chemicals. A biorefinery 
is a facility (or a network of facilities) that integrates biomass conversion processes and 
equipment to produce transportation biofuels, power, and chemicals from biomass. This 
concept is analogous to today’s petroleum refinery, which produces multiple fuels and 
products from petroleum [Cherubini, 2010; Wellish et al., 2010]. 
 
Biorefineries are emerging around the world in a variety of different forms and sizes. 
Their development depends on the demand for given products, the availability of 
biomass feedstock, the existing infrastructure and know-how, the level of investment in 
research and scale-up facilities, public acceptance, and policies that support the 
transition to a greener, more efficient hybrid economy [Wellish et al., 2010]. In the 
United States, it is expected by 2020 to provide at least 25% (compared with 1994) of 
organic carbon-based industrial feedstock chemicals and 10% of liquid fuels from a 
biobased product industry. This would mean that more than 90% of the consumption of 
organic chemicals in the United States and up to 50% of liquid fuel needs would be 
covered by biobased products4 [Kamm & Kamm, 2004]. 
 
It must be pointed out that investigation of hempseed and flaxseed as raw materials for 
the preparation of HVPs was carried out in the frame of VeLiCa Project (“From ancient 
crops materials and products for the future”), funded by Regione Lombardia (Italy).  
The main goal of the VeLiCa project is to make again gainful the growing of flax and 
hemp in Regione Lombardia where it used to be widespread at the beginning of the 20th 
century. This target is being pursued by the exploitation of all the parts of the plant to 
make different products with different added value (biorefinery) [www.velica.org]. 
                                                           
3
 Renewable resources also known as biomass are organic materials of biological origin 
and are, by definition, sustainable natural resources. Sustainable implies that the resource 
renews itself at such a rate that it will be available for use by future generations. 
4
 Fossil carbon sources, such as petroleum and natural gas, should be replaced by a 
renewable raw material: biomass, particularly plant biomass. The corresponding products will 
be called “biobased products” and “bioenergy”. The fundamental basic technology, which will 
be introduced in “biorefineries”, as new production plants, will replace petroleum-based 
refineries. In fact, the term “bioeconomy” will be used.  
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2. Synthesis of glutamate-ribonucleotide hybrids for the study of 
umami taste 
 
Umami taste is an essential element in our appreciation of food and is imparted by 
monosodium L‐glutamate (MSG) and disodium salts of 5′‐ribonucleotides such as 
inosine 5′‐monophosphate (IMP) and guanosine 5′‐monophosphate (GMP). These 
compounds are currently used as flavor enhancers to supplement, increase and round off 
the flavor of many savory‐based processed foods. They are the best flavor enhancers 
that are in commercial use worldwide.  
A very important peculiarity of MSG and the above‐mentioned 5′‐ribonucleotides is 
their capacity to interact synergistically. Such interactions generate amplified and 
lingering taste sensations, far greater than any single ingredient can produce. Thus, the 
phenomenon is of great relevance for the food industry, because it provides an 
opportunity for the food processor to use a ternary varying mixture of MSG, IMP and 
GMP to enhance the flavor, mouthfulness and palatability of culinary products 
[Ninomiya, 2002]. 
Despite extensive investigations on taste receptors, the mechanisms of perception, 
flavor enhancement, and synergism connected with umami substances have not been 
completely elucidated at a molecular level. 
Recently, to assess the role played by substituents of the purine nucleus of 
5’-ribonucleotides in eliciting a synergism with MSG, a number of N2-alkyl N2-acyl 
derivatives of guanosine 5’-phosphate was synthesized by our research group through 
alkylation and acylation of exocyclic amino group of guanosine. These compounds 
were finally evaluated for their capacity to enhance the taste intensity of MSG [Cairoli 
et al., 2008; Morelli et al., 2011]. 
As described in section 1.9.2., Zhang et al. [2008] suggested a possible explanation of 
the phenomenon of synergism at a molecular level in which both glutamate and IMP (or 
GMP) would interact with the extracellular domain of umami receptor, the so-called 
“Venus flytrap” (VFT), but at different sites. The binding of MSG would induce the 
closure of this domain, whereas the binding of 5’-ribonucleotide would stabilize the 
closed conformation thus determining the synergistic effect. 
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According to this model, to gain further insight into the phenomenon of synergism, we 
planned to synthesize hybrid compounds containing the two umami moieties (glutamate 
and purine 5’-ribonucleotide) covalently connected through flexible linkers of variable 
length with the aim to reach both umami receptor sites through a single molecule 
(Figure 2.1). 
 
Figure 2.1. 
 
The first hybrids synthesized (Figure 2.2) were obtained by N2-acylation of the 
exocyclic amino group of guanosine with several linkers of variable length [Cairoli et 
al., 2008]. The linker was condensed with the α-amino group of glutamic acid.  
 
 
Figure 2.2. 
 
However, in these compounds the α-amino group of glutamic acid, which is involved in 
the activation of the umami receptor, according to Zhang model, was locked into the 
binding with the linker. Furthermore, the poor yields obtained prompted us to pursue an 
alternative strategy in which the linker is condensed with the γ-carboxylic group of 
glutamic acid (Figure 2.3). 
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Figure 2.3. 
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3. RESULTS AND DISCUSSION 
PART 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
 
 
 
  
61 
 
3.1. Preparation of HVPs from Rice Middlings through 
Enzyme-catalyzed Hydrolysis 
 
 
 
 
 
 
 
Rice is a very important agricultural resource mainly utilized for food [Bagnasco el al, 
2013]. Rice feeds almost half the world's population and is one of the most attractive 
feed ingredients in the world [Ferrari et al., 2009]. In addition, a variety of interesting 
by-products are obtained when converting raw rice into white rice, such as rice hull, 
bran, middlings, embryo and small brokens. Although an extensive commercial use of 
these by-products would be of great interest for a series of reasons, today a relatively 
small amount of this material is utilized. In fact, these by-products contain excellent 
quality components (proteins, fibers, vitamins and minerals) whose nutritional and 
pharmaceutical potential has been well recognized [Saunders, 1990]. Meaningfully they 
are a renewable resource and their use can reduce waste problems. In particular, rice by-
products have a high content of amino acids, such as glutamic and aspartic acid, as well 
as amides, which makes these matrices a potential source of flavor enhancers for food 
applications [Hamada et al., 2008]. 
Rice by-product proteins obviously need to be isolated and purified for their utilization 
as food stuff, but to date an efficient and reliable method has not yet been developed. 
The procedure traditionally adopted for the extraction of proteins from rice as well as 
from other complex plant matrices, such as industrial by-products, is alkaline treatment 
[Gnanasambandam & Hettiararchchy, 1995; Wang et al., 2008]. However, this method 
could induce side-reactions, such as hydrolysis and extraction of non-protein 
components, and protein denaturation with obvious effects on their functional properties 
[Kinsella, 1981]. 
To overcome those drawbacks, alternative physicochemical [Anderson & Guraya, 2001; 
Van Der Borght et al., 2006] and/or enzymatic [Hamada et al., 1998; Tang et al., 2002] 
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procedures were developed to improve the recovery of rice and its by-product proteins. 
Typically, enzymatic procedures are preferable owing to milder process conditions, 
easier control of reaction parameters and minimum formation of secondary products 
[Manneheim & Cheryan, 1992]. In most cases, enzymatic hydrolysis was also used in 
order to improve the functional properties of proteins or customize the functionality of 
some proteins for specific needs [Arzu et al., 1972; Kim, Park, & Rhee, 1990].  
Developing a protocol as quick and easy as possible for producing protein–peptide 
mixtures with flavor-enhancing properties from rice middlings could be useful to 
produce new functional ingredients with a significant umami taste for food industry. 
 
 
3.1.1. Characterization of protein hydrolysates 
 
3.1.1.1. SDS-PAGE analysis 
 
The SDS-PAGE profiles and the corresponding densitograms obtained after hydrolysis 
performed on rice middlings in presence of Umamizyme and Flavourzyme are detailed 
in Figures 3.1 and 3.2, respectively.  
A spontaneous degradation of proteins, without the addition of an enzyme, could be 
observed in comparison with the control lanes. This could be dependent on the presence 
of intrinsic proteases in the matrix not inhibited through preliminary process, such as by 
heating at high temperature [Hamada, 2000b]. Since the goal of this work was the 
development of a hydrolytic method as quick and easy as possible, aimed at an 
industrial application, the decision was made not to stabilize the matrix by heating or by 
use of antiproteolytic agents, since protein degradation, spontaneous or induced, was the 
main purpose of this work. An overall comparison between control and treated samples 
showed that the intrinsic proteolytic action primarily affected the high molecular mass 
bands (from 200 to 30 kDa), while the added enzymes degraded the bands at medium-
low molecular mass (<30 kDa). 
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Figure 3.1. SDS-PAGE profile of protein fractions obtained at different sampling times during 
the hydrolysis of rice middlings by Umamizyme (hydrolysis parameter: pH 7, 45 °C). Lanes 1–
3–5–7 are rice middlings samples incubated in the presence of Umamizyme for 1, 5, 11, 24 h, 
respectively; lanes 2–4–6–8 are rice middlings samples incubated in the absence of 
Umamizyme for 1, 5, 11, 24 h, respectively. M represents the protein molecular mass marker 
(97, 66, 45, 30, 20.1, 14.4 kDa). Plot on the side of the picture shows changes in optical density 
of main proteins during enzymatic reaction. Letters of the curves (A to H) identify the main 
protein fractions studied. Only five profiles out of eight are represented on the plot due to the 
overlapping of degradation profile of B, C, E and F proteins. Below are represented the single 
protein trends for a clearer interpretation of each degradation profile. 
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Figure 3.2. SDS-PAGE profile of protein fractions obtained at different sampling times during 
the hydrolysis of rice middlings by Flavourzyme (hydrolysis parameter: pH 8, 50 °C). Lanes 1–
3–5–7 are rice middlings samples incubated in the presence of Flavourzyme for 1, 5, 11, 24, 
respectively; lanes 2–4–6–8 are rice middlings samples incubated in the absence of 
Flavourzyme for 1, 5, 11, 24 h, respectively. M represents the protein molecular mass marker 
(97, 66, 45, 30, 20.1, 14.4 kDa). Plot on the side of the picture shows changes in optical density 
of main proteins during enzymatic reaction. Letters of the curves (A to H) identify the main 
protein fractions studied. Below are represented the single protein trends for clearer 
interpretation. 
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In order to verify the performance of the two hydrolytic enzymes, a comparison 
between protein patterns obtained by Umamizyme and Flavourzyme was performed. In 
the case of Umamizyme, a hydrolysis of the main protein fractions was observed, as 
evidenced by the quick and general decrease of optical density showed by most bands. 
In contrast, the catalytic activity of Flavourzyme resulted in a lower and slower 
decrease of optical density. In particular, after 1 h, the sample treated with Umamizyme 
was already different from the control sample, since the high molecular mass bands 
were completely hydrolyzed, whereas in the presence of Flavourzyme, at least 5 h were 
necessary to have differences between control and treated sample, since all the main 
bands were not hydrolyzed in the early times of incubation. After 11 h of incubation, the 
two enzymes showed a comparable behavior: the protein bands with medium-low 
molecular mass and some high molecular mass subunits (labeled with “D” in Figure 3.1, 
in the case of Umamizyme and “A”, “C” and “D” in Figure 3.2, in the case of 
Flavourzyme) persisted, while most high molecular bands disappeared. After 24 h of 
incubation, the greater effectiveness of Umamizyme emerged again, with which only 
three defined bands (“D”, “G” and “H” in Figure 3.1) were not hydrolyzed, while with 
Flavourzyme the lower part of the gel was still completely marked by protein elements.  
The total lane integrated optical density (IOD) reflects the contribution of each protein 
bands to the lane IOD total and provides a global value of protein degradation [Frazer & 
Bucci, 1996]. The total lane IOD confirmed that Umamizyme has a greater catalytic 
activity than Flavourzyme (Figure 3.3). With Flavourzyme the total IOD of protein 
bands decreases significantly compared to the control sample with increased time of 
hydrolysis from 1 to 24 h, while with Umamizyme a short time is sufficient to show a 
significant decrease of total IOD of protein bands. 
The higher hydrolytic efficacy of Umamizyme compared to Flavourzyme was 
illustrated by the measure of the degree of hydrolysis by the Coefficient of Protein 
Degradation (CPD), calculated for each time on the basis of the optical density of the 
main protein bands defined in Figures 3.1 and 3.2 (Table 3.1). A significant difference 
between the two enzymes was shown for each incubation time. After 1 h of incubation, 
it could be noticed that Umamizyme had a 2-fold higher protein degradation compared 
to Flavourzyme (15.69±2.52 % and 6.21±3.75 %, respectively), a trend that seemed to 
be maintained even for the successive times. After 24 h of incubation, it became 
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apparent that Flavourzyme lead to partial proteolysis, with 24.84±1.28% protein 
degradation. In contrast, with Umamizyme the proteolysis of protein content was almost 
complete, with a CPD of 67.04±0.55%. 
 
Figure 3.3. Integrated Optical Density (IOD) of protein fractions obtained at different sampling 
times during the hydrolysis of rice middlings by Umamizyme (hydrolysis parameter: pH 7, 
45 °C) and Flavourzyme (hydrolysis parameter: pH 8, 50 °C). Values represent means±SE 
(n=2). The data were evaluated using one-way analysis of variance followed by Tukey's post-
hoc test. Different characters (a–c) on the top of the columns indicate a significant different 
(p<0.05) among IOD value of hydrolysates obtained without enzyme, with Umamizyme or with 
Flavourzyme at a specific sampling time. 
 
Table 3.1. CPD of rice middlings after enzymatic hydrolysis with Umamizyme and 
Flavourzyme.  
Time (minutes) CPD (%)* 
Umamizyme Treated Flavourzyme Treated 
60 15.69±2.51 a 6.21±3.75 a 
300 27.27±0.76 a 8.79±1.15 b 
660 42.86±2.05 a 17.37±2.11 b 
1440 67.04±0.55 a 24.84±1.28 b 
* Values represent means±SE (n=2). Within the same row, different characters 
(a-b) indicate significant difference with p<0.05 among various samples at a 
specific hydrolysis time. 
 
The higher hydrolytic capability of Umamizyme compared to Flavourzyme was already 
reported by Villafuerte Romero [2006] in an enzymatic modification of wheat proteins 
for flavor generation, but so far a definitive explanation has not been proposed to clarify 
the different performance of the two enzymes.  
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3.1.2. Functional properties 
 
3.1.2.1. Emulsifying properties 
 
The emulsifying activity index (EAI) and the index of stability of the emulsion (ESI) of 
selected hydrolysates were analyzed and they are shown in Figures 3.4A-3.4B, 
respectively. 
The samples obtained after 24 h of incubation with Umamizyme and Flavourzyme 
showed a similar pH-dependent EAI profile. All the samples showed a minimal EAI 
value at acidic and neutral pH, while a higher value was found at pH 9 (Figure 3.4A). 
This behavior is in agreement with a previous study on the hydrolysis of vegetable 
matrices [Yin et al., 2008]. A comparison between emulsifying activity of hydrolysates 
obtained with Umamizyme and Flavourzyme and the sample control showed that 
enzymatic hydrolysis using Flavourzyme led to significant declines in EAI at acid and 
neutral pH. In contrast, the use of Umamizyme did not show a significant difference, 
regardless of the pH value. These data may imply that Umamizyme produces 
hydrolysates with an emulsifying index similar to control sample, but with better 
emulsifying activity compared with hydrolysates obtained using Flavourzyme. The 
better performance of Umamizyme hydrolysates respect to Flavourzyme peptides could 
be related to the higher proteolysis induced by the treatment with Umamizyme 
compared to Flavourzyme. This could account for the lower availability of the free 
amino acid residues and the subsequent lower surface activity responsible for the 
emulsifying capacity. As shown by the SDS-PAGE electrophoresis, the production of 
peptides in Umamizyme was higher than Flavourzyme proteolysis. The emulsifying 
index no higher than control sample can be due to the formation of the aggregates in the 
hydrolysates. It might inhibit the formation of a viscoelastic membrane on the 
oil-in-water surface, thus increasing the oil droplets coalescence [Gbogouri et al., 2004; 
Yin et al., 2008]. Previous studies about rice protein can confirm the aggregates 
formation in this matrix [Wang et al., 1999; Kumagai et al., 2006].  
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Figure 3.4. Emulsifying activity index (EAI) (A) and emulsion stability index (ESI) (B) of rice 
middlings hydrolysates after 24 h of incubation with Umamizyme (hydrolysis parameter: pH 7, 
45 °C) and Flavourzyme (hydrolysis parameter: pH 8, 50 °C). Values represent means±SE 
(n=2). Different characters (a–b) on the top of columns indicate a significant difference (pb0.05) 
among EAI (A) or ESI (B) value of hydrolysates obtained without enzyme, with Umamizyme or 
with Flavourzyme at a specific pH value. 
 
Enzymatic hydrolysis significantly decreased the ESI values at acidic pH, while no 
significant effect was observed at alkaline and neutral pH (Figure 3.4B). These effects 
were already reported by Yin et al. [2008], but so far a definitive explanation has not 
been proposed to clarify the pH dependence of ESI values.  
 
 
3.1.2.2. Foaming properties 
 
Foaming capacity (FC) and foam stability (FS) were determined at pH 7.0. Table 3.2 
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and Flavourzyme on the FC and FS of rice middlings. Enzymatic hydrolysis led to 
significant decreases in FS, while it seemed to have no significant effect on FC. In 
particular, hydrolysates obtained with Flavourzyme showed no foam stability: the foam 
disappeared after less than 30 min. This effect could be due to the lack of formation of a 
thick, cohesive, and viscoelastic film around gas bubbles that prevented the foams from 
collapsing [Damodaran, 1990; Halling, 1981]. 
 
Table 3.2. Foaming capability (FC) and foam stability (FS) of rice middlings hydrolysates after 
1440 minutes of incubation with Umamizyme and Flavourzyme.  
Sample FC (%)* FS (%)* 
Control 75±12.12 a 30±8.01 a 
Flavourzyme Treated 45±7.07 a 0±0.00 b 
Umamizyme Treated 65±6.70 a 15±0.57 a,b 
* Values represent means±SE (n=2). Within the same column, different 
characters (a-b) indicate significant difference with p<0.05 among various 
samples. 
 
It has been shown that the molecular properties of proteins required for good FC and 
good FS differ [Cheftel et al., 1985]. The basic requirement for a protein to be a good 
foaming agent is the ability to rapidly adsorb at the air–water interface during bubbling, 
undergo rapid conformation change and rearrangement at the interface, and form a 
cohesive viscoelastic film via intermolecular interaction. Thus, the decreases in chain 
length of peptides as a result of enzymatic hydrolysis may mainly account for the 
decreases in FC and FS. The result is consistent with the general viewpoint that the 
larger the molecular size of a protein, the higher the foaming stability [Damodaran, 
1997]. 
The good foaming ability of the hydrolysates may be explained by an increased 
interactions between peptides due to their secondary and tertiary structures and resulting 
in greater flexibility of the chains. It has been reported that foaming capacity is favored 
when proteins have more flexible random coiled structure [Damodaran, 1990; Halling, 
1981]. Moreover, the good foaming activity present in our samples may due to the 
medium-low molecular mass protein bands identified by electrophoretic analysis of 
both the hydrolysates. 
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3.1.3.  Sensory analysis 
 
SDS-PAGE analysis showed good proteolytic efficiency through the direct use of food-
grade protease Umamizyme and Flavourzyme on rice middlings. By this procedure, the 
hydrolysates, that are intended for human food, do not derive from a “conventional” 
chemical process, such as treatments with reducing or denaturant agents, but protein 
extraction and protein hydrolysate production occur at the same time through the same 
biotransformation. 
In order to evaluate the sensory characteristics of protein–peptide mixtures, the 
hydrolysates obtained after 24 h of incubation with Umamizyme and Flavourzyme were 
lyophilized and tested by a team of selected and certified panelists.  
Figure 3.5 shows the average taste intensity of the five main flavors for the two 
hydrolysates analyzed and MSG, as reference substance for umami taste. 
Overall, the umami taste was the more intense attribute for both hydrolysates, indicating 
the good sensory quality of the products. In addition, the ANOVA revealed that there 
was no significant difference (p<0.05) of umami taste between recovered protein 
hydrolysates and MSG. 
 
Figure 3.5. Taste profiles of MSG and rice middling hydrolysates after 24 h of incubation with 
Umamizyme and Flavourzyme. Each value represents the averaged taste intensity scored on a 
10-point category scale by five panelists. In the figure the results are represented with a reduced 
scale for easier interpretation. 
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The bitter taste was slightly present in hydrolysates, as previously suggested by the 
hydrolysis of vegetable matrices for long times [Hamada, 2000b]. However, this taste 
did not prevail on the umami taste, since Umamizyme and Flavourzyme cut terminal 
hydrophobic residues [Pommer, 1995], responsible for the bitter taste. A little sweet 
taste, meaning pleasantness of taste sensation, was present in both hydrolysates, 
particularly using Flavourzyme, while a hint of acidity was characteristic of hydrolyzed 
with Umamizyme. These secondary tastes did not alter taste sensation and they may be 
at the basis of flavor defined for the hydrolysates. This typical flavor is named 
“amaretto”, that is detected in some typical Italian products, such as almond and apricot 
based products. This flavor is pleasant, comfortable and soft on the palate. Finally, salty 
taste, present in MSG reference sample, was completely negligible in the hydrolysates. 
This seems to confirm that the flavor enhancement observed in our hydrolysate samples 
can be ascribed to umami taste and not salty compounds. 
The described enzyme-assisted aqueous extraction method could be useful to obtain 
protein–peptide mixtures from rice middlings as raw material with sensory properties. 
The straightforward approach proposed allows to obtain hydrolysates characterized by 
high umami and slightly bitter taste, revealing the good performance of our protocol to 
gain tasty quality products. Thus, the taste profile of our hydrolysates suggests that the 
proposed approach can be an effective, quick and easy process to produce new umami 
flavor enhancers from under-utilized industrial products. The potential food industry 
application can be favored by the functional properties as emulsifying and foaming 
agents mainly observed in Umamizyme-derived protein–peptide mixtures. This 
highlights the versatility of the proposed protocol and thus the possibility of using the 
same process for different applications. 
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3.2. Preparation of HVPs from Hempseed through Enzyme-
catalyzed Hydrolysis 
 
 
 
 
 
 
 
Cannabis sativa, an annual, dioecious herbaceous plant, has been an important source of 
food, fiber, dietary oil and medicine for thousands of years in Europe, Asia and Africa 
[Callaway, 2004]. Its cultivation has been prohibited in many countries, due to the 
presence of the phytochemical drug component delta-9-tetrahydrocannabinol (THC) 
[Oomah et al., 2002]. However, in the last decades the renewed interest for natural, 
biological and ecological products brought to the harvest reintroduction of the varieties 
of C. sativa L., containing less THC than common hemp, in the european and american 
agriculture especially because of hemp seeds properties. 
The seeds of C. sativa L., commonly referred to ‘hempseed’, are an excellent source of 
nutrition [Callaway, 2004]. Hempseed has been documented as a source of food 
throughout recorded history – raw, cooked or roasted, and its oil has been used as a 
food/medicine for at least 3000 years [Callaway, 2004]. Hempseed are an important 
source of essential fatty acids, dietary fiber, vitamins and minerals, and in particular are 
an excellent dietary source of easily digestible, gluten-free protein. Their overall protein 
content of about 35% (mainly edestin and albumin) is higher, or comparable to, that of 
soy. Moreover, hempseed protein content is superior to that found in nuts, other seeds, 
dairy products, meat, fish, or poultry. Hemp proteins are very nutritional and provide a 
well-balanced array of all essential amino acids for humans [Wang et al., 2008]. An 
important aspect of hemp seed proteins is a high content of arginine and histidine, both 
of which are important for growth during childhood, and of the sulfur-containing amino 
acids methionine and cysteine, which are needed for proper enzyme formation. Hemp 
proteins also contain relatively high levels of the branched-chain amino acids that are 
important for the metabolism of exercising muscle. For these properties, hemp proteins 
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are of interest in new value-added products. Furthermore, HVPs from hempseed have 
good potential to be applied as a valuable source of proteins for human nutrition as well 
as products to be investigated for their potential in several market sectors (food, pharma, 
cosmesis). 
 
 
3.2.1. Hempseed meal: defatting and protein extraction 
 
Hempseed protein extraction was carried out according to the protocol described by 
Tang et al. (2006) with a few modifications. Hemp seeds were ground using a home-
style grinder, defatted by stirring with n-hexane and air-dried. The organic phase was 
dried s.v. at 30 °C and the composition of the resulting dark yellow oil (yield=30±5%) 
with regard to fatty acid content was assessed at the University of Pavia by GC-FID 
analysis according to a well-established protocol [FIL-IDF International Dairy 
Federation, 1999. Milk Fat. Preparation of fatty acid methyl esters. Standard 182:1999. 
IDF, Brussels, Belgium]. The hempseed meal, about 65-70% of the starting material, 
was used for protein extraction by alkali solubilization/acid-precipitation methods using 
two different approaches. According to the former process, as described by 
Wang et al. [2008], NaOH was used for alkali extraction and the resuspended proteins 
were precipitated with HCl. In the latter method, NH3 and HCOOH were used instead 
of NaOH and HCl, respectively, in order to avoid the presence of NaCl in the final 
product. In both cases proteins were extracted using a base, NaOH in the first case and 
NH3 in the second case, and precipitated using an acid, hydrochloric acid and formic 
acid, respectively. In both cases recovered protein precipitates were resuspended in 
distilled water. The resulting solutions were dialyzed using a 3500 MWCO membrane, 
and finally freeze-dried. An aliquot of this product was analyzed by 1H NMR 
spectroscopy (1D 500 MHz, pH 7, 37 °C).  
From the inspection of 1H NMR spectra of the proteins extracted by NH3/HCOOH or 
NaOH/HCl treatment it clearly appears that both the protocols allowed the extraction of 
the same proteins, as depicted by 1H NMR spectra overlapping (Figure 3.6). The 
presence of signals in the 3-4 ppm range can be ascribed to the presence of sugars. The 
widened signals suggest the presence of unfolded proteins, probably glicoproteins that 
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might be precipitated upon the extraction process. Figure 3.7 shows that a higher 
amount of sugars was obtained when NaOH/HCl extraction was performed. 
 
Figure 3.6. 1D 1H NMR performed using a 500-MHz NMR instrument at pH 7 and 37 °C. 
Comparison of 1H NMR spectra of the proteins extracted by NH3/HCOOH (above) or 
NaOH/HCl (below) treatment. 
 
Figure 3.7. Overlapping of 1H NMR spectra of the proteins extracted by NH3/HCOOH (blue) 
and NaOH/HCl (black) treatment. 
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3.2.2.  Enzymatic Hydrolysis - SDS–PAGE  
 
3.2.2.1. SDS–PAGE of protein extract 
 
The SDS-PAGE (sodium dodecyl sulphate-polyacrylamide gel electrophoresis) profiles 
of hempseed protein constituents in the presence and absence of 2-mercaptoethanol (2-
ME) are depicted in Figure 3.8. The estimated molecular weights and the relative 
contents of the different subunits are reported in Table 3.3. 
Hempseed proteins include a kind of legumin, the so-called “edestin”. Edestin is the 
major storage protein of hemp seed and accounts for about 60-80% of the total protein 
content; whereas the second most abundant protein is the globular protein albumin. 
Edestin is easily digested and contains all essential amino acids for humans [Callaway, 
2004]. This protein was reported to be similar to serum globulins, and could be 
metabolized in the human body to biosynthesize immunoglobulins, hormones, 
haemoglobin, and enzymes [Tombs, 1960]. Using crystallographic techniques Patel et 
al. [1994] showed that, like the hexamer of soy glycinin, the edestin molecule is 
composed of six identical subunits, and each one consists of an acidic subunit (AS) and 
a basic subunit (BS) linked by one disulfide bond [Tang et al., 2006; Kim & Lee, 2011]. 
BS is more heterogeneous than AS. 
In absence of 2-ME (non-reducing conditions) the disulphide bonds between the acidic 
and the basic subunits are not totally destroyed, and thus the subunits of edestin would 
be mainly in the form of various AB units. As expected, the subunits marked as AS, 
BS1 and BS2 were in small amount (relative content <20%) in the SDS-PAGE profiles 
(unreduced) and, accordingly, there were miscellaneous bands of about 60-65 kDa 
(marked as AB unit) which were clearly attributed to the AB unit (Table 3.3 and 
Figure 3.8). Furthermore, under these conditions, all samples contained a relatively high 
content of aggregates stacking on the top of separating gel, or even not entering the 
stacking gel.  
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Table 3.3. Molecular weight (MW) and relative content of the major subunits of hemp proteins from hempseed meal defatted by n-hexane. 
Extraction  
solution 
MW and content Non-reducing Sample Buffer 
AB unit Other bands AS BS1 BS2 
NaOH MW (kDa) 61.88±0.69 / 35.22±0.53 17.78±0.57 15.78±0.03 
 
Relative content (%) 36.00±1.04 / 44.66±1.90 8.30±1.09 11.03±1.05 
HCl MW (kDa) 61.55±0.23 / 34.44±0.19 17.84±0.07 15.82±0.15 
 
Relative content (%) 39.46±2.27 / 47.62±1.27 9.39±1.54 8.53±0.93 
SDS/UREA MW (kDa) 62.04±0.46 / 35.88±0.13 20.78±0.12 19.01±0.28 
 
Relative content (%) 71.72±1.25 / 26.63±1.57 1.06±0.18 0.60±0.14 
SDS/UREA/DTT MW (kDa) / 55.29±0.10 33.67±0.25 20.18±0.11 18.25±0.17 
 
Relative content (%) / 8.92±0.68 72.48±0.77 8.69±2.37 9.91±0.93 
  
            
Extraction 
solution 
MW and content Reducing Sample Buffer 
AB unit Other bands AS BS1 BS2 
NaOH MW (kDa) 63.04±1.89 55.16±0.34 34.95±1.05 18.94±0.46 16.97±0.38 
 
Relative content (%) 18.27±1.70 3.51±1.43 60.50±2.37 5.77±0.03 11.95±0.27 
HCl MW (kDa) 62.37±0.23 57.72±4.46 34.53±0.32 19.12±0.43 17.54±0.10 
 
Relative content (%) 17.30±0.51 2.63±0.25 56.01±1.01 6.98±1.83 17.09±1.08 
SDS/UREA MW (kDa) 63.63±2.02 56.71±1.70 33.77±1.01 19.76±0.33 17.47±0.20 
 
Relative content (%) 11.65±1.23 2.73±0.61 64.20±0.02 9.32±0.33 12.10±1.54 
SDS/UREA/DTT MW (kDa) / 56.93±0.11 33.85±0.38 19.91±0.04 17.84±0.13 
  
Relative content (%) / 8.22±0.23 66.26±1.41 10.77±0.68 14.75±1.50 
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By adding a reducing agent (such as dithiothreitol, DTT) or using a sample buffer 
containing 2-ME, there were two major kinds of protein constituents, corresponding to 
AS and BS subunits of edestin, respectively. In this case, the AS of about 30-40 kDa 
was relatively homogeneous, while the BS mainly consisted of two subunits of about 
20 kDa and 18 kDa respectively. From these MWs and the relative content data, the 
MW of edestin (hexamer form) can be estimated to be about 300-400 kDa. Besides the 
bands of acidic and basic subunits of edestin, under reducing conditions, all samples 
contained minor components at about 45-55 kDa and some peptides with MW lower 
than 17 kDa.  
 
Figure 3.8. SDS-PAGE profiles of hemp proteins from hempseed meal defatted by n-hexane, in 
absence (non-reducing conditions) or in presence (reducing conditions) of 2-ME. AB unit 
represents the miscellaneous bands of hemp edestin, while AS and BS represent the acidic and 
basic subunits of hemp edestin. Lanes 1 and 5 are the hempseed protein solution extracted with 
NaOH (2 h, 37 °C). Lanes 2 and 6 are the hempseed proteins precipitated with HCl and 
resuspended in 50 mM Tris/0.05% SDS pH 8.0. Lanes 3 and 7 are the hempseed protein 
solution extracted with 2% SDS/6 M urea (2 h, 37 °C). Lanes 4 and 8 are the hempseed protein 
solution extracted with 2% SDS/6 M urea/1%DTT (1:20, 2 h, 37 °C). M represents the protein 
molecular mass marker (130, 95, 72, 55, 43, 34, 26, 17 kDa). 
 
The relative content of edestin and other components was approximately estimated by 
densiometric scanning technique (Figure 3.9). The results showed that edestin 
(including AS and BS) is the major protein component in hemp proteins, consisting of 
about 85% of total proteins. The other subunits were about 15%. These results are 
consistent with literature data [Patel et al., 1994; Tang et al, 2006; Kim & Lee, 2011]. 
unreduced reduced
1 2 3 4 M      5 6 7 8
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Figure 3.9. Densiometric profile in presence of 2-ME of hempseed meal proteins extracted with 
2% SDS/6 M urea solution. Red arrow indicates the difference in the distribution of the minor 
component. 
 
 
 3.2.2.2. SDS–PAGE of protein hydrolysates 
 
Enzymatic hydrolysis of defatted hempseed meal was performed using two commercial 
food grade protease cocktails (Flavourzyme® and Umamizyme®), in ammonium 
bicarbonate as a buffer. Defatted hempseed cake was incubated under the same 
experimental conditions without the enzyme as a control. The reaction was stopped after 
1, 5, 11 and 24 h by addition of formic acid to the mixture, and finally centrifuged.  
The characterization of molecular weight profile of enzymatic hydrolysates is 
important, especially when these compounds are used for clinical nutrition or allergic 
patients [Tossavainen et al., 1997]. Several authors reported the use of SDS-PAGE to 
evaluate and quantify the level of protein hydrolysis [Nugent et al., 1983; Savoie, 
1994]. Indeed, this approach is useful for the assessment of the role of individual 
enzymes in protein breakdown. In 2001 Alacorn et al. [2001] suggested the possibility 
of using a calculated numerical index taking into account both the percentage of 
reduction in optical density for each protein band after a given reaction time, and the 
relative proportion that such band represents to total protein in the sample. Thus, SDS-
PAGE was used to evaluate the degree of hydrolysis (DH), which is defined as the 
percent ratio of the number of peptides bonds cleaved to the total number of peptides 
bonds in the substrate. DH is a measure of the extent hydrolytic degradation of proteins 
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and is also the most used indicator for comparison among different proteolytic process 
[Alacórn et al., 2001]. 
The SDS-PAGE profiles and the corresponding densiometric profile obtained after 
hydrolysis performed on hempseed meal in presence of Umamizyme® and 
Flavourzyme® are detailed in Figures 3.10, 3.11 and 3.12.  
 
Figure 3.10. SDS-PAGE profile of protein fractions obtained at different sampling times during 
the hydrolysis of hempseed meal by Umamizyme® (hydrolysis parameter: pH 7, 45 °C). Lanes 
1, 3, 5 and 7 are 1, 5, 11, 24 h of control digestion, respectively. Lanes 2, 4, 6, 8 are 1, 5, 11, 24 
h of hempseed meal digestion, respectively. M represents the protein molecular mass marker 
(130, 95, 72, 55, 43, 34, 26, 17 kDa). 
 
Figure 3.11. SDS-PAGE profile of protein fractions obtained at different sampling times during 
the hydrolysis of hempseed meal by Flavourzyme® (hydrolysis parameter: pH 8, 50 °C). Lanes 
1, 3, 5 and 7 are 1, 5, 11, 24 h of control digestion, respectively. Lanes 2, 4, 6, 8 are 1, 5, 11, 24 
h of hempseed meal digestion, respectively. M represents the protein molecular mass marker 
(130, 95, 72, 55, 43, 34, 26, 17 kDa). 
1 2 3 4 5 6 7 8 M
1 2 3 4 5 6 7 8 M
81 
 
 
Figure 3.12. Densiometric profile of hydrolyzed hempseed meal after 24 h incubation. A. 
Umamizyme®-catalysed process. B. Flavourzyme®- catalysed process. 
 
A limited, spontaneous degradation of proteins, in the absence of the enzyme, could be 
observed in comparison with the control lanes. A comparison between protein patterns 
obtained by Umamizyme® and Flavourzyme® revealed a similar performance of the two 
hydrolytic enzymes. A significant hydrolysis of the main protein fractions (edestin 
subunits, indicated as AS and BS) was observed for both proteases, as evidenced by the 
fast and general decrease of optical density showed by these bands (Figure 3.12). In 
particular, after 1 hour, samples treated with both enzymes were already significantly 
different from the control samples, since the AS and BS bands were completely 
hydrolyzed, particularly when Umamizyme® was used as the biocatalyst. After 5 hours 
of incubation, in the sample treated with Umamizyme® also the protein bands with the 
molecular weight range from 10 kDa to 2-3 kDa disappeared, whereas with 
Flavourzyme® the lower part of the gel (<10 kDa) was still completely spotted by 
protein elements. For both enzymes, no further proteolysis was detected after 11 h and 
24 h, as shown by the protein profiles. In conclusion, Umamizyme® hydrolyzed all 
proteins with high molecular weight after 1 h incubation and only two defined bands 
(about 10 kDa and about 2-3 kDa) were not hydrolyzed after 5 h. On the other hand, 
Flavourzyme® hydrolyzed all proteins with a molecular weight >10 kDa after 5 h, 
whereas protein bands with low molecular weight (>10 kDa) were unaffected after 24 h 
incubation. For both enzymes, a 5 h incubation process was shown to be suitable to 
achieve the highest hydrolysis. 
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3.2.3. Protease activity assay 
 
The activity of the enzymes (Umamizyme® and Flavourzyme®) used to obtain the 
hempseed HVPs was evaluated by a non-specific protease activity assay (casein assay). 
This assay uses casein as the substrate and Folin & Ciocalteu Phenol (F-C), or Folin’s 
reagent, as the indicator [Folin, 1927; Anson, 1938]. When a protease digests casein, the 
amino acid L-tyrosine is liberated along with other amino acids and peptide fragments. 
F-C reagent primarily reacts with free L-tyrosine to produce a blue colored 
chromophore, which is quantifiable by measuring spectrofotometrically the absorbance 
at 750 nm (Figure 3.13). 
 
Figure 3.13. Casein assay for protease activity determination  
 
The more L-tyrosine is released from casein, the more chromophores are generated and 
the stronger the activity of the protease is. The absorbance values generated by the 
protease are compared to a standard curve which is obtained by reacting known 
amounts of L-tyrosine with the F-C reagent and by correlating the changes in 
absorbance with the micromoles of L-tyrosine. From the standard curve the protease 
activity is determined in terms of units (U), which are the equivalents of L-tyrosine 
(µmol) released from casein per minute [Cupp-Enyad, 2008]. 
The assay is performed in two steps. In the first one a sample solution is prepared by 
adding a known volume of protease to casein, which releases L-tyrosine; after 5 minutes 
the hydrolysis is stopped by addition of trichloroacetic acid (TCA). In the second step 
the solution is mixed with the F-C reagent; the reaction between the released L-tyrosine 
and the F-C reagent produces blue colored chromophores which are quantified by 
measuring the absorbance at 750 nm. At the same time the absorbances of a blank and a 
control solution are evaluated. The blank solution contains the reagents of the protease 
solutions except that TCA is added before the protease in order to inactivate it 
CASEINE  + PROTEASE AA  + PEPTIDES
L-Tyrosine
FOLIN-CIOCALTEU
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immediately. The control solution, instead, contains the reagents of protease solutions 
except for the enzyme. The µmoles of released L-tyrosine equivalents are determinated 
by using the calibration curve. The activity of Flavourzyme® was calculated by using 
equation 3.1. 
 
U/ml enzyme = (µmol of tyrosine equivalents released)x(ml used in step 1)  (3.1) (ml of enzyme)x(reaction time, min)x(ml used in step 2) 
 
where, the µmoles of released L-tyrosine, the volume of the enzyme assay (ml), the 
amount of enzyme used (ml), the reaction time (minutes) and the volume of the 
colorimetric assay (ml) are used. 
As Umamizyme® is available as a solid, the enzymatic activity was calculated by 
dividing the activity in U/ml by the starting concentration of the solid (in mg/ml), as 
reported in equation 3.2. 
 
U/mg enzyme = U/ml enzyme     (3.2) 
mg protein/ml enzyme 
 
 
Figure 3.14 shows the standard curve obtained by the reaction of increasing amounts of 
1.1 mM L-tyrosine solutions with the F-C reagent. The calculated protease activities are 
reported in Table 3.4. 
 
Figure 3.14. a) Standard curve obtained by plotting the change in absorbance (ABS) recorded 
(λ=750) (Y axis) versus the µmoles of L-tyrosine (X axis). b) In the Table the used amounts of 
L-tyrosine for the standard curve and the recorded absorbance values are reported. 
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Table 3.4. Calculated protease activities (IU) of Umamizyme® and Flavourzyme®. 
Enzyme 
 
IU 
(as supplier) 
Amount 
add 
ABS  
(750 nm) 
Equivalentes  
of L-tyr (µmol) 
IU 
(calculated) 
IU 
(calculated) 
Umamizyme® 74.3 U/g 0.03 mg 
0.156 0.035  258.3U/g 
261 U/g 0.06 mg 0.306 0.072 263.7 U/g 
Flavourzyme® 500 U/ml 0.02 µl 
0.173 0.039  429 U/ml 
432 U/ml 0.04 µl 0.342 0.079  435 U/ml 
 
 
3.2.4. Chemical characterization of hempseed HVPs 
 
Total nitrogen of defatted hempseed meal was assessed by Kjeldahl method performed 
by Centro di Ricerca per le Produzioni Foraggere e Lattiero-Casearie (CRA) of Lodi 
(Italy). Crude protein content was estimated by multiplying total nitrogen content by the 
conversion factor 6.25 (Table 3.5).  
The Kjeldahl method is considered the standard method for estimating the protein 
concentration in foods, due to the high precision and reproducibility [AOAC, 1980]. A 
food is heated in presence of a strong acid (usually sulfuric acid) and releases nitrogen 
which can be determined by a suitable titration technique. Since the Kjeldahl method 
does not measure the protein content directly, a conversion factor is needed to calculate 
the amount of protein present from the measured nitrogen concentration. In most 
applications the average value 6.25 (equivalent to 0.16 g nitrogen per gram of protein) 
is used as a conversion factor [McClements, 2009]. 
 
Table 3.5. Calculated protein content in defatted hempseed meal by Kjeldal method. 
Number of analysis N total g/100g of meal % Protein (N total X 6.25) 
27 5.73 35.8 
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3.2.5. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging 
activity 
 
Free radical reactive oxygen species (ROS) are usually formed from normal essential 
metabolic processes in the human body, or from external sources such as exposure to 
X rays, ozone, cigarette smoking, air pollutants, and industrial chemicals [Lobo et al., 
2010].  
A free radical is a molecular species containing an odd electron in an atomic orbital. 
Many radicals are unstable, highly reactive, and able to either donate to or accept an 
electron from other molecules. The most dangerous oxygen-containing free radicals are 
hydroxyl radical (OH) superoxide anion radical (O2−), hydrogen peroxide (H2O2), 
oxygen singlet (1O2), hypochlorite (ClO−), nitric oxide radical (ONOO−), and 
peroxynitrite radical (ROO). Indeed, these species appear to be responsible for 
damaging of the nucleus and the membranes of cells in human body, because they are 
able to attack lipids, nucleic acids, proteins and carbohydrates [Young and Woodside, 
2001]. As a result, free radicals may contribute to the development of degenerative or 
pathological processes such as aging, cancer, coronary heart disease and 
neurodegenerative diseases [Uttara et al., 2009]. 
Oxidative stress is a term used to describe a oxidative damage resulting from the 
imbalance between free radical production and antioxidant defenses in the body [Rock 
et al., 1996]. For example, this condition could arise from a tissue injure, i.e. trauma or 
infection.  
An antioxidant is a stable molecule capable to donate an electron to a free radical and 
neutralize it.  
To detoxify from the free radical usually formed in the human body, both enzymatic 
and non-enzymatic antioxidants exist in the intracellular and extracellular environment 
[Frie et al., 1988]. Among non-enzymatic antioxidant systems, glutathione, ubiquinol, 
and uric acid are produced during normal metabolism in the body [Shi et al., 1999]. 
Other antioxidants are the vitamins E (α-tocopherol), C (ascorbic acid), and B-carotene. 
The body cannot produce these latter micronutrients, so they must be supplied in the 
diet [Levine et al., 1991]. 
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Hence, diet-derived antioxidants may be particularly important in protecting against the 
diseases arising from oxidative stress. The role of compounds with antioxidant potential 
in nutrition is an area of increasing interest. For example, several reports about the 
antioxidant activities of natural compounds in fruit and vegetables (such as anthocyanin, 
the storage proteins of sweet potato root yam tuber, yam mucilage and potato tuber) 
were published [Liu et al., 2007]. 
Antioxidants are used to mitigate the consequences of oxidative damage in the human 
body and also as food preservatives. Indeed, these compounds can prolong the shelf life 
and maintain the nutritional quality of lipid-containing foods [Halliwell et al., 1995]. 
Proteins are key nutrients for humans and also play an important functional role in food 
processing. 
Several peptides derived by partial hydrolysis of proteins show high antioxidant activity 
in food, for their ability to retard lipid and protein oxidation, associated with 
deterioration of food quality during the processing and storage [Yang et al., 2013]. 
Natural antioxidant peptides can be produced from a variety of protein sources, 
including whey protein [Peña-Ramos et al., 2004], potato protein [Wang & Xiong, 
2005], maize zein [Zhu et al., 2008] and buckwheat protein [Ma & Xiong, 2009].  
A further advantage to use protein hydrolysates to improve the antioxidant activity in 
food is that they confer nutritional value. This property depends on amino acid 
composition of the peptides released, which on its turn depends on the type of proteases 
used, as well as on pH, temperature, substrate concentration and enzyme-substrate (E/S) 
ratio used in hydrolysis process [Chen et al., 1995]. 
Antioxidant activities of hempseed and flaxseed hydrolysates were reported by Tang et 
al. [2008] and Udenigwe et al. [2009], respectively. 
 
Several methods are routinely used to evaluate the efficiency of synthetic/natural 
antioxidants. Among them, the DPPH assay is one of the best-known and frequently 
employed for measuring the radical scavenging activity. DPPH (1,1-diphenyl-2-
picrylhydrazyl) is a stable free radical because of its spare electron delocalization over 
the whole molecule, so that the molecules do not dimerize such as the most of free 
radicals. The delocalization causes a deep purple color with a strong absorption 
maximum around 520 nm in ethanol solution.  
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When a solution of DPPH is mixed with a substrate acting as a hydrogen atom donor (a 
free radical scavenger), a stable non-radical form of DPPH reduced (DPPH-H) is 
obtained. Simultaneously the color of solution turns from purple to pale yellow (due to 
picryl group still present) and the molar absorbance at 517 nm decreases from 9660 to 
1640 [Molyneux, 2004; Szabo et al., 2007]. The resulting decolorization is 
stoichiometric with respect to the number of electrons captured which depends on the 
antioxidant activity of the substrate. The reaction is depicted in Figure 3.15. 
  
Figure 3.15. Principle of antioxidant (DPPH) assay. 
 
The scavenging effects against DPPH radical was evaluated both for hempseed HVPs 
obtained by enzyme treatment (ultrafiltered fractions with MW<10 kDa) and by 
chemical hydrolysis according to previously reported procedures [Li et al., 2007; 
Udenigwe et al., 2009]. Defatted hempseed meal incubated under the same 
experimental conditions without the enzymes was used as the negative control; whereas 
reduced glutathione (GSH) and butylated hydroxytoluene (BHT) were used as the 
positive control. All assays were performed in triplicate. Concentration-dependence of 
the scavenging properties against DPPH was also determined using three concentrations 
of the peptide fractions. The antioxidant activity was evaluated as IC50 value, that is the 
concentration of the hydrolysates at which 50% of antioxidant activity is observed. The 
IC50 value thus describes the scavenging activity: the lower the IC50 value, the higher is 
the free radical scavenging ability.  
Table 3.6 and Figure 3.16 report the IC50 values obtained for hempseed enzymatic 
hydrolysates. 
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Table 3.6. DPPH radical scavenging activity of HVPs obtained at hydrolysis time of 1, 5, 11 
and24 h. 
Time of 
hydrolysis  
Enzyme 
    
Control 
Flavourzyme® Umamizyme®     
1 h 2.8±0.1 2.6±0.5  2.95±0.6 
5 h 2.3±0.4 1.8±0.5  2.9±0.2 
11 h 1.9±0.1 1.7±0.7  2.8±0.17 
24 h 2.5±0.1 1.6±0.6   2.8±0.1 
Results are expressed as half maximal effective concentration 
(IC50, mg protein/mL) ± confidence interval (CI, α=0.05), n=6. 
 
 
Figure 3.16. DPPH radical scavenging activity of HVPs obtained at hydrolysis time of 1, 5, 11 
and 24 h. 
 
The assay showed that the release of DPPH-scavenging peptides from hempseed 
proteins depends in part on the specificity of the proteases used in hydrolysis. In 
particular, the antioxidant activity of the samples treated with Umamizyme® increases 
as much as the hydrolysis up to 1.6 mg/ml after 24 hours of hydrolysis. By contrast, the 
activity of the samples treated with Flavourzyme® increases up to 1.9 mg/ml after 11 
hours and slightly decreases at 24 hours.  
 
Several studies reported that the DPPH scavenging activities of food protein 
hydrolysates may depend on both buffer and pH used in the assay, as well as on the size 
of their constituent peptides [Udenigwe et al., 2009; Lin et al., 2008]. To investigate the 
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effect of buffer and pH on the DPPH scavenging properties, the assay was also 
performed by dissolving the hydrolyzed fractions at 24 hours in three different buffers: 
acetate (pH 4.0), phosphate (pH 7.0) and sodium carbonate (pH 9.0). The hydrolyzed 
fractions exhibited better radical-scavenging activity in acetate buffer at pH 4.0 
(Table 3.7). These preliminary results are in agreement with those previously reported 
[Udenigwe et al., 2009; Lin et al., 2008] and show that pH affects the DPPH radical 
scavenging properties of antioxidants. 
 
Table 3.7. DPPH radical scavenging activity (%) of HVPs obtained at hydrolysis time of 24 h 
(0.5% w/v) using three different buffers.  
pH, buffer Enzyme 
  
Umamizyme® Flavourzyme® 
4, acetate buffer 86.73% 76.05% 
7, phosphate buffer 36.51% 31.86% 
9, sodium carbonate buffer 12.63% 10.11% 
 
 
The DPPH radical scavenging activities of chemically hydrolyzed hempseed obtained 
with HCl at different acid concentration, time and temperature was also investigated. 
Table 3.8 shows the calculated IC50 values. The assay showed that the antioxidant 
activity of the chemical hydrolyzed is similar to that of enzymatic hydrolyzed. The 
highest activity is observed for peptides obtained with 1.0 M HCl at 63 °C for 48 hours. 
Probably these conditions allow the production of peptides with optimal sizes to 
antagonize the DPPH activity. 
Table 3.8. DPPH radical scavenging activity of chemical HVPs obtained in different hydrolysis 
conditions of concentration, temperature and time.  
 
Hydrolysis  
Conditions (in HCl) 
IC50 values 
(mg/ml) 
0.1 M, 48 h, 63 °C 2.22±0.1 
1.0 M, 48 h, 63 °C 1.59±0.2 
1.0 M, 6 h, 110 °C 2.68±0.3 
6.0 M, 6 h, 110 °C 2.33±0.4 
 
 
 
 
 90 
 
3.2.6. Ferrous ion-chelating potency  
 
Iron has been found to be involved in several key pathogenic processes (such as 
neurodegeneration). In particular redox-active Fe(II) reacts with H2O2 to generate the 
highly reactive •OH (hydroxyl radical) via the Fenton reaction (equation 3.3) [Wardman 
& Candeias, 1996]: 
 
Fe(II) + H2O2  Fe(III) + OH- + •OH           (3.3) 
 
The Fe(II)-chelating potency of a substrate is usually assessed by the ferrozine method. 
Ferrozine is the disodium salt of 3-(2-pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-
triazine (Figure 3.17). This compound binds to divalent iron and forms a stable magenta 
complex species which is very soluble in water and is characterized by an absorption 
band centred about at 562 nm, being useful for the direct determination of iron in water 
[Lawrence, 1970; Sanchez-Moreno, 2002]. The addition of iron chelators interferes with 
the ferrozine-Fe(II) complex in a concentration-dependent manner resulting in low 
absorbance. 
 
Figure 3.17. 
 
The assay showed that samples treated with Umamizyme® at 5 hours displayed a 
remarkable Fe(II)-chelating potency (0.08 mg/ml). By contrast, the activity of the 
samples treated with Flavourzyme® is higher than the one of samples treated with 
Umamizyme® at each time and slightly increases with hydrolysis time up to 0.044 
mg/ml.  
Table 3.9 and Figures 3.18, 3.19 and 3.20 report the IC50 values obtained for 
enzymatically hydrolyzed hempseed. 
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Table 3.9. Fe(II)- chelating ability of HVPs obtained at hydrolysis time of 1, 5, 11 and 24 h. 
Time of 
hydrolysis  
Enzyme 
  
Control 
Flavourzyme® Umamizyme® 
  
1 h 0.062±0.008 0.16±0.02 0.18±0.6 
5 h 0.06±0.01 0.08±0.01 0.165±0.2 
11 h 0.055±0.003 0.11±0.01 0.155±0.17 
24 h 0.044±0.005 0.13±0.03 0.16±0.1 
Results are espressed as half maximal effective concentration 
(IC50, mg protein/mL) ± confidence interval (CI, α=0.05), n=6. 
 
Figure 3.18. Fe(II)- chelating ability (%) calculated versus concentration (mg/ml) of the sample 
treated with Umamizyme®. 
 
Figure 3.19. Fe(II)- chelating ability (%) calculated versus concentration (mg/ml) of the sample 
treated with Flavourzyme®. 
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Figure 3.20. Fe(II)- chelating ability of HVPs obtained at hydrolysis time of 1, 5, 11 and 24 h. 
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3.2.7. Glutamate content 
 
The determination of L-glutamate content is of utmost importance to evaluate the 
sensory profile of a sample. The free L-glutamate content in the fractions <10 kDa was 
assessed by an enzymatic assay in which L-glutamic acid is oxidised by nicotinamide-
adenine dinucleotide (NAD+) in the presence of glutamate dehydrogenase (GlDH), 
leading to the formation of 2-oxoglutarate and of reduced nicotinamide-adenine 
dinucleotide (NADH) (Figure 3.21). 
 
 
Figure 3.21. Mechanism of the glutamate dehydrogenase reaction. 
  
The amount of reduced NADH is stoichiometric with the amount of free L-glutamic 
acid. This assay takes advantage of the difference in the ultraviolet absorption spectra 
between the oxidized (NAD+) and reduced forms (NADH) of this coenzymes at a 
wavelengths of 339 nm (Figure 3.22). 
 
 
Figure 3.22. Absorbance spectra of NAD+ and NADH. 
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A calibration curve was obtained using L-glutamate solutions in water at different 
concentrations (Figure 3.23). Defatted hempseed meal incubated under the same 
experimental conditions without the enzyme was used as control. 
 
 
Figure 3.23. a) Standard curve obtained by plotting the change in absorbance recorded (λ=339) 
(Y axis), versus the µmoles of L-glutamate on (X axis). b) The amounts of L-glutamate used to 
obtain the standard curve and the recorded absorbance values are reported in the Table. 
 
The assay shows that the free L-glutamate amount in samples treated with 
Flavourzyme® is not affected by the hydrolysis time, while the one in samples treated 
with Umamizyme® is time dependent (Figure 3.24 and Table 3.10) and increases until 
reaching a maximum value after 24 hours of hydrolysis. 
 
Table 3.10. Free L-glutamate percentage in hemp protein hydrolysates obtained at hydrolysis 
time of 1, 5, 11 and 24 h. 
Time of 
hydrolysis  
Control Enzyme 
  
Flavourzyme® Umamizyme® 
1 h 0.41±0.32 0.62±0.098 1.25±0.04 
5 h 0.41±0.12 0.80±0.1 1.24±0.53 
11 h 0.51±0.08 0.90±0.17 1.45±0.67 
24 h 0.73±0.15 0.73±0.1 3.72±1.65 
Results are expressed as amount of free L-glutamate (%) ± confidence interval 
(CI, α=0.05), n=6. 
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Figure 3.24. Free L-glutamate percentage in the enzymatic hydrolysates fractions and controls 
plotted against the hydrolysis time. 
 
 
3.2.8. Sensory Profile 
 
In order to complete the sensory profile of protein–peptide mixtures, the hempseed 
hydrolysates were tested by a team of selected and certified panelists, as described for 
rice middlings hydrolysates (section 6.2.2.3.). Six subjects, having variable experiences 
of descriptive analysis, were recruited as panelists. These subjects were previously 
trained to evaluate the taste of aqueous solutions of the following standard taste 
compounds: sucrose for sweet taste (50 mmol/L); lactic acid for sour taste (20 mmol/L); 
NaCl for salty taste (20 mmol/L); caffeine for bitter taste (1 mmol/L); monosodium L-
glutamate for umami taste (3 mmol/L). 
The freeze-dried hempseed hydrolysates were dissolved in water and equilibrated at 
room temperature (20 ± 2 °C) to give a final concentration of 0.1 and 0.5 % (w/v). 
Aliquots (20 mL) of each sample were presented to the panelists. The sensory attributes 
were evaluated using a quantitative descriptive analysis method [Jo & Lee, 2008], based 
on “sip and spit” procedure, to minimize the uptake of any toxic compound. 
Tables 3.11-3.12 and Figures 3.25-3.26 show the mean taste intensity ratings of the five 
main flavors for the analyzed hydrolysates. Data of Tables 3.11 and 3.12 indicate that 
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both the taste quality and intensity are strongly dependent on the concentration tested as 
well as on the enzyme utilized and the hydrolysis time. 
 
Table 3.11. Taste intensity of hempseed hydrolysates water solutions (0.1% w/v) after 
incubation with Umamizyme and Flavourzyme. Each value represents the mean taste intensity 
rating scored on a 10-point category scale by six panelists.  
Sample (0.1% w/v) Bitter Sweet Sour Salty Umami 
Flavourzyme 1 h 0 1.6 0 0 1.0 
Flavourzyme 5 h 0 1.0 0 0 1.1 
Flavourzyme 11 h 0 0.7 0 0 1.0 
Flavourzyme 24 h 0 0.7 0 0 0.8 
      
Umamizyme 1 h 0 1.0 0 0 0.6 
Umamizyme 5 h 0 1.0 0 0 0.7 
Umamizyme 11 h 0 1.0 0 0 1.0 
Umamizyme 24 h 0 0.6 0 0 1.4 
 
 
Table 3.12. Taste intensity of hempseed hydrolysates water solutions (0.5% w/v) after 
incubation with Umamizyme and Flavourzyme. Each value represents the mean taste intensity 
rating scored on a 10-point category scale by six panelists. 
Sample (0.5%) Bitter Sweet Sour Salty Umami 
Flavourzyme 1 h 0 0.9 2.0 1.0 1.6 
Flavourzyme 5 h 0 1.0 2.0 1.3 2.1 
Flavourzyme 11 h 0 0.7 2.8 1.2 1.5 
Flavourzyme 24 h 0 1.0 2.4 1.1 2.8 
      
Umamizyme 1 h 1.0 0 1.6 0.9 1.9 
Umamizyme 5 h 1.9 0 2.7 0.8 2.4 
Umamizyme 11 h 1.4 0 2.5 1.2 3.5 
Umamizyme 24 h 1.3 0 2.9 0 3.5 
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Figure 3.25. Taste profiles of hempseed hydrolysates after incubation with Umamizyme and 
Flavourzyme. Each value represents the mean taste intensity rating scored on a 10-point 
category scale by six panelists. The results are represented with a reduced scale (0-3.5) for a 
easier reading. 
 
At the lower concentration (0.1% w/v) umami and sweet taste are the main attribute for 
each sample. In particular, umami taste was prevalent in samples incubated with 
Umamizyme for 24 hours.  This is in agreement with the results of the glutamate assay 
which indicate the highest concentration of glutamate in these samples. 
At the higher concentration (0.5% w/v) the umami sensation becomes more intense, 
particularly for the samples incubated with Umamizyme for 11 and 24 hours. At the 
same time also the other taste perceptions increase. This may be in agreement with the 
characteristic flavor enhancing activity of umami substances. In particular, a sour 
sensation is detect, probably due to the release of acidic aminoacids by hempseed 
proteins. However, the sour taste does not alter the taste sensation: it might be the basic 
flavor defined for the hydrolysates (as discussed for rice middlings hydrolysates in 
section 3.1.3.). The bitter taste was present in the samples incubated with Umamizyme; 
however, it does not prevail on the umami taste. Instead, the sweet taste is present only 
in the hydrolyzed samples deriving from Flavourzyme.  
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Figure 3.26. Taste profiles of MSG and rice middling hydrolysates after 24 h of incubation with 
Umamizyme and Flavourzyme. Each value represents the average taste intensity scored on a 10-
point category scale by six panelists. Results are represented with a reduced scale for a easier 
reading. 
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3.3. Preparation of HVPs from Hempseed through Chemical 
Hydrolysis 
 
 
 
 
 
 
 
 
Chemical hydrolysis of proteins can be carried out in either acidic or alkaline 
conditions. 
The alkaline hydrolysis of proteins is unattractive in term of taste because it destroys 
key amino acids such as L-cysteine and L-arginine. Upon this process other destroyed 
amino acids are L-serine and L-threonine, whereas L-tryptophan is not involved.  
The acidic hydrolysis is preferred and widely used in food industry because it is rapid, 
cheap and produces savory peptides that can be used as flavor enhancers. During this 
process the essential amino acids L-tryptophan, L-methionine, and L-cysteine are 
destroyed, whereas L-asparagine and L-glutamine are converted into aspartic and 
glutamic acid, respectively. Usually the biological and organoleptic properties of the 
end product depend on the conditions of hydrolysis (concentration and type of acid, 
temperature, pressure, time of hydrolysis) and on the starting material [Nagodawithana, 
2010].  
Hempseed proteins, extracted as described in section 6.3.2. (Method A), were subjected 
to acidic hydrolysis according to Aaslyng [1998]. The hydrolyses were performed either 
in strong or weak conditions in order to obtain peptides with different molecular weight. 
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3.3.1. Chemical hydrolysis of hempseed proteins with Acetic Acid  
 
The first hydrolysis on hempseed proteins was carried out 
with 50% acetic acid solution at 110 °C for 18 hours. 
Upon this process the color of the solution did not change 
and few precipitate was produced. The freeze-dried product 
was an amber odorless amorphous solid (Figure 3.27).  
The SDS-PAGE of this product could not be performed due 
to the high concentration of acetic acid used.  
 
The hempseed hydrolysates were analyzed by reverse-phase HPLC, using 0.1% TFA in 
water/acetonitrile as the mobile phase and a UV/VIS detector set at three different 
wavelengths (226, 254, 280 nm). The chromatogram showed the presence of many 
compounds, most of which probably are peptides with different molecular weights as 
shown by absorption at 226 nm. The first group of peaks, with maximum absorbance at 
256 nm, is characteristic of aromatic amino acids (Figure 3.28). 
 
Figure 3.28. Chromatograms of hempseed protein hydrolysates obtained with acetic acid. 
 
  
Figure 3.27. Freeze-
dried hempseed protein 
hydrolysates. 
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3.3.2. Chemical hydrolysis of hempseed proteins with Formic Acid  
 
Formic acid (HCOOH) can be easily removed and reduces the 
time of hydrolysis due its higher acidity in comparison with 
acetic acid. 
The hydrolysis was carried out with 20% HCOOH solution at 
110 °C for 8 hours. The pale brown and clear starting solution 
did not change the color during the hydrolysis.  
The freeze dried product was an amber amorphous solid with a 
distinct flavor of salt and a spicy note (Figure 3.29).  
 
The SDS-PAGE profile shows a large distribution of molecular weights, which cannot 
be compared with the standards (Figure 3.30). 
Figure 3.30. SDS-PAGE profiles of hemp proteins from defatted hempseed flour in absence 
(unreduced) and presence (reduced) of 2 mercaptoethanol (2-ME). S represents the protein 
molecular mass marker. Lanes EB are hempseed protein extracted at pH 10.00 and analyzed in 
both unreduced and reduced conditions. Lanes EA are hempseed proteins precipitated at pH 5.00 
and analyzed in unreduced and reduced conditions. Lane H represents the hydrolysates obtained 
with HCOOH. 
 
The RP HPLC analysis shows peaks very similar to those registered for the peptides 
obtained with acetic acid (Figure 3.31). However, formic acid cannot be used on 
industrial scale and should be present only in traces in the formulation of functional 
foods. 
Figure 3.29. Freeze-
dried hempseed pro-
tein hydrolysates. 
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Figure 3.31. Chromatograms of hempseed protein hydrolys
 
 
3.3.3. Chemical hydrolysis of defatted hempseed
Hydrochloric Acid 
 
To reduce the number of steps, according to Aaslyng, defatted hempseed 
hydrolyzed with 4 M HCl at 110 °C for 6 hours
The mixture quickly became dark brown probably due to the Maillard reaction 
(Figure 3.32). At the end of the hyd
neutralization and filtration under vacuum. Furthermore
which were absent in defatted hemp seed 
(Figure 3.33). The dark solution bec
activated carbon followed by filtration using celite 
The lyophilization of this product was very difficult due to the high content of salts
     Figure 3.32.   
ates obtained with formic acid.
 meal
 [Aaslyng, 1998].  
rolysis, the solution was very dark even after 
, very dark and small clusters, 
meal, were present in the undigested material 
ame clear and light yellow by treatment with 
(Figure 3.34).  
         Figure 3.33.        Figure 
 
 
 with 
meal was 
. 
 
3.34. 
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The RP-HPLC analysis was not useful to separate the peptides formed during the 
hydrolysis, as shown by the chromatogram. Presumably, these compounds are in the salt 
form and hence very hydrophilic under the analysis conditions (Figure 3.35). 
Figure 3.35. Chromatograms of hempseed hydrolysates obtained by hydrochloric acid 
treatment. 
 
 
3.3.4.  Chemical hydrolysis of hempseed proteins with Hydrochloric 
Acid 
 
To reduce the problems arising from using defatted hempseed meal, we decided to 
perform the hydrochloric acid hydrolysis on hempseed protein extract. The hydrolyses 
were performed under different conditions, i.e. concentration, temperature, time. 
 0.1 M HCl for 48 hours at 63 °C;  
 1 M HCl for 48 hours at 63 °C;   
 1 M HCl for 6 hours at 110 °C 
in these cases, the solutions were neutralized using an ion-exchange resin (Amberlite 
402) to reduce the pH and remove chlorides; 
 3 M HCl for 8 hours at 100 °C; 
 6 M HCl for 6 hours at 110 °C. 
the strong acidity of these solutions was reduced adding 2 M NaOH and sodium 
carbonate, Na2CO3, as the buffer. Preparative RP-HPLC was used to remove salts. 
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3.3.4.1. Chemical characterization 
 
Figures 3.36-3.40 show the recorded RP-HPLC chromatograms of the hydrolysates 
obtained under the above conditions, using 0.1% TFA in water/acetonitrile as the 
mobile phase and a UV/VIS detector set at three different wavelengths (226, 254, 280 
nm). The blue line corresponds to the absorption at 226 nm (typical of the peptidic 
bond), the red one at 254 nm and the violet one at 280 nm (typical of the aromatic 
compounds). The green line corresponds to the acetonitrile concentration. Each 
chromatogram shows a characteristic peak at short elution times, probably due to 
hydrophilic compounds. The maximum absorption at 254 nm is typical of aromatic 
amino acids.  
 
Figure 3.36. Chromatograms of hempseed protein hydrolyzed with 0.1 M HCl, at 63 °C for 48 
hours. 
 
Figure 3.37. Chromatograms of hempseed protein hydrolyzed with 1 M HCl, at 63 °C for 48 
hours. 
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Figure 3.38. Chromatograms of hempseed protein hydrolyzed with 1 M HCl, at 110 °C for 6 
hours. 
 
 
Figure 3.39. Chromatograms of hempseed protein hydrolyzed with 3 M HCl, at 100 °C for 8 
hours. 
 
 
Figure 3.40. Chromatograms of hempseed protein hydrolyzed (HHI) with 6 M HCl, at 110 °C 
for 6 hours. 
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Figure 3.41 shows the chromatogram of peptides obtained with 3 M HCl at 100 °C for 8 
hours after RP-HPLC purification. 
 
Figure 3.41. Chromatograms of hempseed protein hydrolyzed with 3 M HCl, at 100 °C for 8 
hours after RP-HPLC purification. 
 
The purified fraction was analyzed by the NMR experiments 3D DOSY (Figure 3.42) 
and 2D TOCSY (Figure 3.43). The NMR spectra show the presence of peptides with 
molecular weight of 200 Da, 500 Da and 750 Da, sugars (with molecular weight around 
170 Da) and presumably a high concentration of salts. 
 
Figure 3.42. 3D DOSY spectra of hempseed protein hydrolyzed with 3 M HCl, at 100 °C for 8 
hours after RP-HPLC purification. 
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Figure 3.43. 2D TOCSY spectra of hempseed protein hydrolyzed with 3 M HCl, at 100 °C for 8 
hours after RP-HPLC purification. 
 
DOSY-NMR analysis (500 MHz, 310 K) was carried out in order to evaluate the range 
of molecular weights of the peptides in the reaction mixtures. However the accuracy of 
this analysis decreases with increasing molecular weight variability of the components. 
For example, Figure 3.44 shows the overlapped DOSY spectra of the mixtures obtained 
in the mildest (0.1 M HCl, 48 hours, 63 °C, black) and strongest (6 M HCl, 6 hours, 
110 °C, red) hydrolysis conditions. 
The DOSY-NMR experiments measure the diffusion coefficient values for the different 
components of a mixture giving a rough estimation of their molecular weight. 
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Figure 3.44. Overlapped DOSY spectra of the mixtures obtained with 0.1 M HCl for 48 hours at 
63 °C (black) and 6 M HCl for 6 hours at 110 °C (red). 
 
The following results were obtained. 
 
 
(a) 0.1 M HCl, 48 h, 63 °C 
Under these conditions the Maillard reaction did not take 
place and the mixture remained pale brown. Furthermore a 
small amount of dark tiny clusters, which were removed by 
filtration, was formed. The freeze-dried product was a 
brown amorphous solid (Figure 3.45). 
The DOSY-NMR analysis revealed the presence of several 
components with molecular weights ranging from 20000 to 
80000 Da, most of which ranging from 45000 (D = -9.86) to 
77000 Da (D = -9.94). 
Another species in low concentration with molecular weight 
of 25000 Da (D = -9.78) was detected. 
 
 
  
Figure 3.45. Freeze-dried 
hempseed hydrolysates 
resulting from 0.1 M HCl 
at 63 °C for 48 h 
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(b) 1 M HCl, 48 h, 63 °C 
With increasing concentration of HCl up to 1 M at the same 
temperature, the Maillard reaction still did not take place and 
the reaction mixture remained pale brown. Furthermore a 
higher amount of dark small clusters, which were removed by 
filtration, was formed. The freeze-dried product was a dark 
brown amorphous solid (Figure 3.46).  
The DOSY-NMR analysis showed the presence of 
components with molecular weights ranging from 8000 to 
27000 Da. In particular three main components with molecular weight of 11000, 13800 
and 17000 Da were identified. 
 
(c) 1 M HCl, 6 h, 110 °C 
To evaluate the influence of temperature on the degree of 
hydrolysis the hempseed protein were reacted with 1 M HCl 
at a higher temperature (110 °C) for a shorter time. The 
freeze-dried product was a dark brown amorphous solid 
(Figure 3.47). 
The DOSY-NMR analysis confirmed the presence of several 
components with molecular weight ranging from 3000 to 
10000 Da. The main components had molecular weights of about 9700 and 6000 Da. 
 
(d) 6 M HCl, 6h, 110 °C 
Increasing the HCl concentration up to 6 M under the same conditions of time and 
temperature, the Maillard reaction took place and the mixture became dark brown. The 
freeze-dried product (HHI) was a brown amorphous solid with a smell of mushroom 
rice. Interestingly, the chromatogram of HHI (Figure 3.40) showed a principal peak 
(HHP) after 11 ml of mobile phase. This fraction was purified by preparative RP-HPLC.  
The NMR-DOSY spectra oh HHP revealed the presences of four main component with 
molecular weights around 300 (D = -9.13), 470 (D = -9.20), 570 (D = -9.23), and 760 
Da (D = -9.27). Another component with higher molecular weight (around 900 Da) and 
in lower amount was present (Figure 3.48). 
Fig 3.47. Freeze-dried 
hempseed hydrolysates 
resulting from 1 M HCl 
at 110 °C for 6 h. 
Figure 3.46. Freeze-
dried hempseed hydro-
lysates resulting from 1 
M HCl at 63 °C for 48 
h. 
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Figure 3.48. NMR-DOSY spectra of purified hempseed protein hydrolyszed (HHP) with 6 M 
HCl for 6 h at 110 °C. 
 
The NMR-TOCSY spectra of HHP revealed the spin systems of L-arginine (7.21 ppm), 
L-lysine (7.52 ppm), L-leucine, L-alanine, L-tyrosine (6.94, 7.2 ppm). Weak signals 
corresponding to two L-tryptophan residues were identified as well. Other detected 
signals could not be unambiguously assigned to specific amino-acids (Figure 3.49). 
 
Figure 3.49. NMR-TOCSY spectra of purified hempseed protein hydrolyzed (HHP) with 6 M 
HCl for 6 h at 110 °C. 
111 
 
To obtain precise MW data of HHP, mass spectrometry data were recorded. The 
MALDI results showed the presence of a main component with molecular weight of 
780 Da.  
In agreement with DOSY-NMR data, other components with lower molecular weight 
were detected (Figure 3.50). 
 
 
Figure 3.50. MALDI-TOF spectra of purified hempseed protein hydrolyzed (HHP) with 6 M 
HCl for 6 h at 110 °C. 
 
Usually, chemical hydrolysis are not specific especially under strong conditions, thus 
different peptides mixtures are formed under similar hydrolysis conditions.  
The hydrolysis of hempseed proteins with 6 M HCl for 6 hours at 110°C was repeated 
four times. Surprisingly the obtained chromatograms can be superimposed each other 
(Figure 3.51), showing that the obtained peptides are quite similar. Presumably these 
peptides belong to a repeated sequence of amino acids within proteins of the hempseed. 
The small differences depend on the consecutive extractions of proteins from hempseed.  
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Figure 3.51. Chromatograms of hempseed hydrolyzed (HHI) with 6 M HCl for 6 hours at 
110°C. 
 
HHP 
HHP 
HHP 
HHP 
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A further purification of HHP by preparative RP-HPLC, under different elution 
conditions, allowed the separation of two components (HHP-1 and HHP-2) as shown by 
the chromatogram in Figure 3.52. 
 
 
Figure 3.52. Chromatogram of HHP purified by RP-HPLC. 
 
These components were analyzed by DOSY-NMR and TOCSY-NMR. 
The DOSY-NMR analysis of the first fraction (HHP-1) showed the presence of three 
components with molecular weight of about 350, 470 and 800 Da. The correlations of 
the TOCSY-NMR analysis identified the spin systems of L-arginine, L-alanine, 
L-tyrosine, L-tryptophan, L-glutamic acid/glutamine (Figure 3.53). L-Glutamine cannot 
be identified since it is degradated to glutamic acid in the conditions of hydrolysis. 
The DOSY-NMR analysis of the second fraction (HHP-2) showed the presence of three 
components with molecular weight of about 350, 470 and 600 Da. The TOCSY-NMR 
spectrum is similar to the former revealing the same spin systems  with the exception of 
one which is not present in the first fraction and may correspond to the peptide with 
molecular weight of 600 Da (Figure 3.54). 
HHP-1 
HHP-2 
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Figure 3.53. TOCSY-NMR spectra of first fraction. 
 
 Figure 3.54. TOCSY-NMR spectra of second fraction. 
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3.3.4.2. ACE-inhibitory activity 
 
Hypertension is one of the main risk factors of cardiovascular diseases (i.e. 
atherosclerosis, coronary heart disease, stroke, and heart failure) which are one of the 
leading causes of death in most industrialized countries [Boschin et al., 2014]. 
The disease is commonly treated with blood pressure lowering drugs, in particular with 
the inhibitors of the angiotensin I converting enzyme (ACE; EC 3.4.15.1), which plays 
an important role in regulating blood pressure in the renin-angiotensin system. This 
enzyme catalyses the conversion of the biologically inactive angiotensin I to the potent 
vasoconstrictor angiotensin II, and inactivates the potent vasodilator bradykinin. 
Inhibitors bind tightly to the ACE active site, competing with angiotensin I for 
occupancy; as a consequence, ACE cannot convert angiotensin I to angiotensin II 
[Skeggs et al., 1956]. Considering that synthetic ACE inhibitors, such as captopril, 
lisinopril and enalapril, may produce side effects, such as coughing, taste disturbances 
and skin rashes, there is interest in natural inhibitors, and numerous studies are focused 
on the production and isolation of ACE-inhibitory peptides from different food proteins. 
Food derived ACE-inhibitory peptides can be introduced into functional foods or 
dietary supplements. The first active peptides were obtained from milk proteins 
[Nakamura et al., 1995], but some have been isolated from plant seeds, such as soybean 
[Chen et al., 2004], pea [Aluko, 2008; Barbana & Boye, 2010], rice, sunflower, and 
wheat [Guang & Phillips, 2009]. Recently, the antihypertensive effects of enzymatic 
hempseed protein hydrolysates and its peptide fractions was reported by Girgih et al. 
[2011]. Several reports showed an increase in ACE-inhibitory activity with decreasing 
molecular weight (MW) of peptide [Benjakul & Morrissey, 1997; Jeon et al., 1999]. 
The ACE-inhibitory activity of hempseed peptides resulting from the chemical 
hydrolyses was assessed according to the slightly modified method developed by 
Cushman & Cheung [1971]. Two samples were investigated: the crude obtained by 
hydrolysis with 6 M HCl for 6 hours at 110 °C (HHI) and the corresponding purified 
fraction by preparative RP-HPLC (HHP, Figure 3.55). 
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Figure 3.55. Chromatograms of hempseed peptides obtained by hydrolysis with 6 M HCl 
for 6 hours at 110 °C (HHI, left) and the corresponding purified fraction (HHP, right). 
 
Figures 3.56-3.57 show the charts obtained plotting the % ACE inhibition vs. log10 
inhibitor concentrations for both samples. Very good fits with sigmoid curves and 
reproducible IC50 values were obtained.  
 
 
Figures 3.56  Diagrams reporting % ACE inhibition vs. log10 concentrations of hempseed 
peptides obtained by hydrolysis with 6 M HCl for 6 hours at 110 °C (HHI). 
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Figure 3.57. Diagrams reporting % ACE inhibition vs. log10 concentrations of hempseed 
peptides obtained by hydrolysis with 6 M HCl for 6 hours at 110 °C and purified with RP-
HPLC (HHP). 
 
The maximum percentage of ACE inhibition and the IC50 values are reported in Table 
3.13.  
 
Table 3.13. Values of highest inhibitor concentration (µg/ml), maximum percentage of ACE-
inhibition and IC50 (µg/ml) for hempseed peptides resulting from hydrolysis with 6 M HCl for 6 
hours at 110 °C. Values are reported as mean value ± standard deviation of three independent 
experiments; values with different letters are significantly different (p < 0.05). 
Sample Highest inhibitor 
concentration 
(µg/ml) 
Max ACE 
inhibition 
(%) 
IC50  
(µg/ml) 
HHI 1035.9 85 180.11 ± 3.07 
HHP 1035.9 79 191.62 ± 1.57 
 
 
Both samples show similar IC50 values. The slowly reduced ACE-inhibitory activity of 
the purified fraction HHP suggests that there was some synergistic effect in the crude 
product HHI. These results are in agreement with the values reported in a previous 
study performed on enzymatic hempseed hydrolysates HVPs [Girgih et al., 2001]. 
However, the comparison of our data with those obtained by other authors is a complex 
task, since the observed differences in the ACE-inhibitory activity may be related to a 
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variety of causes, such as the sample and the protein extraction procedure, as well as the 
differences in the peptide mixture composition, related to changes in the parameters of 
the digestion process, i.e. enzyme, pH, time, temperature, substrate/enzyme ratio 
[Barbana & Boye, 2010], or the different analytical method used for the determination 
of the ACE-inhibitory activity.  
Our data indicate that chemical hempseed hydrolysates may become a valuable source 
of ACE-inhibitory peptides, which in the future may be used for the formulation of 
functional foods or dietary supplements for the prevention or treatment of hypertension. 
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3.4. Preparation of HVPs from Flaxseed through Enzyme-
catalyzed Hydrolysis 
 
 
 
 
 
 
 
Production and characterization of HVPs from flaxseed by-products is currently under 
investigation. In particular, four Italian cultivar of flax (Linum usitatissimum L.), 
namely, Solal, Merlin Linoal and Natural are being considered. 
 
Flaxseed (Linum usitatissimum L., family: Linaceae) has been cultivated since 
antiquity, mainly for the use of its oil and fiber. Whole flaxseed is rich in lipids, dietary 
fibre, proteins and lignans [Oomah & Mazza, 1993]. The main product obtained from 
flaxseed is oil, which is the richest known plant source of the ω-3 fatty acid α-linolenic 
acid [Sammour, 1999]. Flaxseed meal is the main by-product from the flaxseed oil 
extraction process. This product, traditionally used as animal feed, contains three 
important fractions: proteins (about 35-40%), essential amino acids; mucilage, which is 
a mixture of neutral arabinoxylans and rhamnogalacturonans with good water-holding 
capacities and high viscosity [Ribeiro et al., 2013]. In particular, the amino acid 
composition of flaxseed proteins is comparable to that of soy with high amounts of 
glutamic acid (about 40%), aspartic acid, leucine, arginine, lysine and branch-chain 
amino acids [Marambe et al., 2008].  
Because of these properties, flaxseed meal has recently received much attention as a 
functional food constituent. Moreover, flaxseed HVPs appear to be valuable component 
for human nutrition as well as for the production of flavor enhancers. 
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3.4.1. Removal of Mucilage  
 
The procedure of hydrolysis described for both rice middlings and hempseeds meal 
could not be performed on flaxseed due to the high amount of mucilage that hampered 
the hydrolysis of proteins. Flaxseed mucilage contains about 50–80% carbohydrates and 
4–20% proteins and ash. The major constituent consists of two polysaccharide 
components, neutral and acidic, that largely contribute to the soluble fiber fraction of 
flaxseed and are suggested to have a hypoglycemic effect in humans [Cunnane et al., 
1993]. Moreover, mucilage appears to play a role in reducing diabetes and coronary 
heart disease, preventing colon and rectal cancer and reducing the incidence of obesity 
[Singer et al., 2011]. Flaxseed mucilage is commonly employed in the cosmetic 
industry as texturing agents; however, in food industry, its application as functional 
food has not yet been extensively examined. Recently, Kaewmanee et al. [2014] 
evaluated the chemical composition, physicochemical, functional and sensory properties 
of flaxseed mucilage supporting their use for industrial applications. 
To perform the hydrolysis, we decided to remove mucilage by shaking defatted flaxseed 
meal in water [Kaewmanee et al., 2014]. The resulting viscous solutions containing the 
dissolved polysaccharides were filtered and precipitated with ethanol. Mucilage was 
then recovered by centrifugation. The pellet was dissolved in distilled water and freeze-
dried.  
In order to evaluate the presence of protein in the extracted mucilage, SDS-analysis was 
performed. However these results are still preliminary and the characterization of 
mucilage protein profile of all the flaxseed cultivar is under investigation. 
 
 
3.4.2. Enzymatic Hydrolysis 
 
The enzymatic hydrolysis of de-mucilagenated and defatted flaxseed meal was 
performed in semi-preparative scale according to the method described for hempseed 
meal in section 6.3.3. [Bagnasco et al., 2013]. Briefly, enzymatic hydrolysis of defatted 
and de-mucilagenated flaxseed meal was performed using two commercial food grade 
protease cocktails (Flavourzyme® and Umamizyme®), in ammonium bicarbonate as a 
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buffer. Defatted and de-mucilagenated flaxseed meal was incubated under the same 
experimental conditions without the enzyme as a control. The reaction was stopped after 
1, 5, 11 and 24 h by addition of formic acid to the mixture, and finally centrifuged.  
 
 
3.4.3 Chemical Characterization of Flaxseed HVPs 
 
Total nitrogen of defatted flaxseed meal was assessed by Kjeldahl method performed by 
Centro di Ricerca per le Produzioni Foraggere e Lattiero-Casearie (CRA) of Lodi. 
Crude protein content was estimated by multiplying total nitrogen content by the 
conversion factor 6.25 (Table 4.14).  
 
Table 4.14. 
Number of analysis N total g/100g of meal % Protein (N total * 6.25) 
25 5.18 32.4 
 
 
The SDS-PAGE as well as the characterization of flaxseed hydrolysates are in progress.  
Current studies are being focused on assessment of the sensory profile as well as of the 
nutraceutical properties (such as antioxidant and ACE activities) of both flaxseed 
hydrolysates and extracted mucilage. 
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4. RESULTS AND DISCUSSION 
PART 2 
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4.1. Alkylation of N2 of guanosine 
 
 
 
 
 
 
 
 
The reactivity of the exocyclic amino group in position 2 of the guanosine ring is 
significantly different from that of a -NH2 on an aromatic ring. Indeed, the carbonyl 
group in position 6 pulls the electrons of the purine ring substituents, especially those of 
the nitrogen in position 2 (Scheme 4.1). The preferred tautomeric form in guanosine is 
the keto form, making the guanosine ring electron-poor. 
 
Scheme 4.1. 
The prevalence of the keto-amino tautomer makes the C2-NH2 bond significantly 
shorter than a typical single Carom-NH2 bond, as confirmed by measuring the length of 
the C-N bond in various structural contexts (Table 4.1). 
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Table 4.1. 
  
 
Observed 
bond lenght [Å] 
Calculated 
bond lenght [Å] 
Ref. 
 
 1.336 1.377 JACS1970, 92, 2929-2936 
C2-NH2 1.341   
http://ndbserver.rutger
s.edu/archives/proj/val
ence/bases8.html 
(nucleic acid database) 
 
1.330   ActaCryst. C2006, 62, 515-517 
 
Carom-NH2 1.426 
  
F. Taddei “Il legame 
chimico”, UTET, 1976 
 
Csp2-NH2 1.322 
  
 
Csp3-NH2 1.472 
  
 
Csp2=NH2 1.340 
  
 
The length of the C2-NH2bond in guanosine nucleus (1.336 Å) is more similar to a 
double C=N bond (1.322 Å) than an amino group of an aromatic ring (1,426 Å) and the 
electron-withdrawing properties of the guanosine nucleus render the amino group 
scarcely reactive as a nucleophile. For this reason, specific strategies have been 
developed for its alkylation. 
A procedure for the alkylation of the exocyclic amino group of guanosine was described 
in 1980 by Kemal and Reese [1980]. This strategy requires two steps. The first step 
involves the reaction of the nucleoside with an aldehyde and p-thiocresol in refluxing 
ethanol, affording a N2-[1-(p-tolylthio)alkyl] guanosine through the intermediacy of an 
imine. Reduction of the resulting p-tolylthioalkyl derivative with NaBH4in the second 
step gives the desired alkylated product. However, the recovery of the final product is 
difficult and sometimes the protection of the ribose hydroxyl groups is required. 
 
Through a modification of this procedure, our group succeeded in synthesizing the 
derivatives shown in Table 4.2 [Cairoli et al., 2008]. The starting material was 2′,3′-O-
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isopropylideneguanosine and the reduction step was carried out without prior 
purification of intermediate thio adduct (Scheme 4.2). 
 
Scheme 4.2. 
 
Table 4.2. 
RCHO NHCH2R yield 
HCHO NHCH3 23% 
CH3CHO     NHCH2CH3 23% 
CH3SCH2CHO  NHCH2CH2SCH3 36% 
CH3SCH2CH2CHO       NHCH2CH2CH2SCH3 49% 
CH3CH2CH2CHO NHCH2CH2CH2CH3 46% 
CH3(CH2)6CHO NH(CH2)7CH3 35% 
PhCH2CH2CHO NHCH2CH2CH2Ph 48% 
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4.2. 2-halogeno purine 
 
Since the exocyclic amino group of guanosine has proved to be scarcely reactive, we 
decided to pursue an alternative approach based on the activation of the position 2 of the 
purine ring as halo-derivative, followed by the displacement of the halogen with 
diamines, as shown in the retrosynthetic plan reported in Scheme 4.3. The resulting 
intermediates carry a free amino group at the end of the side chain, which should be 
condensed with the gamma carboxylic group of glutamic acid. Two different 
approaches were attempted in order to achieve this goal. 
 
 
Scheme 4.3. 
 
 
4.2.1. First Strategy (through 6-chloro-2-iodo-purine) 
 
According to evidences from the literature, the replacement of the amino group in 
position 2 of the guanosine nucleus by a halogen atom was at first carried out on 
derivatives in which the amido function in positions 1 and 6 of the guanosine was 
masked (Scheme 4.4). The hydroxyl groups of commercial guanosine 4.1 were 
protected as acetyl derivatives using acetic anhydride in the presence of triethylamine 
(TEA) and p-(dimethylamino)-piridine (DMAP) affording derivative 4.2 [Bridson et al., 
1977]. Then 2’,3’,5’-tri-O-acetylguanosine 4.2 was converted into 2-amino-6-chloro-9-
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(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)-purine 4.3 by reaction with phosphorus 
oxychloride (POCl3) in the presence of tetraethylammonium chloride and N,N-
dimethylaniline (DMA) in refluxing acetonitrile (CH3CN) [Robins&Uznasnski,1981]. 
Since decomposition of the 6-chloro derivative 4.3 could occur during the reaction, 
Robins and Uznasnski studied this reactionby 31P NMR spectroscopy reproducing the 
chlorination conditions in an NMR tube containingPOCl3, DMA andtri-O-
acetylguanosine 4.2 in CD3CN at 70°C. The authors concluded that the first step of the 
reaction involves the phosphorylation of 4.2 to give an aromatic phosphorodichloridate 
intermediate B, followed by the attack of chloride at position 6 of B to give 4.3 and 
dichlorophosphate C (Scheme 4.5). A higher concentration of external chloride anions 
should favor conversion of B in 4.3 before decomposition occurs. Indeed, the addiction 
of tetraethylammonium chloride to the reaction mixture in a cognate experiment 
resulted in the faster disappearance of intermediate B and in an increased yield of 4.3. 
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Scheme 4.5. 
 
The iodine atom in position 2 of derivate 4.3 was introduced by reaction with 
t-butylnitrite and diiodomethane to give compound 4.4 [Ohno et al., 2004]. The 
mechanism of this reaction (Sandmeyer’s reaction) involves a purinyl radical which was 
generated transiently through the thermal homolysis of the 2-diazonium intermediate 
[Nair & Fasbender, 1993]. 
 
Introduction of an alkoxy group in position 6 of 4.4 can be achieved by nucleophilic 
substitution of the chorine atom with the proper alcoholate. The reaction outcome is 
strongly dependent on the temperature as well as on the structure of the alcoholate. The 
introduction of a methoxy group in position 6 was achieved by reaction of the derivative 
4.4 with sodium methoxyde at room temperature. Indeed, at room temperature the 
desired mono-substituted product 4.5a is preferentially formed because position 6 is 
more reactive than the position 2, although in position 2 there is a better leaving group. 
By raising the temperature up to 60 °C, the di-substituted product in positions 2 and 6 
(4.6a) is formed (Scheme 4.6) [Nair et al., 1988]. The introduction of a benzyloxy 
group in position 6 to give derivative 5b (Scheme 4.7) was carried out by using sodium 
benzyloxide according to the method described by Casu et al. [2012].This reaction is 
more sensitive to the temperature than the first one. Indeed, at room temperature the 
di-substituted product in positions 2 and 6 (4.6b) was obtained as the major product. 
The desired mono-substituted derivative (4.5b) was obtained by adding a stoichiometric 
amount of sodium benzyloxyde to a DMF solution of 4.4 at 0 °C. Sodium benzyloxyde 
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was previously generated by adding a stoichiometric amount of sodium to benzyl 
alcohol. 
In both cases (compounds 4.5a and 4.5b), the alkaline environment determined the 
cleavage of the acetyl protecting groups of the ribose. 
 
Scheme 4.6. 
 
 
Scheme 4.7. 
 
The presence of a reactive iodine atom in position 2 of derivatives 4.5a and 4.5b paved 
the way to a further functionalization of the purine moiety.  
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The 2’ and 3’ hydroxyl groups of compound 4.5a and 4.5b were reprotected by reaction 
with 2,2-dimethoxypropane (DMP) in acetone in the presence of a catalytic amount of 
p-toluenesulfonic acid, affording compounds 4.7a and 4.7b (Scheme 4.8). 
 
Scheme 4.8. 
 
Displacement of iodine atom of derivative 4.7a was carried out at high temperature 
using hexamethylenediamine A in DMF [Gunic et al., 2004]. Two products were 
obtained:the desired product 4.8a as minor component of the reaction mixture and a 
principal product, the structure of which is not yet univocally attributed. However, 
NMR spectra of this compound showed the presence of the diamine moiety and the lack 
of the methoxy group in position 6. 
Since the purification of derivative 4.8a was proved to be very difficult due to its high 
polarity, which hampered column chromatography separation, we tried to use the 
monocarbamate of 1,6-hexamethylenediamine A1 as the nucleophile for the 
displacement of the iodine atom of intermediate 4.7a (Scheme 4.9). Monocarbamate A1 
was obtained by the dropwise addition of a CH2Cl2 solution of di-tert-butyl dicarbonate 
(Boc2O) to an excess of 1,6-hexamethylenediamine at 0 °C. Then, displacement of 
iodine atom of derivatives 4.7a was carried out using monocarbamate A1 according to 
the procedure described above. Even in this case two principal products were formed 
and the desired derivative 4.8b was isolated as minor component. Furthermore, the 
conversion of the methoxy group at position 6 into a carbonyl group was unsuccessful. 
The reaction was performed according to Nair et al. [1988] by treatment with 
trimethylsilyliodide, generated in situ from trimethylsilylchloride and potassium iodide, 
in the presence of a catalytic amount of acetonitrile followed by addition of few drops 
of water to hydrolyze all the silyl groups. 
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Scheme 4.9. 
 
The synthetic plan so far described revealed some drawbacks up to this point: low 
solubility of intermediates; high polarity of the involved compounds, which rendered 
the chromatographic separations difficult or even impossible; unusual stability of the 
protecting group in position 6 of the purine nucleus, which proved to be difficult to 
remove. For all these reasons we set up an alternative approach based on the 
protectionsof the 5’ hydroxyl group of ribose as tert-butyldimethylsilylether andof the 
position 6 of the purine ring as benzyloxy derivative. Reaction of intermediate 4.7b with 
tert-butyldimethylsilylchloride in DMF in the presence of imidazole afforded the 
protected derivative 4.9 (Scheme 4.10).Displacement of the iodine atom in position 6 of 
derivative 4.9 was then carried out at high temperature using an excess of 
hexamethylenediamine in 2-ethoxyethanol [Bressi et al., 2000]. Even in this case, two 
principal products were formed and the desired product 4.10 was isolated as the minor 
component. 
The coupling of 4.10 with the γ-carboxylic group of glutamic acid, protected at the 
α-carboxy- and α-amino positions, was carried out in the presence of DCC at room 
temperature to give the hybrid compound 4.11 (Scheme 4.10). 
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Scheme 4.10. 
 
The critical step of this strategy appeared to be the reaction of the iodo-derivatives with 
the diamine. Reaction mixtures became indeed dark-red and many compounds were 
detected by TLC analysis. Presumably, some radical species were formed, even when 
the reactions were carried out in the dark. Consequently, the isolation of the desired 
products was in many cases very difficult. In addition, every attempt to remove the 
benzyloxy function in position 6results to be unsuccessful. 
For these reasons we decided to pursue an alternative approach, based on the activation 
of position 2 of the purine-ring as halo-derivative, but leaving the amido function in 
positions 1 and 6 of the purine nucleus untouched. 
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4.2.2.  Second Strategy (through 2-halogeno-6-oxopurine) 
 
4.2.2.1. 2-Iodo-purine 
 
In 2007 Nair et al. [2007] reported the synthesis of 2-iodo-6-oxo-9-(2',3',5'-tri-O-acetyl-
β-D-ribofuranosyl) purine 4.12 (Scheme 4.11) by reaction with isoamyl nitrite in the 
presence of an excess of iodoform (CHI3) in dryCH3CN in 72% yield. However, no 
experimental details were given and also the characterization of the formed product was 
lacking. When we tried to reproduce those experiment, the desired product 4.12 was 
isolated in very low yield. Moreover, the high amount of CHI3 used made purification of 
product 4.12 very difficult. Finally, the major product of the reaction was compound 
4.13, which probably arises from a radical reaction involving the CH3CN used as the 
solvent [Matsuda et al., 1992]. 
 
 
Scheme 4.11. 
 
For these reasons we undertook a detailed study of the reaction, by varying solvent and 
temperature, in order to achieve better yields and to minimize the formation of by-
products (Scheme 4.12 and Table 4.3).  
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Scheme 4.12. 
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Table 4.3. 
Entry Solvent Temperature 
12a CH3CN 0 °C  95 °C 
12b CH3CN 65 °C 
12c DMF 65 °C 
12d ClCH2CH2Cl 0 °C  65 °C 
12e ClCH2CH2Cl r.t. 65 °C 
12f ClCH2CH2Cl 65 °C 
 
The best results were obtained using 1,2-dichloroethane as the solvent at the fixed 
temperature of 65°C. Also in this case, however, the yield did not exceed 30%. 
As the acetyl protecting groups of the ribose moiety would interfere in the reaction with 
the diamine at a later stage of the synthesis, we tried also different protective groups 
using compound 4.14 as the starting material, as shown in Scheme 4.13. The yields 
remained however low. 
 
Scheme 4.13. 
 
The scarce results obtained up to this point and the observed low stability of the iodo 
derivative 4.12 prompted us to consider the use of halogens other than iodine. 
 
  
137 
 
4.2.2.2. 2-Bromo- and 2-Chloro-purine  
 
A procedure by Quian and Glaser [2005] (Scheme 4.14) reported the introduction of a 
bromine atom in the position 2 of the purine nucleoside 4.16, protected in position 6 as 
benzyloxy derivative. Compound 4.17 was obtained in 62% yield by a diazotization-
halogenation reaction in the presence of tert-butyl nitrite and antimony bromide (SbBr3) 
in methylene bromide (CH2Br2)at low temperature.  
 
Scheme 4.14.Procedure by Quian and Glaser [2005]. 
 
We tried the reaction using the protected guanosine 4.14, without masking the oxo 
group in position 6 of the purine nucleus, obtaining the desired, stable bromo derivative 
4.18 in 60% yield (Scheme 4.15).  
 
Scheme 4.15. 
 
On the basis of this good result, the same procedure was repeated using antimony 
trichloride in dichloromethane, affording the 2-chloro derivative 4.19. However, in this 
case the yield dropped to 30% (Scheme 4.16). 
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Scheme 4.16. 
 
Antimony (III) halides are effective catalysts for diazotization reaction [Quian & 
Glaser, 2005] and have Lewis acidic properties as well as serving as halogen donors. 
Because antimony compounds are toxic and SbCl3 has been shown to bind to DNA 
[Huang et al., 1998], efficient halo-dediazoniation procedures that do not employ SbX3 
are preferred. Nitrosyl chloride (NOCl) in the presence of Lewis acids such as AlCl3, 
PCl3, AsCl3, or TiCl4 has been used for the in situ diazotization of aliphatic amines 
[Doyle et al., 1978]. Generation of NOCl from silicon chlorides and alkyl nitrites is 
reported in early patent literature [Beckman et al., 1951] and trimethylsilyl chloride 
(TMS-Cl)-NaNO2 have been used for halo-dediazoniation [Ku et al., 1981].  
Francom and Robins [2003] reported the treatment of 6-chloro-9-(2',3',5'-tri-O-acetyl-β-
D-ribofuranosyl)-2-aminopurine 4.3 with TMS-Br and tert-butyl nitrite (TBN) in 
dibromomethane to give the crystalline 2-bromo-6-chloropurine 4.20b in 85% yield. It 
is also described a procedure to insert a chlorine atom. TMS-Cl and 
benzyltriethylammonium nitrite (BTEA-NO2) gave the crystalline 2,6-dichloropurine 
nucleoside 4.20a (83%) and acetyl chloride/BTEA-NO2 was equally affective (86%) 
(Scheme 4.17).  
a) TMSCl, BTEA-NO2
CH2Cl2 or
AcCl, BTEA-NO2
CH2Cl2, 0-5 °C
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AcO
OAc OAc OAc OAc
b) TMSBr, t-butyl nitrite
CH2Br2, 0-5 °C
 
Scheme 4.17. Procedure by Francom and Robins [2003]. 
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On the basis of this evidences [Francom & Robins, 2003] we reacted the protected 
guanosine derivative 4.14 with t-butylnitrite in the presence of trimethylbromosilane in 
dibromomethane at low temperature (Scheme 4.18). The 2-bromoderivative 4.18 was 
obtained in a satisfactory 70% isolated yield.  
 
Scheme 4.18. 
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4.3. Introduction of the spacer: Nucleophilic aromatic substitution on 
the purine ring of guanosine 
 
The spacer was then linked to position 2 of the protected guanosine activated as halogen 
derivative. The selected linkers were represented by terminal diamines of variable 
lengths: 
A 1,6-diaminohexane  H2N(CH2)6NH2 
B 1,4-diaminobutane   H2N(CH2)4NH2 
C 1,2-diaminoethane   H2N(CH2)2NH2 
 
In a first experiment we carried out a nucleophilic aromatic substitution on the crude 
iodo derivative 4.12 with 1,4 diaminobutane B. 
 
Scheme 4.19. 
 
The reaction was carried out in refluxing MeOH (Scheme 4.19). The progress of the 
reaction proved to be difficult to monitor by TLC, thus we observed only the 
disappearance of the starting material 4.12. The product 4.21 was not isolated, but 
evidences of its formation came from ESI-MS spectra of the reaction crude. 
As the acetyl protecting groups of the ribose moiety do not tolerate the treatment with 
the nucleophilic diamine in boiling methanol, we evaluated the possibility of using other 
protecting groups from the beginning of the synthetic plan. The reaction was therefore 
repeated using the iodo derivative 4.15 as the starting material (Scheme 4.20).  
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Scheme 4.20. 
 
Evidence of the formation of the desired product 4.22 came once again from ESI-MS 
spectra, but 4.22 was not purified, although different techniques, such as precipitation 
and ion exchange chromatography, were attempted. Reactions in Schemes 4.19 and 4.20 
required very long times for completion, up to 5-6 days, so we decided to change the 
solvent, in order to raise the temperature. Using DMF (Scheme 4.21) compound 4.23, 
different from that we expected, was obtained as the major reaction product. 
 
Scheme 4.21. 
 
Finally, by using 2-methoxyethanol (Scheme 4.22), the product 4.22 was formed, as 
shown by ESI-MS analysis, but we did not succeed in purifying it through the usual 
laboratory techniques (silica gel chromatography, ion exchange chromatography, 
crystallization etc). 
 
Scheme 4.22. 
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According to these results, we carried out nucleophilic aromatic substitutions also on 
the chloro- and bromo derivatives 4.18 and 4.19, using diamines of different lengths (A, 
B and C). All these reactions were carried out in 2-methoxyethanol as the solvent at 85 
°C (Schemes 4.23-4.25). 
4.18 X=Br
4.19 X=Cl
H2N NH2NH
N
N
O
XNO
OO
TBDMSO
NH
N
N
O
N
O
OO
N
H
4.24
TBDMSO NH2
2-methoxyethanol, 85°C
C
 
Scheme 4.23. 
 
 
Scheme 4.24. 
 
 
Scheme 4.25. 
 
Even in this cases, isolation of the products was difficult. We had evidence of the 
formation of the product by ESI-MS and NMRspectra. In particular, inspection of the 
1H NMR spectra showed that the obtained compounds were ca 80-90% pure and they 
have been obtained in ca 70% yield.  
143 
 
In order to prove the identity of compound 4.22, its free amino group was reacted di-
tert-butyl dicarbonate (Boc2O) affording compound 4.26 (Scheme 4.26), which was 
fully characterized by ESI-MS and 1D and 2D-NMR spectroscopy. 
Scheme 4.26. 
 
Due to the easier purification of 26, we decided to use the Boc-protected 1,4-
diaminobutane B1 as the nucleophile in the halogen-displacing reaction (Scheme 4.27). 
The reaction of B1 and either bromo 4.18 or chloro 4.19 derivative gave the desired 
product in 63% and 82% yield, respectively.  
 
Scheme 4.27. 
 
However, the cleavage of the N-Boc-protecting group in the next stage of the synthesis 
gave unsatisfactory results, due to the partial cleavage of the hydroxyl-protecting groups 
of the ribose moiety (Scheme 4.28). 
 
Scheme 4.28. 
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We concluded that the use of the mono-Boc derivatives of the nucleophilic diamines 
was not convenient, at least for two reasons. First, the removal of the Boc-protecting 
group revealed to be a non-selective reaction, forcing us to protect the ribose hydroxyl 
groups once again. Secondly, this approach required the use of huge amounts of 
diamines. A large excess of diamine is indeed requested in order to assure the 
mono-Boc protection in the preparation of reactant B1, and the mono-Boc amine B1 is 
in turn used in large excess in the nucleophilic aromatic substitution reaction. On the 
basis of these evidences, we concluded that a better strategy could involve the use of the 
crude, unpurified derivatives 4.22, 4.24 and 4.25, which were obtained with a 
satisfactory degree of purity (vide supra). 
Derivatives 4.22, 4.24 and 4.25 were then reacted withL-glutamic acid protected at the 
α-carboxyl- and α-amino positions (z-Glu-OtBu-γOH) in the presence of DCC at room 
temperature, to give the hybrid compounds 4.27, 4.28 and 4.29 (Scheme 4.29). 
 
Scheme 4.29. 
 
The hybrid compounds 4.27, 4.28 and 4.29 were obtained in satisfactory yields (Table 
4.4) after flash column chromatography. 
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Table 4.4 
 Hybrid compound Chain lenght Yield1 
4.27 
 
CH2=2 64% 
4.28 
 
CH2=4 47% 
4.29 
 
CH2=6 50% 
1) overall yield after two steps 
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4.4. Phosphorylation of the position 5' of ribose 
 
In order to phosphorylate the hybrid compound 4.27, 4.28, 4.29, the TBDMS groups in 
position 5’ of such derivatives were cleaved by using tetra-n-butylammonium fluoride 
(TBAF • 3H2O) in THF at room temperature (Scheme 4.30). The products were purified 
by flash chromatography (table 4.5). 
 
 
Scheme 4.30. 
 
Table 4.5 
Hybrid compound Chain lenght Yield 
4.30 
 
CH2=2 84% 
4.31 
 
CH2=4 82% 
4.32 
 
CH2=6 58% 
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The subsequent phosphorylation of the free position 5’ of the ribose was obtained 
following the procedure described by Yoshikawa et al. [1969], using phosphorus 
oxychloride (POCl3) as the phosphorylating agent and triethylphosphate (TEP) as the 
solvent.  
The reaction proceeds through the intermediacy of a guanosine-triethylphosphate 
complex (Figure 4.1), as described by Ikemoto et al. [1995]. This Guo-TEP complex 
showed excellent selectivity and high reactivity toward phosphorus oxychloride 
compared with those of free guanosine. After the activation of the 5’-hydroxyl group of 
guanosine through the formation of the complex, attack of the phosphorylating agent 
POCl3 occurs and the O5'-POCl2 bond is formed (intermediate 4.34 in Scheme 4.31). 
Hydrolysis of intermediate 4.34 at pH 2-3 at 70 ºC furnished the phosphorylated 
compound 4.35, in which the isopropylidene protection on the 2',3' positions of the 
ribose has been removed. 
 
Figure 4.1. 
 
 
 
Scheme 4.31. 
 
 
This procedure was applied on the hybrid compounds previously synthesized 4.31 and 
4.32 (Schemes 4.32 and 4.34). The obtained products were purified by preparative 
HPLC. 
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In the phosphorylation step of hybrid compound 4.31 some difficulties were 
encountered (Scheme 4.32). While the formation of the O-P bond takes place without 
any apparent problems (formation of a single spot on TLC plate), during the successful 
hydrolytic step a series of by-products appeared in the reaction mixture.  
The by-products were isolated by preparative HPLC (Figure 4.2). As results, the desired 
compound 4.36a was obtained in 42% yield. 
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Scheme 4.32. 
 
 Figure 4.2. 
 
Indeed the conditions of the hydrolytic step determined the cleavage of the linker
glutamic acid bond as well as the Boc protection on the glutamic acid moiety
Formation of compound 
t-butyl ester group [Green & Wuts, 1999] during the hydrolytic step following the 
phosphorylation (Scheme 4.32).
Among the by-products, compound 
rationalized assuming the cleavage of the 
& Wuts, 1999] followed by an intramolecular attack of the amino group of the glutamic 
acid moiety on the γ-
detectable in HPLC), and derivative 
4.36b could be rationalized on the basis of the removal of the 
 
4.36c was detected too. Its origin can be 
N-protecting benzyloxycarbonyl group [Green 
carboxyl, affording pyroglutamates 4.37a 
4.36c (Scheme 4.33). 
4.36b 
4.36a 
4.36c 
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and/or 4.37b (not 
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Scheme 4.33. 
 
We tried the same reaction on hybrid compound 4.32, but we encountered the same 
problems (Scheme 4.34 and Figure 4.3). 
 
Scheme 4.34. 
 
 Figure 4.3. 
 
 
Removal of the glutamic acid moiety protecting groups from compound 
achieved in almost quantitative yield by reaction in neat trifluoroacetic acid (TFA) at 
low temperature for few minutes (Scheme 4.35).
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Scheme 4.35. 
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On the basis of this result, we decided to change slightly our strategy, avoiding the 
HPLC purification step after the phosphorylation reaction. The protected hybrid 
compound 4.30 was thus phosphorylated as previously reported (Scheme 4.36), but the 
reaction crude was not purified. Instead, it was desalted by the use of a XAD-4 resin. 
XAD-4 resin is a polystyrene-based polimer able to bind aromatic compounds through 
hydrophobic interactions when the products are solubilized in water. Resin-adsorbed 
compounds can then be recovered by elution with methanol.  
 
Scheme 4.36. 
 
Attempts to deprotect the desalted intermediate 4.40 with trifluoroacetic acid gave 
unsatisfactory results, but the addition of a trace amount of trifluoromethanesulfonic 
acid (TFMS) to a trifluoroacetic acid solution of 4.40 at 0 °C afforded rapidly the 
desired product 4.41 (Scheme 4.37). A single preparative HPLC purification could 
therefore be carried out at the level of the final product 4.41. 
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Scheme 4.37. 
 
The overall synthetic plan is shown in Scheme 4.38. 
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Scheme 38. 
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5. CONCLUSIONS AND FUTURE PERSPECTIVES 
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In conclusion: 
 
1. By-products from food industry can be exploited as valuable sources of bioactive 
peptides.  In addition, the mixture of peptides obtained from rice middlings and hemp 
seeds through enzymatic hydrolysis were shown to elicit intense glutamate-like umami 
taste. Such hydrolyzed vegetable proteins could then potentially be used as ingredients 
in culinary products. The same hydrolytic protocol will be applied to proteins of flax 
seeds. 
 
2. The synthesis of two hybrid compounds in which the umami moieties (glutamate and 
purine 5’-ribonucleotide) are covalently connected through flexible linkers (4.39 and 
4.41) was carried out. We plan to apply the same synthetic protocol to the preparation of 
other hybrids with different linker lengths. 
Using the T1R1 extracellular VFTD obtained by homology modeling [Mouritsen, 2012] 
and the hybrids 4.39 and 4.41 and those which will be synthesized as ligands, molecular 
dynamics simulation will be performed in order to verify the optimal length of the 
linker to reach both receptor sites and to unravel the molecular mechanism behind the 
synergistic effect of the two ligands on the dynamics of the receptor. 
 
In addition, to assess the binding affinity constant of the hybrids and of potential ligands 
for the umami receptor we aim at developing a biochromatographic system through 
immobilization of this receptor on a chromatographic support, taking advantage of the 
accumulated experience of the group of Pharmaceutical Analysis from the University of 
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Pavia (Italy) and of a recent joint collaboration about the immobilization of a purine 
nucleoside phosphorylase (from Aeromonas hydrophila) as an on-line enzyme reactor 
for biocatalytic applications [Calleri et al., J. Chromatography B, accepted with 
revisions]. 
This task represents a future perspective of the work in the view to take on structure–
activity relationship (SAR) studies on umami receptor ligands. 
 
Development of new technologies to facilitate and speed up the screening of ligand 
libraries is raising considerable interest, particularly in drug discovery. Current 
screening assays typically rely on function- or affinity-based assays. Following the 
former approach, the “event” triggered by ligand-receptor binding can be measured, for 
example, through the quantification of a released second messanger, or by experiments 
performed on isolated tissues.  
On the other hand, binding assays, frequently performed with radioligands, allow to 
estimate ligand-receptor affinity. The binding affinity for a ligand can be described by 
measuring several parameters such as Ki (equilibrium dissociation constant of a ligand 
determined in inhibition studies), Kd (equilibrium dissociation constant), and IC50 
(molar concentration of an antagonist that reduces the response to an agonist by 50%). 
In this frame, affinity chromatography is a quite recent method used to assess 
interactions between a ligand and its protein target [Schiel et al., 2010]. Basically, the 
assay is performed in HPLC systems where a column contains the protein immobilized 
on a stationary phase or on the inner surface of silica capillaries [Sanghvi et al., 2011]. 
In this technique the retention of analytes depends on the same type of specific, 
reversible interactions that are encountered in biological systems, as is the case of the 
ligand-receptor binding. Another evident advantage of such a system relies on the 
repeated use of the column without a significant loss of properties of immobilized 
protein, and on the possibility of automation of the analytical assay to assist in the high-
throughput screening of a large number of candidates. 
Two general formats can be applied in affinity chromatography: zonal elution and 
frontal analysis. While in zonal elution a small plug of analyte is injected to get 
information on the interaction of the analyte with the immobilized target, frontal 
analysis uses the continuous infusion of analyte through a column. Although frontal 
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analysis requires a larger volume of sample than zonal elution, this method has the 
advantage to provide more information per analysis. Frontal affinity chromatography 
(FAC) can be used to measure binding constants of the analyte for the immobilized 
biomolecule with accuracy and precision and to rank potential ligands for a specific 
receptor [Hage & Tweed, 1997; Moaddel et al., 2002]. 
Frontal affinity chromatography coupled online to an electrospray mass spectrometer 
(FAC/MS) is a recently developed screening method for high-throughput screening of 
combinatorial libraries and compound mixtures [Schriemer, 2004; Calleri et al., 2009]. 
In this approach, a sample consisting of a mixture of compounds is continuously infused 
through the column and the order of elution, monitored by the specific m/z values, 
parallels the order of affinity, with the strongest ligand eluting the latest [Calleri et al., 
2009; Calleri et al., 2011. Ranking affinity studies may represent a rapid and convenient 
method for the selection of new potential candidates. 
Such a biochromatographic tool has been successfully applied to assess the binding 
affinity constant of potential ligands for the A2A adenosine receptor subtype [Temporini 
et al., 2013], for the gamma isoform ligand binding domain (LBD) of peroxisome 
proliferator-activated receptor (PPAR-γ) belonging to the nuclear receptor superfamily 
of ligand-activated transcription factors [Calleri et al., 2012], and for the G-protein-
coupled receptor (GPCR) GPR17 [Calleri et al., 2010]. 
It is worth mentioning that two out of the three mentioned applications above involve 
adenine related compounds [Temporini et al.; 2013] or purine nucleotide analogues as 
well [Calleri et al., 2010], that is molecules structurally related to newly here 
synthesized potential flavor enhancers. 
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6. EXPERIMENTAL SECTION 
PART 1 
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6.1. General - Enzymatic and Chemical Hydrolyses  
 
 
 
 
 
 
 
 
 
Unless otherwise stated, all reagents were purchased from Sigma-Aldrich (Milan, Italy) 
and were of analytical grade. All the solvents were of HPLC grade. 
Umamizyme (declared activity of 74.3 U/g) was a gift from Amano Enzyme Inc. 
(Nagoya, Japan) and Flavourzyme (declared activity of 500 U/g) was purchased from 
Sigma (Milan, Italy).  
These are fungal food-grade protease/peptidase complexes produced by submerged 
fermentation of a strain of Aspergillus oryzae. They exhibit both endoprotease and 
exopeptidase activities. These enzymes were selected on the basis of their ability to 
debitter bitter protein hydrolysates at low degrees of hydrolysis (10% to 20%) and to 
enhance flavor for high degrees of hydrolysis (50% or above) [Hamada, 2000a]. Their 
optimum activity occurs at 45 °C and pH 7 for Umamizyme® and at 50 °C and pH 8 for 
Flavourzyme®, respectively. 
 
HPLC Analysis: Each chemical hydrolyzed solution was analyzed and purified by RP 
HPLC using an Amersham pharmacia biotech (P900) liquid chromatographer connected 
to a UV-vis detector; chromatographic conditions were as follows: column for 
analytical HPLC, Jupiter RP-18 (4µ proteo 90A size: 250x4.60 mm, Phenomenex); 
column for semipreparative HPLC, Jupiter- RP-18 (10 µm, size:250x10 mm, 
Phenomenex); flow rate, 0,5 ml/min; detector, λ 226 and 254 nm; mobile 
phase: A (0,1% TFA (v/v) in water) and B (80% acetonitrile/ 20% water with 0,1% of 
TFA), gradient elution from 5% to 100% B in 45 min. 
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NMR Spectroscopy: NMR analysis was performed by ISMAC-CNR and was used to 
characterize the hydrolyzed compounds by recording homonuclear 2D TOCSY, 
NOESY and ROESY spectra and diffusion experiments (DOSY). From scalar and 
dipolar NMR experiments an indication of the kind of amino-acids present in the 
peptides was derived, while DOSY experiments allowed to define the range of peptide 
molecular weights present in the samples obtained with different hydrolysation-
conditions. 
 
Mass Spectrometry: Mass spectra were obtained with a Bruker ion-trap Esquire 3000 or 
6000 apparatus (ESI ionization) and Microflex apparatus (MALDI ionization) from 
Bruker.  
 
Other Analytical Methodos: UV measurements were carried out with a Jasco V-360 
UV-Vis Spectrophotometer (Jasco International, Tokyo, Japan) equipped with software 
Spectramenager (Fixed Wavelength Measurement). 
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6.2. Preparation of HVPs from Rice Middlings through 
Enzyme-catalyzed Hydrolysis 
 
 
 
 
 
 
 
Rice middlings were kindly provided by a local milling factory (Curti Riso, Valle 
Lomellina, Pavia, Italy). Rice middlings defatting was achieved as previously described 
[Van Der Borght et al., 2006], by stirring continuously for 1 hour at room temperature a 
suspension of bran with n-hexane (1:5 w/v). The defatting matrix was recovered using a 
Buchner funnel and air dried under a hood overnight. The protein content of defatted 
rice middlings was determined by the Kjeldahl method [AOAC, 1990]. The value of 
5.95 was used as protein conversion factor. 
 
 
6.2.1. Enzymatic Hydrolysis 
 
The protein hydrolysates from rice middlings were obtained according to the method of 
Hamada [1999], with some modifications. Four reactor system (PolyBLOCK, Hel, UK) 
interfaced to a PC by means of WinISO software (Hel, Borehamwood, UK) was 
employed. For any reactor, defatted rice middlings (3 g of matrix corresponding to 540 
mg of proteins) were suspended in 100 mM ammonium bicarbonate buffer (final 
concentration 10% w/v) by adjusting pH to the optimal value for any enzyme, as 
indicated by manufacturers. Any suspension was pre-incubated for 25 min at the desired 
temperature. The specific protease was added to the reaction mixture in order to give a 
final enzyme/substrate ratio (E/S) of 5% w/w and the mixture was stirred at 400 rpm 
during reaction. Proteolysis was stopped at time interval of 1, 5, 11, and 24 h and 
immediately the enzyme was inactivated by addition of formic acid up to pH 3.5. After 
proteolysis, the suspensions of rice middlings were subjected to sonication processing in 
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a water-bath. The solubilized proteins and peptides were recovered after centrifugation 
at 3000 rpm and 20 °C for 30 min. Controls of the proteolysis experiments were 
prepared by repeating the above reported procedure without enzyme. 
 
 
6.2.2. Characterization of protein hydrolysates 
 
6.2.2.1. Protein electrophoresis 
 
SDS-PAGE was performed on a discontinuous buffered system according to the method 
of Laemmli [Laemmli, 1970] using 17 % separating gel and 5 % stacking gel. 
Electrophoresis was performed with a Mini-PROTEAN Tetra Cell apparatus (Biorad) 
connected to a power supply PowerPac HC (Biorad). Fractions (25µl) of protein 
hydrolysates were diluted using loading sample buffer solution, namely 60% glycerol, 
12% SDS, 0.2% bromophenol blue in 250 mM Tris–HCl buffer pH 6.6, and heated at 
97 °C for 3 min. After a short centrifugation, samples were subjected to SDS-PAGE. 
Before the sample entered the separating gel, electrophoresis was performed at 100 V 
and after-wards it was performed at 150 V until the tracking dye reached the bottom of 
the gel. Electrophoresis of each protein sample was carried out in duplicate. The gels 
were fixed with 45% methanol and 10% acetic acid for 20 min, stained with Coomassie 
Brillant Blue R-250 blue–picric acid solution and destained with water. For protein pat-
tern characterization by densitometric scanning, the individual lanes of the stained gels 
were scanned by an Image Scanner (Amersham Pharmacia Biotech) and analyzed by 
the Lazarsoftware and NIH software. Image analysis software calculated integrated 
optical density (IOD) for bands resolved in each lane, thereby generating a total lane 
IOD values corrected for background. Total lane IOD was used to estimate a global 
value of protein degradation [Frazer & Bucci, 1996]. Changes in the relative amount of 
each protein bands present in successive samples were estimated from their respective 
percent area on the densitograms against the percentage area of the same band at time 
zero [Alarcón et al., 2001]. The rate of hydrolysis was expressed by a numerical value 
obtained considering both the percentage of reduction in optical density for each band 
after the reaction time, and the relative proportion such band represented to total 
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proteins. Only those bands representing at least 10% of total protein in the sample at the 
beginning of the assay were considered for estimations. The value obtained was named 
Coefficient of Protein Degradation (CPD) and it was estimated using the following 
mathematical expression [Alarcón et al., 1999; Alarcón et al., 2001]: 
 
CPD = Σn i=1 [(ODi(t0) - ODi(t) / ODi(t0)] x [ODi(t0) / Σn i=1 ODi(t0)]           (eq. 6.1) 
 
where i = major protein bands identified from 1 to n; ODi = optical density of the 
protein band i; t = time of reaction. 
 
 
6.2.3.  Functional properties 
 
6.2.3.1. Emulsifying properties  
 
The emulsifying activity index (EAI) and emulsion stability index (ESI) of the samples 
were determined according to the method of Pearce and Kinsella [1978], with minor 
modifications made by Yin et al. [2008]. For the emulsion formation, 3 ml of 0.2% 
protein hydrolysate dispersion (in deionized water adjusted to pH 3.0, 5.0, 7.0 and 9.0 
with 1 N NaOH or HCl) and 1 ml of corn oil were homogenized by manual agitation for 
1 min. One hundred microliters of emulsion were taken from the bottom of the 
homogenized-emulsion, immediately (0 min) or 10 min after homogenization, and 
diluted (1:100, v/v) in 0.1% (w/v) SDS solution. After shaking in vortex mixer for about 
5 s, the absorbance of diluted emulsions was read at 500 nm in the spectrophotometer. 
EAI and ESI values were calculated by the following equations: 
 
EAI(m2/g) = [2*2.303*A0*DF/c*φ*(1-θ)*10000]                    (eq. 6.2) 
 
ESI (min) = (A0/ A0- A10)*10                  (eq.6.3) 
 
 
where DF is the dilution factor (100), c the initial concentration of protein (g/ml), φ the 
optical path (0.01 m), θ the fraction of oil used to form the emulsion (0.25), and A0 and 
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A10 the absorbance of the diluted emulsions at 0 and 10 min. Measurements were 
performed in duplicate. 
 
 
6.2.3.2. Foaming properties  
 
Foaming properties including foaming capacity (FC) and foam stability (FS) were 
determined according to the method of Fernandez and Macarulla [1997] with minor 
modifications made by Yin et al. [2008]. Aliquots (5 ml) of protein hydrolysate 
solutions (1%, w/v, pH 7.0) were homogenized in a measuring cylinder (15 ml) by 
manual agitation for 2 min. FC was calculated as the percent increase in volume of the 
protein dispersion upon mixing, while FS was estimated as the percentage of foam 
remaining after 30 min. Measurements were performed in duplicate. 
 
 
6.2.4. Sensory analysis 
 
The sensory profiling was carried out at the Sensory Laboratory at Special Company for 
Professional Training and Technological and Commercial Promotion of the Chamber of 
Commerce of Savona (Albenga, Italy). Five subjects participated in the descriptive 
analysis as panelists. The subjects had variable experiences of descriptive analysis. Five 
samples were prepared as 0.5% solutions in deionized water consisting of protein 
hydrolysates selected in the SDS-PAGE experiment. A 0.5% MSG solution was 
presented as a reference. Aliquots (20 ml) of each sample, equilibrated with room 
temperature (20 ± 2 °C), were presented to the panelists in a disposable plastic cup 
coded with random numbers. The presentation order of the samples was randomized to 
minimize the presentation order effect. The subjects were previously trained until 
consensus was reached to evaluate the five basic tastes (sweet, bitter, sour, salty and 
umami). The sensory attributes were evaluated using a quantitative descriptive analysis 
method [Jo & Lee, 2008], based on “sip and spit” procedure. The subjects rinsed their 
mouths with filtered water before tasting and between tasting samples. The subjects 
rated the intensity of stimulus using a 10-point category scale whose left and right ends 
 169 
 
were labeled “weak” and “strong”, respectively. Each sample was evaluated 2 times in 
different sessions. Odor references were also determined in order to obtain the 
characteristic flavor for each protein hydrolysate. 
 
 
6.2.5. Statistical analysis 
 
Statistical analyses were performed with the Origin Pro 8 software (Origin Lab Inc., 
Northampton, MA). The data were expressed as mean ± SE and evaluated using one-
way analysis of variance followed by Tukey's post-hoc test. A level ofpb0.05 was used 
as a criterion for statistical significance. 
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6.3. Preparation of HVPs from Hempseed through Enzyme-
catalyzed Hydrolysis 
 
 
 
 
 
 
 
 
6.3.1. Defatted Hempseed Meal 
 
Hemp (Cannabis sativa L., var. Futura) seeds, harvested in Cavriana (MN) and 
Treviglio (BG), were provided by CNR-Institute of Biology and Biotechnology (IBBA) 
of Milan, Italy, during 2011/2012. A voucher specimen is stored and preserved in our 
laboratory at Department of Chemistry at University of Milan. Seeds were stored at 
4 °C in the dark until use. 
Hempseeds were defatted by stirring a suspension of seeds with n-hexane (1:4 w/v) at 
room temperature for 3 hours and overnight with renewed n-hexane (1:6 w/v). The 
defatted seeds were recovered using a Buchner funnel, air dried under a hood overnight, 
and ground with a home-style grinder (Braun Multiquick System 2K100). The obtained 
flour was again defatted with the same procedure described above. After vacuum 
filtration of the defatted matrix, the organic phase was concentrated under reduced 
pressure and the flour was air dried under a hood overnight. Both defatted hempseed 
flour and extracted hemp oil were stored at -20 °C until use. 
Commercial hempseed samples were kindly provided from Exhemplara® - Prodotti 
Biologici in Canapa (Roma, Italy). Hempseeds were defatted and ground as described 
above. The obtained flour was used to provide hempseed hydrolysates for sensory 
profiling.  
The protein contents of both defatted hempseed flours were determined according to the 
Kjeldahl method, which was performed by Centro di Ricerca per le Produzioni 
Foraggere e Lattiero-Casearie (CRA) of Lodi, by measuring the nitrogen content with a 
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CNH analyzer [AOAC, 1980]. The value of 6.25 was used as conversion factor to 
determine the protein content. 
 
 
6.3.2. Protein Extraction 
 
Hempseed protein extraction was carried out by alkali solubilization/acid-precipitation 
procedures using two different methods. 
Method A (NaOH/HCl). According to Wang et al. [2009], defatted hempseed meal was 
suspended in distilled water (in ratio 1:20 v/w, dry weight basis) and the pH was 
adjusted to 10.00 with 1 M NaOH at 37 °C. The mixture was stirred for 3 h to extract 
the proteins and then centrifuged at 8000 rpm for 30 min. to recover both supernatant 
and the residue. The residue was subjected to one more protein extraction followed by 
centrifugation using the same procedure described above. The latter residue was 
discarded and the combined alkali extracts were adjusted to pH 5.0 with 1 M HCl at 
room temperature to precipitate the proteins. Recovered protein precipitate was 
collected by centrifugation (8000rpm, 30 min, rt), suspended again in distilled water and 
pH was adjusted to 7.0 using 1 M NaOH.  
Method B (NH3/HCCOH). The same procedure was followed for the method B where 
NH3 was used for the alkali-extraction and HCOOH was used for the acid-precipitation.  
In both cases, the protein solution was dialyzed against distilled water (MWCO 3500, 
Spectra/Por®) at 4 °C for 48 h to remove small molecules, such as salts, and finally 
lyophilized. The freeze-dried hemp seed protein isolate was stored at -20 °C until use. 
An aliquot of this product was analyzed by 1H NMR spectroscopy (1D 500 MHz, pH 7, 
37 °C). 
To analyze the protein extract by SDS-PAGE the procedure of extraction was slightly 
modified by using two different approaches. In the first one defatted hempseed meal (75 
g) was subjected to the same protein extraction reported in Method A. After 
centrifugation, the obtained precipitate was washed with pre-cooled deionized water, 
dispersed in 50 mM Tris/0.05% SDS pH 8.0 (1.5 ml), stirred in termomixer (1000 rpm, 
20 °C, 1h 30 min) and subjected to sonication processing in a water-bath. 
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In the second one defatted hempseed meal (75 g) was mixed with 2% SDS/6 M urea 
(1.5 ml) and with 2% SDS/6 M urea/1% DTT (1:20 w/v, 1.5 ml). After continuously 
stirring for 2 h at 37 °C, the suspension was centrifuged at 8000 rpm for 30 min and the 
residue discarded. Both protein solutions were preserved at -20 °C until use. 
 
 
6.3.3. Enzymatic Hydrolysis  
 
The enzymatic hydrolysis of defatted hempseed meal was performed according to the 
method described by Bagnasco et al. [2013]. Four reactor system (PolyBLOCK, Hel, 
UK) interfaced to a PC by means of WinISO software (Hel, Borehamwood, UK) was 
employed on hemp seeds provided by CNR-IBBA of Milan. A semi-preparative scale 
protocol was used for commercial hempseed samples. 
Defatted hempseed flour (3 g of harvest matrix and 30 g of commercial matrix 
corresponding to 675 mg and 6.750 g of proteins, respectively) were suspended in 100 
mM ammonium bicarbonate buffer (final concentration 10% w/v) by adjusting pH to 
the optimal value for any enzyme, as indicated by manufacturers. Any suspension was 
preincubated for 20 minutes at the desired temperature. The specific protease was added 
to the reaction mixture in order to give a final enzyme/substrate ratio (E/S) of 5% w/w 
and the mixture was stirred at 400 rpm.  
Hydrolyses were carried out in the above conditions and stopped after 1, 5, 11 and 24 
hours by addition of formic acid up to pH 3.5 to inactivate the enzyme. Subsequently 
the suspensions were sonicated in a water-bath for 10 minutes and centrifuged at 8000 
rpm for 30 min at room temperature to recover solubilized proteins and peptides and 
remove the undigested materials. The supernatants, containing HVPs, were collected, 
freeze-dried and stored at -20 °C before further analysis. Controls of the proteolysis 
experiments were obtained by repeating the above procedure without the enzymes. 
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6.3.4. Ultrafiltration  
 
The freeze-dried hydrolysates (350 mg) were resuspended in bi-distilled water (50 ml), 
sonicated for 15 minutes and passed through an Amicon stirred ultrafiltration cell 
(Stirred Cell - Millipore) using a 10000-Da Molecular Weight Cutoff (MWCO) 
membrane, to remove the molecules (peptides and undigested proteins) larger than the 
membrane pores. The permeate, containing low-MW peptides (<10000 Da), was freeze-
dried and stored at -20 °C until needed. 
 
 
6.3.5. SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis) 
 
6.3.5.1. SDS-PAGE of protein extract 
 
SDS-PAGE was performed on a discontinuous buffered system according to the method 
of Laemmli [1970] using 12% separating gel and 4% stacking gel. Electrophoresis was 
performed with a Mini-PROTEAN Tetra Cell apparatus (Biorad) connected to a power 
supply PowerPac HC (Biorad). Fractions of protein extract, corresponding to 60 µg of 
proteins, determined with 2-D Quant Kit (Amersham Biosciences), were diluted using 
loading sample buffer solution, namely 60% glycerol, 12% SDS, 0.2% bromophenol 
blue in 250 mM Tris–HCl buffer (pH 6.6), and heated at 97 °C for 3 min. After a short 
centrifugation, samples were subjected to SDS-PAGE. Before the sample entered the 
separating gel, electrophoresis was performed at 100 V and afterwards it was performed 
at 150 V until the tracking dye reached the bottom of the gel. Electrophoresis of each 
protein sample was carried out in duplicate. The gels were stained with Coomassie 
Brillant Blue R-250 in 40% ethanol and 10% acetic acid solution and destained with 
40% ethanol and 10% acetic acid solution. For protein pattern characterization by 
densitometric scanning, the individual lanes of the stained gels were scanned by an 
Image Scanner (Amersham Pharmacia Biotech) and analyzed by the Lazarsoftware. The 
relative protein amount of each subunit (protein band) of protein was calculated from 
their respective percent area on the densitograms against the total subunits area of 
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protein. Only the main bands, representing at least 10% of total proteins, were 
considered for estimations. 
 
 
6.3.5.2. SDS-PAGE of protein hydrolysates 
 
SDS-PAGE was performed on a discontinuous buffered system according to the method 
of Laemmli [1970] using 17% separating gel and 4% stacking gel. Electrophoresis was 
performed with a Mini-PROTEAN Tetra Cell apparatus (Biorad) connected to a power 
supply PowerPac HC (Biorad). Fractions (20 µl) of protein hydrolysates were diluted 
using loading sample buffer solution, namely 60% glycerol, 12% SDS, 0.2% 
bromophenol blue in 250 mM Tris–HCl buffer (pH 6.6), and heated at 97 °C for 3 
minutes. After a short centrifugation, samples were subjected to SDS-PAGE. Before the 
sample entered the separating gel, electrophoresis was performed at 100 V and 
afterwards it was performed at 150 V until the tracking dye reached the bottom of the 
gel. Electrophoresis of each protein sample was carried out in duplicate. The gels were 
stained with Coomassie Brillant Blue R-250 in 40% ethanol and 10% acetic acid 
solution and destained with 40% ethanol and 10% acetic acid solution. For protein 
pattern characterization by densitometric scanning, the individual lanes of the stained 
gels were scanned by an Image Scanner (Amersham Pharmacia Biotech) and analyzed 
by the Lazarsoftware and NIH software. 
Image analysis software calculated integrated optical density (IOD) for bands resolved 
in each lane, thereby generating a total lane IOD values corrected for background. Total 
lane IOD was used to estimate a global value of protein degradation [Frazer & Bucci, 
1996]. Changes in the relative amount of each protein bands present in successive 
samples were estimated from their respective percent area on the densitograms against 
the percentage area of the same band at time zero [Alarcón et al., 2001].  
The rate of hydrolysis was expressed by a numerical value obtained considering both 
the percentage of reduction in optical density for each band after the reaction time, and 
the relative proportion such band represented to total proteins. Only those bands 
representing at least 10% of total protein in the sample at the beginning of the assay 
were considered for estimations. The value obtained was named Coefficient of Protein 
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Degradation (CPD) and it was estimated using the following mathematical expression 
[Alarcón et al., 1999; Alarcón et al., 2001]:  
 
CPD = Σn i=1 [(ODi(t0) - ODi(t) / ODi(t0)] x [ODi(t0) / Σn i=1 ODi(t0)]           (eq. 6.1) 
 
where i = major protein bands identified from 1 to n; ODi = optical density of the 
protein band i; t = time of reaction. 
  
 
6.3.6. Protease activity assay 
 
The activity of Flavourzyme® and Umamizyme® was determined according to Cupp-
Enyad with some modifications (Cupp-Enyad, 2008).  
The assay was performed with the following reagents: 
A. A 50 mM K2HPO4 buffer, pH 7.5, placed at 37 °C until use. 
B. Casein in buffer A (0.65% w/v) at pH 7.5 prepared by stirring 650 mg of casein with 
1 ml of buffer A and gradually increasing the temperature up to 80-85 °C in 10 
minutes. The solution was finally placed at 37 °C until use. 
C. 110 mM trichloroacetic acid (TCA). 
D. Folin & Ciolcaltea’s reagent (Sigma-Aldrich) diluted in water (1:4 v/v). 
E. 500 mM Na2CO3.  
F. 10 mM sodium acetate + 5 mM calcium acetate at pH 7.5, placed at 37 °C until use. 
G. 1.1 mM L-tyrosine standard. 
H. Protease solutions of Flavourzyme® and Umamizyme® in F 
 
A calibration curve was obtained by measuring the absorbances of four solutions 
containing increasing volumes of a 1.1 mM solution of L -tyrosine G (0.03, 0.06, 0.08 
and 0.12 ml), 0.25 ml of the F-C reactive solution D, 1.25 ml of 500 mM Na2CO3 E, 
and water up to 1 ml (Table 6.1). A sample containing the same reagents without 
L-tyrosine was used as blank. 
  
 177 
 
Table 6.1. 
Reagent Blank Sample 1 Sample 2 Sample 3 Sample 4 
1.1 mM  l-tyrosine (G) / 30 µl 60 µl 80 µl 120 µl 
H2O 500 µl 470 µl 440 µl 420 µl 380 µl 
500 mM Na2CO3 (E) 1.25 ml 1.25 ml 1.25 ml 1.25 ml 1.25 ml 
F-C reactive solution 
(D) 250 µl 250 µl 250 µl 250 µl 250 µl 
  Calculated ε = 10979  
 
The absorbances of the standard solutions were measured with a spectrophotometer at a 
wavelength of 750 nm. The calibration curve was obtained with a graphing program by 
plotting the amount (µmol) of L-tyrosine solution G on the Y axis, versus the change in 
absorbance recorded on the X axis. 
The assay is performed at 25 °C in two steps. In the first one blank, sample, and control 
solutions are prepared. The sample solution was obtained by adding the protease 
solution H (0.1 ml) to casein B (0.5 ml) in a plastic microcentrifuge tube. After 5 
minutes TCA C (0.5 ml) was added to inactivate the enzyme. The control solution was 
prepared with the same procedure but adding the buffer F (0.1 ml) instead of  the 
protease solution H. The blank solution was prepared by adding in a plastic 
microcentrifuge tube the protease solution H, TCA C (0.5 ml) and casein B (0.5 ml) at 
the same time. Afterwards each tube was centrifuged at 13200 rpm for 1 minute. 
In the second step 500 mM Na2CO3 E (0.625 ml) and the F-C reactive D (0.125 ml) 
were added to each supernatant (0.25 ml) in a plastic microcentrifuge tube. After 15 
minutes each solution was centrifuged at 13200 rpm for 1 minute and the supernatant 
absorbances were read at 750 nm in disposable plastic cuvettes. 
The µmoles of tyrosine equivalents released were determinate using the calibration 
curve. The activity of Flavourzyme® was obtained by the equation: 
 
U/ml enzyme = (µmol of tyrosine equivalents released)x(ml used in step 1)   (eq. 6.4)(ml of enzyme)x(reaction time, min)x(ml used in step 2) 
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As Umamizyme® is a solid protease, the enzymatic activity was obtained by the 
equation: 
 
U/mg enzyme = U/ml enzyme     (eq. 6.5) 
mg protein/ml enzyme 
 
 
6.3.7. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging 
activity 
 
DPPH radical scavenging activity was evaluated as described by Li et al. [2007] with 
slightly modification. In disposable plastic cuvettes each hydrolyzed sample dissolved in 
water (400 µl) was mixed with 99.5% ethanol (400 µl) and 0.02% DPPH (w/v) in 99.5% 
ethanol (100 µl). The resulting solutions was incubated in the dark at room temperature 
for 60 minutes, then absorbance at 339 nm was recorded (As) using a UV-visible 
spectrophotometer. A lower absorbance As of the reaction mixture suggested a higher 
free radical scavenging ability. A mixture containing distilled water (400 µl) instead of 
the hydrolyzed samples was used as control (Ac). A mixture containing hydrolyzed 
sample solution (400 µl) and 99.5% ethanol (500 µl) without DPPH was used as blank 
(Ab). The percentage of the DPPH scavenging activity was calculated by the equation: 
 
Radical scavenging activity (%) = 
Ac + Ab – As 
x 100                                  (eq. 6.6) 
Ac 
 
Defatted hempseed meal incubated under the same experimental conditions without the 
enzyme was used as negative control; whereas reduced glutathione (GSH, 0.005% - 
0.015% w/v) and butylated hydroxytoluene (BHT, 0.0005% - 0.0025% w/v) were used 
as positive control. 
The IC50 value was determined at three different concentrations (0.1%, 0.3%, 0.5% w/v) 
of the hydrolyzed fractions by plotting the calculated free radical scavenging activity 
(%) against the sample concentration [Udenigwe et al., 2009]. 
To investigate the effect of buffers and pH on the scavenging activities, the hydrolyzed 
fractions at 24 hours (60 µl at final concentration of 0,5 % w/v) was mixed with 40 µl of 
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0.1 M acetate buffer (pH 4.0), 0.1 M phosphate buffer (pH 7.0) and sodium carbonate 
buffer (pH 9.0). The assay was performed as described above.  
All assays were performed in triplicate. 
 
 
6.3.8. Ferrous ion-chelating potency 
 
The iron (II) chelating potency was determined as described by Blat et al. [2008] with 
slight modifications. Reactions were carried out in distilled water. In a plastic 
microcentrifuge tube each hydrolyzed sample (800 µl) was incubated with 2 mM FeCl2 
(10 µl) for 30 minutes, followed by addition of 5 mM ferrozine (20 µl, Sigma-Aldrich). 
The resulting solution was kept at room temperature for 1 hour, then the absorbance at 
562 nm (As) was recorded using a UV-visible spectrophotometer. A complex of 
FeCl2/ferrozine has a strong absorbance at 562 nm. A high ferrous ion-chelating ability 
in the test sample results in a low absorbance. A solution of 2 mM FeCl2 (10 µl) in 
distilled water (800 µl), instead of the hydrolyzed samples, was used as control (Ac). A 
water solution of each hydrolyzed sample (800 µl) without FeCl2 was used as blank 
(Ab). The percentage of the Fe(II)-chelating ability was calculated by the following 
equation: 
 
Chelating effect (%) = Ac + Ab – As x100                                                        (eq. 6.7) 
Ac 
 
Defatted hempseed meal incubated under the same experimental conditions without the 
enzyme was used as negative control, whereas the disodium salt of the 
ethylenediaminetetraacetic acid (EDTA(Na2), at various concentration from 0.0001% to 
0.03% w/v) was used as a standard metal chelating agent. All assays were performed in 
triplicate.  
The IC50 value was determined at three different concentrations (0.005%, 0.01%, 0.03% 
w/v) of the hydrolyzed fractions by plotting the reciprocal of the calculated chelating 
effects (%) against that of the sample concentrations (Double Reciprocal plot method). 
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6.3.9. Glutamate content 
 
The amount of free L-glutamate in hempseed hydrolysates was assessed by a 
L-glutamate determination kit (GLN-1, Sigma, Milan - Italy). 
The assay was performed using a buffer containing 1 ml of Hydrazine Hydrate (64% 
Hydrazine) and 19 ml of Tris (100 mM)-EDTA (2 mM) at pH 9.0. A calibration curve 
was obtained using water solutions at different concentrations of L-glutamate (25, 50, 
100, 150 and 250 µM).  
In disposable plastic cuvettes containing 500 µl of buffer were added in succession 30 
mM β-Nicotinamide Adenine Dinucleotide (NAD, 50 µl); 100 mM Adenosine 5'-
Diphosphate (ADP, 5 µl) and the hydrolysate solution (125 µl). The volume was 
adjusted to 1.0 mL with water (320 µl). 
After mixing by inversion, the absorbance of the resulting solutions was recorded at 339 
nm to obtain background reading. Afterward Glutamate Dehydrogenase (L-GLDH; 
1200 U/ml, 10 µl) was added to each solution. The cuvettes were mixed by inversion 
and kept at 37 °C for 1 h, then absorbance at 339 nm was recorded. Net absorbance was 
calculated by subtracting the background absorbance. A solution containing the same 
reagents without hydrolysates was used as blank. 
 
 
6.3.10. Sensory analysis 
 
The sensory profiling was carried out at the Sensory Laboratory of the Special 
Company for Professional Training and Technological and Commercial Promotion of 
the Chamber of Commerce of Savona (Albenga, Italy). At least six subjects participated 
in the descriptive analysis as panelists. The subjects had variable experiences of 
descriptive analysis. Each sample was prepared as 0.1% and 0.5% solutions in 
deionized water. Aliquots (20 mL) of each sample, equilibrated at room temperature (20 
± 2 °C), were presented to the panelists in a disposable plastic cup coded with random 
numbers. The presentation order of the samples was randomised to minimize the 
presentation order effect. The subjects were previously trained until consensus was 
reached to evaluate the five basic tastes (sweet, bitter, sour, salty and umami). The 
 181 
 
sensory attributes were evaluated using a quantitative descriptive analysis method [Jo & 
Lee, 2008], based on “sip and spit” procedure. In more detail, the subjects rinsed their 
mouths with filtered water before tasting each sample. The subjects rated the intensity 
of stimulus using a 10-point category scale whose limits were labelled as “weak” and 
“strong”, respectively. Each sample was evaluated 2 times in different sessions. 
 
 
6.3.11. Statistical analysis 
 
Statistical analyses were performed with the Origin Pro 8 software (Origin Lab Inc., 
Northampton, MA). The data were expressed as mean±SE and evaluated using one-way 
analysis of variance followed by Tukey’s post-hoc test. A level of p<0.05 was used as a 
criterion for statistical significance. 
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6.4. Preparation of HVPs from Hempseed through Chemical 
Hydrolysis  
 
 
 
 
 
 
 
 
6.4.1. Chemical hydrolysis with Acetic Acid  
 
In a flask 50% acetic acid (60 ml) was added to hempseed proteins (100 mg) extracted 
with Method A (section 6.3.2.). The mixture (pH 2.0) was stirred at 110 °C for 18 h, 
then allowed to cool to room temperature and freeze-dried. The freeze-dried product 
was analyzed by reverse-phase HPLC under the following conditions. Flow rate: 0.5 
ml/min. Detection λ: 226, 254, 280 nm. Mobile phase: solvent A, 0.1% TFA in water; 
solvent B, 0.1% TFA in water/acetonitrile (20/80). Gradient elution from 5% to 100% 
solvent B: 
1. column equilibration 0,3 CV + wash out unbound sample 1 CV (corresponding to 1.3 
CV with 5% B) 
2. gradient 1: from 5% to 30% B in 1 CV  
3. gradient 2: from 30% to 50% B in 3 CV  
4. gradient 3: from 50% to 100% B in 1 CV  
5. clean after gradient 1: 100% B for 1 CV 
6. re-equilibration: 5% B for 2 CV 
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6.4.2. Chemical hydrolysis with Formic Acid  
 
In a flask 20% formic acid (60 ml) was added to hempseed proteins (100 mg) extracted 
with Method A (section 6.3.2.). The mixture was stirred at 110 °C for 6 hours, then at 
room temperature overnight, and finally freeze-dried. The freeze-dried product was 
analyzed by reverse-phase HPLC and by SDS-PAGE under the conditions described in 
6.4.1. and 6.3.5.2 sections, respectively. 
 
 
6.4.3. Chemical hydrolysis of defatted hempseed flour with 
Hydrochloric Acid 
 
Hydrolysis of defatted hempseed flour with hydrochloric acid was performed according 
to Aaslyng [Aaslyng, 1998]. In a three-necked flask, a solution of 4 M HCl (150 ml) 
was added to defatted hemp seed flour (3.0 g). The mixture was stirred at 110 °C for 6 
hours, then was allowed to cool to room temperature, neutralized with 4 M NaOH and 
vacuum filtered on a sintered glass filter. The undigested material formed very dark and 
small clusters. After treatment with active carbon, followed by filtration trough celite, 
the dark solution became clear and light yellow in color. The product was stored at -
20 °C. 
 
 
6.4.4. Chemical hydrolysis of hempseed proteins with 6 M HCl for 6 h 
at 110 °C 
 
In a round bottom flask, a solution of 6 M HCl (150 ml) was added to hempseed 
proteins (1.5 g). The mixture was stirred at 110 °C for 6 hours, then was allowed to cool 
to room temperature. Finally it was neutralized with 4 M NaOH, adding Na2CO3 as a 
buffer, at 0 °C up to pH 5.8. The solution was diluted with water (1:20) and freeze-
dried. The freeze-dried product was analyzed and purified by RP HPLC.  
Analytical RP HPLC was performed under the conditions described in 6.4.1. section. 
Preparative RP HPLC was performed under the following conditions. Flow rate: 0.5 
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ml/min. Detection λ: 226, 254, 280 nm. Mobile phase: solvent A, 0.1% TFA in water; 
solvent B, 0.1% TFA in water/acetonitrile (20/80). Gradient elution from 5% to 100% 
solvent B: 
1. column equilibration 0,3 CV + wash out unbound sample 1 CV (corresponding to 1.3 
CV with 5% B) 
2. gradient 1: from 5% to 30% B in 2 CV  
3. gradient 2: from 30% to 50% B in 6 CV  
4. gradient 3: from 50% to 100% B in 1 CV 
5. clean after gradient 1: 100% B for 1 CV  
6. reequilibration: 5% B for 2 CV  
The fractions purified by RP-HPLC were analyzed by 1H-NMR, DOSY and TOCSY (at 
500 MHz and 310 K). NMR analysis was performed by ISMAC-CNR of Milan. The 
major peak was also analyzed by MS-MALDI.  
Moreover, the ACE-inhibitory activity was assessed. 
 
 
6.4.5. Chemical hydrolysis of hempseed proteins with 0.1 M HCl for 48 
h at 63 °C 
 
In a round bottom flask, a solution of 0.1 M HCl (100 ml) was added to hempseed 
proteins (1.11 g). The mixture (pH 4.0) was stirred at 63 °C for 48 hours, then was 
allowed to cool to room temperature. To remove salts, activated AMBERLITE 402 
resin (2.0 g) was added to the mixture. After stirring for 2 hours, the resin was filtered 
under vacuum and the solution was freeze-dried. A brown amorphous solid (1.0 g) was 
obtained.  
Analytical RP HPLC was performed under the conditions described in 6.4.1. section. 
The freeze-dried product was analyzed by 1H-NMR, DOSY and TOCSY (at 500 MHz 
and 310 K). NMR analysis was performed by ISMAC-CNR of Milan. 
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6.4.6. Chemical hydrolysis of hempseed proteins 1 M HCl M for 6 h at 
110 °C 
 
In a two-necked bottom flask, a solution of 1 M HCl (150 ml) was added to hempseed 
proteins (1.50 g). The mixture was stirred at 110 °C for 6 hours, then was allowed to 
cool to room temperature. To remove salts, activated AMBERLITE 402 resin (30.0 g) 
was added to the mixture. After stirring for 2 hours, the resin was filtered under vacuum 
and the solution was freeze-dried. 
Analytical and preparative RP HPLC were performed under the conditions described in 
6.4.1. section. The freeze-dried product was analyzed by 1H-NMR, DOSY and TOCSY 
(at 500 MHz and 310 K). NMR analysis was performed by ISMAC-CNR of Milan. 
 
 
6.4.7. Chemical hydrolysis of hempseed proteins with 1 M HCl for 48 h 
at 63 °C 
 
In a two-necked bottom flask, a solution of 1 M HCl (100 ml) was added to hempseed 
proteins (1.00 g). The mixture was stirred at 63 °C for 48 hours, then was allowed to 
cool to room temperature. To remove salts, activated AMBERLITE 402 resin (30.0 g) 
was added to the mixture. After stirring for 1 hours, the resin was filtered under vacuum 
and the solution was freeze-dried. A brown amorphous solid (400 mg) was obtained.  
Analytical and preparative RP HPLC were performed under the conditions described in 
6.4.1. section. The freeze-dried product was analyzed by 1H-NMR, DOSY and TOCSY 
(at 500 MHz and 310 K). NMR analysis was performed by ISMAC-CNR of Milan. 
 
 
6.4.8. Chemical hydrolysis of hempseed proteins with 3 M HCl for 8 h 
at 100 °C 
 
In a two-necked bottom flask, a solution of 3 M HCl (200 ml) was added to hempseed 
proteins (2.00 g). The mixture was stirred at 100 °C for 8 hours, then was allowed to 
cool to room temperature. To remove salts, activated AMBERLITE 400 resin (15.0 g) 
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was added to the mixture. After stirring for 3 hours, the resin and insoluble product 
were filtered under vacuum. The solution was neutralized with 4 M NaOH, adding 
Na2CO3 as a buffer, up to pH 5.8 and freeze-dried. 
Analytical and preparative RP HPLC were performed under the conditions described in 
6.4.1. section. 
 
 
6.4.9. ACE-inhibitory activity assay 
 
The assay was performed by using Hippuryl-Histidyl-Leucine (HHL) as substrate 
[Cushman & Cheung, 1971] and HPLC DAD for the detection of Hippuric Acid (HA) 
[Wu at al., 2002]. Some modifications were introduced, as described below. A volume 
of 100 µl of 2.5 mM HHL in buffer 1 (100 mM tris-HCOOH, 300 mM NaCl pH 8.3) 
was mixed with 30 µl of “inhibitor” in buffer 1 at different concentrations. 
The “inhibitor” is a peptide mixture obtained from the digestion of proteins, i.e. TPEs, 
industrial isolates, or laboratory purified proteins. Usually, at least 6 concentrations 
were used for each inhibitor, and each solution was tested twice: the highest 
concentration used in the assays was 1035.9 µg/ml; serially dilutions were performed to 
obtain the other concentrations (Table 6.2). 
 
Table 6.2. 
Conc. Inib (µg/ml) 
0.00 
28.75 
115.02 
345.07 
690.13 
1035.9 
 
HHL solution was daily prepared because, in line with our experience and literature 
data [Shalaby et al., 2006], it is not very stable. Samples were pre-incubated at 37 °C 
for 15 min, then 15 µl of ACE solution, corresponding to 3 mU of enzyme in buffer 2 
(100 mM tris-HCOOH, 300 nM NaCl, 10 µM ZnCl2, pH 8.3), were added; samples 
were then incubated for 60 min at 37 °C. The reaction was stopped with 125 µl of 0.1 M 
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HCl. The aqueous solution was extracted twice with 600 µl of ethyl acetate, and the 
solvent was evaporated at 95 °C, the residue was then dissolved in 500 µl of buffer 1 
and analyzed by HPLC. In our experiments, the direct injection in HPLC did not give 
optimal results regarding peak shape and baseline for a reliable and accurate 
quantification. For this reason, we decided to perform the extraction step, using ethyl 
acetate and a double step of extraction followed by the evaporation of solvent in glass 
vials. The evaporation conditions greatly influenced the results of the assay: a trace of 
residual solvent results in abnormally high absorbance values [Lam et al., 2007]. 
Obviously the sample preparation requires one more step, but the extraction assures 
good reproducibility in the quantification of the HA chromatographic peak and the 
absence of interfering peaks due to peptides. Sigmoid curves (Figure 2) fit very well the 
data points representing the ACE inhibition in function of inhibitor concentration, as 
pointed out by the correlation coefficient (R2). 
HPLC analyses were performed with a HPLC 1200 Series equipped with an 
autosampler (Agilent Technologies, Santa Clara, US) with a Lichrospher 100, C18 
column (4.6-250 mm, 5 lm; Grace, Italy). Water and acetonitrile were used as solvents 
with the following gradient: 0 min 5% acetonitrile, 10 min 60% acetonitrile, 12 min 
60% acetonitrile, 15 min 5% acetonitrile. Injection volume was 10 µl, wavelength 228 
nm, flow 0.5 ml/min. The retention time of hippuric acid (HA) was 4.2 min. The 
detector response for standard HA was linear in the range 1–100 µg/ml. The relative 
standard deviation for determination of the 10 µg/ml HA solution was 2.5% (n = 8), 
very similar to already published data [Wu et al., 2002]. 
 
ACE inhibition measurement 
The evaluation of ACE inhibition was based on the comparison between the 
concentrations of HA in the presence or absence of an inhibitor (inhibitor blank). The 
phenomenon of autolysis of HHL to give HA was evaluated by a reaction blank, i.e. a 
sample with the higher inhibitor concentration and without the enzyme. 
The percentage of ACE inhibition was computed considering the area of HA peak with 
the following formula: 
 
% ACE inhibition = [(AIB - AN)/ [(AIB - ARB)]x10               (eq. 6.8) 
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where AIB is the area of HA in Inhibitor Blank (IB) sample (i.e. sample with enzyme but 
without inhibitor), AN is the area of HA in the samples containing different inhibitor 
amounts and ARB is the area of HA in the reaction blank (RB) sample (i.e. sample 
without enzyme and with inhibitor in the highest concentration). 
The percentages of ACE inhibition were plotted vs. log10 inhibitor concentrations, 
obtaining a sigmoid curve; IC50 was defined as the inhibitor concentration needed to 
observe a 50% inhibition of the ACE activity. Only when the ACE-inhibitory activity 
was more than 50%, the IC50 value was calculated. The IC50 values were obtained 
independently testing each inhibitor three times. 
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6.5. Preparation of HVPs from Flaxseed through Enzyme-
catalyzed Hydrolysis. 
 
 
 
 
 
 
 
Four Italian cultivars of flax (Linum usitatissimum L.) seeds, namely, Solal, Merlin 
Linoal and Natural, harvested in Cavriana (MN) and Treviglio (BG), were provided by 
CNR -Institute of Biology and Biotechnology (IBBA) of Milan, Italy, during 
2011/2012. A voucher specimen is stored and preserved in our laboratory at Department 
of Chemistry at University of Milan. Seeds were stored at 4 °C in the dark until use. 
 
 
6.5.1. Defatted Flaxseed Meal 
 
According to the method described for hemp seeds in section 6.3.1, defatted flaxseed 
flour was obtained by stirring with n-hexane and milling the flax seeds. Both defatted 
flaxseed flour and extracted hemp oil were stored at -20 °C until use. 
The protein contents of defatted flaxseed flour was determined according to the 
Kjeldahl method, which was performed by Centro di Ricerca per le Produzioni 
Foraggere e Lattiero-Casearie (CRA) of Lodi, by measuring the nitrogen content with a 
CNH analyzer [AOAC, 1980]. The value of 6.25 was used as conversion factor to 
determine the protein content. 
 
 
6.5.2. Extraction of Mucilage 
 
Mucilage of defatted flaxseed flour was extracted according to the slightly modified 
method of Bagnasco et al. (2013). Each cultivar of defatted flaxseed flour was 
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suspended with distilled water (ratio 1:10 w/v) and kept under shaking for 12 h in a 
shaker at room temperature. The suspension was centrifuged at 8000 rpm for 30 min to 
recover both supernatant and the residue. The residue, containing de-mucilaginated and 
defatted flaxseed flour, was dried in an oven at 50-70 °C for two days. The resulting 
viscous solutions containing the dissolved polysaccharides was filtered through a sterile 
gauze and precipitated with ethanol (in ration 1:1.5 v/v) for 1 hour at 4 °C. Mucilage 
was then recovered by centrifuging at 8000 rpm for 30 min at room temperature. The 
pellet was dissolved in distilled water and freeze-dried. Both freeze-dried mucilage and 
dried flaxseed flour were stored at -20 ° C until use. 
 
 
6.5.3. Enzymatic Hydrolysis 
 
The enzymatic hydrolysis of defatted flaxseed flour was performed in semi-preparative 
scale according to the method described for hemp seeds in section 6.3.3.. 
Defatted hempseed flour (20 g corresponding to 3.5 g of proteins) was suspended in 100 
mM ammonium bicarbonate buffer (final concentration 10% w/v) by adjusting pH to 
the optimal value for any enzyme, as indicated by manufacturers. Any suspension was 
preincubated for 20 minutes at the desired temperature. The specific protease was added 
to the reaction mixture in order to give a final enzyme/substrate ratio (E/S) of 5% w/w 
(135 µl of Flavourzyme® and 200 mg of Umamizyme® were used, respectively) and the 
mixture was stirred at 400 rpm. 
Hydrolyses were carried out in the above conditions and stopped after 1, 7, 14 and 24 
hours by addition of formic acid up to pH 3.5 to inactivate the enzyme. Subsequently 
the suspensions were sonicated in a water-bath for 10 minutes and centrifuged at 8000 
rpm for 30 min at room temperature to recover solubilized proteins and peptides and 
remove the undigested materials. The supernatants, containing HVPs, were collected, 
freeze-dried and stored at -20 °C before further analysis. Controls of the proteolysis 
experiments were obtained by repeating the above procedure without the enzymes. 
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6.5.4. SDS-PAGE  
 
The SDS-PSGE analysis of flaxseed  mucilage was carried out according to the method 
described for hemp seeds in section 6.3.5.. 
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7. EXPERIMENTAL SECTION 
PART 2 
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7.1 General - Synthesis of modified nucleosides 
 
 
 
 
 
 
 
 
 
All reagents were purchased from Sigma-Aldrich (Milan, Italy) and/or from VWR 
International and were used without further purification. All the solvents were of HPLC 
grade. 
Analytical Thin Layer Chromatography TLC was performed on silica gel 60 F254 or 60 
RP-18 F254s precoated aluminum sheets (0.2 mm layer; Merck, Darmstadt, Germany); 
components were detected under an UV lamp (λ 254 nm), by spraying with a ceric 
sulfate/ammonium molybdate solution or with a ninhydrin solution [5% (w/v) ninhydrin 
in ethanol], followed by heating at about 150 °C. Hybrid compounds were detected by 
exposing the TLC sheets to iodine vapors. 
 
Puritication Methods: Amberlite XAD-4 was purchased from Supelco (Sigma-Aldrich). 
Purification of products was accomplished either by flash chromatography (silica gel 
60, 40–63 mm, Merck) or by preparative HPLC using an Amersham pharmacia biotech 
(P900) liquid chromatographer connected to a UV-vis detector; chromatographic 
conditions were as follows: column, Jupiter RP-18 (4µ, proteo 90 A size: 25x2.12 cm, 
Phenomenex); flow rate, 0,5 ml/min; detector, λ 226 and 254 nm; mobile phase: 
A (0,1% TFA (v/v) in water) and B (80% acetonitrile/ 20% water with 0,1% of TFA), 
gradient elution from 5% to 100% B in 45 min.  
 
NMR Spectroscopy: 1H, 13C and 13P NMR spectra were acquired at 400.13, 100.61 and 
161.96 MHz, respectively, on a Bruker Advance 400 spectrometer (Bruker, Karlsruhe, 
Germany) interfaced with a workstation running a Windows operating system and 
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equipped with a TOPSPIN software package. 1H and 13C chemical shifts (δ) are given in 
parts per million (ppm) and are referenced to the solvent signals [δH 7.25, δC 77.00; δH 
2.50 and δC 39.50 ppm from Tetramethylsilane (TMS) for CDCl3 and DMSO-d6, 
respectively]. 31P chemical shifts (ppm) are referred to 85% H3PO4 as the external 
standard (δ 0.00 ppm). 13C NMR signal multiplicities were based on attached proton test 
(APT) spectra. 1H signals were assigned with the aid of 1H–1H correlation spectroscopy 
(1H–1H COSY). 13C NMR signals were assigned on the basis of heteronuclear multiple-
quantum correlation (HMQC) and heteronuclear multiple-bond correlation (HMBC) 
experiments.  
 
Mass Spectrometry: Electrospray ionization mass (ESI-MS) spectra were recorded on a 
Thermo Finnigan LCQ Advantage spectrometer (Hemel Hempstead, Hertfordshire, 
UK). 
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7.2. Synthesis of 1,6-Diamino-N-tert-butyloxycarbonylhexane (A1) 
 
 
 
A solution of (Boc)2O (764 mg, 3.5 mmol) in CH2Cl2 (30 ml) was added dropwise over 
1 hto a stirred solution of 1,6-diaminohexane A (2.034 g, 17.5 mmol) in CH2Cl2 (70 ml) 
at 0 °C. The mixture was stirred at 0 °C for 2 h, then at room temperature for another 
1 h (TLC monitoring, eluent MeOH/30% NH39:1, Rf product = 0.36). 
The mixture was filtered trough celite and the filtrate was evaporated under reduced 
pressure. The colorless oily residue was taken up with AcOEt (80 ml) and washed with 
brine (20 ml x 5). The aqueous layer was extracted with AcOEt (50 ml). The combined 
organic layers were dried over Na2SO4 and the solvent was evaporated under reduced 
pressure to give 1,6-Diamino-N-tert-butyloxycarbonylhexane A1 (725 mg, 3.35 mmol) 
as a slightly coloured oil.  
 
Yield = 96% 
 
1H NMR (400 MHz, CDCl3): 
δ 1.14 (s, 2H, -NH2), 1.26-1.37 (m, 4H, -CH2-), 1.37-1.52 (s + m, 9H + 4H, t-Bu + -
CH2-), 2.67 (t, 2H; NCH2-), 3.09 (q, 2H, -C(O)NCH2-); 4.60 (bs, 1H, -C(O)NH-). 
 
13C NMR (100 MHz, CDCl3): 
δ 26.4 (2C, CH23,4); 26.5 (CH22); 28.3 (3C, -COOC(CH3)3); 29.9 (CH25); 33.6 (CH26); 
42.0 (CH21NHCO-); 78.8 (C(CH3)3); 155.9 (-COOC(CH3)3). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 217 [M+H+]. 
 
[Pons, 1998] 
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7.3. Synthesis of 1,4-diamino-N-tert-buthoxycarbonylbutane (B1) 
 
B1
O O O
O
H
N O
O
H2NH2N
CHCl3
O
B
0 °C
NH2
 
 
A solution of (Boc)2O (1.59 g, 7.3 mmol) in CHCl3 (15 ml) was added dropwise over 
4 h to a stirred solution of 1,4-diaminobutane B (3.82 ml, 38.0 mmol) in CHCl3 (30 ml) 
at 0 °C. The resulting solution was stirred at room temperature overnight monitoring the 
progress of the reaction by TLC (eluent ammonia-saturated CH2Cl2/MeOH 9:1, 
Rf product = 0.34). 
Then, the resulting slurry mixture was diluted in CHCl3 (30 ml) and washed with 1 N 
NaHCO3 (30 ml x 2) and brine (30 ml). The organic layer was dried over Na2SO4 and 
concentrated under reduced pressure to obtain compound B1 as a clear yellow oil 
(5.84 g, 31.0 mmol). 
 
Yield: 80% 
 
1H NMR (400 MHz, CDCl3): 
δ 4.88 (br s, 1H); 3.12 (m, 2H); 2.72 (m, 2H); 1.49 (m, 4H); 1.45 (s, 9H); 1.18 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): 
δ 155.79; 41.54; 40.11; 30.64; 28.14; 27.19. 
 
Mass spectrum 
ESI-MS positive mode, m/z:189.0 [M+H]+. 
 
[Pons, 1998] 
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7.4. Synthesis of 2’,3’,5’-Tri-O-acetylguanosine (4.2) 
 
 
 
In a three-necked round-bottom flask, to a suspension of guanosine 4.1 (5.0 g, 17.66 
mmol) in dry acetonitrile (100 ml) dimethylaminopyridine (DMAP 130 mg, 1.06 mmol) 
and triethylamine (TEA 8.8 ml, 63.56 mmol) were added under nitrogen atmosphere. 
The mixture was stirred for some minutes and acetic anhydride (5.8 ml, 61.81 mmol) 
was added dropwise at 0 °C. Then the mixture was allowed to cool to room temperature 
under stirring. The reaction progress was monitored the by TLC analysis 
(eluent CH2Cl2/MeOH 9:1, Rf product = 0.45).  
After the complete dissolution of 4.1 (about 30 minutes), methanol (150 ml) was added 
and the solution was evaporated under reduced pressure. The crude yellow oil residue 
was recrystallizated adding 2-propanol (20 mL). This mixture was stored at 4 °C 
overnight, filtered and washed with 2-propanol and n-hexane to give compound 4.2 (6.8 
g, 17.66 mmol) as a white soft solid. 
 
Yield = 94% 
 
1H NMR (400 MHz, DMSO-d6): 
δ 2.04 (s, 9H, -COCH3); 4.28 (m, 2H, CH25’a/b); 4.36 (dd, J = 3.7 Hz, 1H, CH4’); 5.49 
(dd, J = 6 Hz, 1H, CH3’); 5.78 (dd, J = 6 Hz, 1H, CH2’); 5.98 (d, J = 6 Hz, 1H, CH1’); 
6.59 (br s, 2H, NH2); 7.93 (s, 1H, CH8); 10.85 (br s, 1H, N1H). 
 
13C NMR (100 MHz, DMSO-d6): 
δ 20.09-20.27-20.42 (3 -CacetylH3) ; 63.02 (C5’); 70,29 (C3’); 72.07 (C2’); 79.51 (C4’); 
84.53 (C1’); 116.85 (C5); 135.59 (C8); 151.05 (C4); 153.83 (C2); 156.60 (C6); 169.6-
169.8-170.4 (3 -COacetyl). 
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Mass spectrum 
ESI-MS positive mode, m/z: 410.1 [M+H+]; 432.2 [M+Na+];  841.1 [2M+Na+]; 1249.8 
[3M+Na+]; 1659.5 [4M+Na+].  
 
[Bridson, 1977] 
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7.5. Synthesis of 2’,3’,5’-O-triacetyl-6-chloroguanosine (4.3) 
 
 
 
In an anhydrous two-necked round-bottom flask to a mixture of pre-dried 2’,3’,5’-tri-O-
acetylguanosine 4.2 (10.233 g, 25 mmol) and Et4NCl (8.288 g, 50 mmol, pre-dried in 
vacuo at 80°C for one day over P2O5), acetonitrile (50 mL, distilled from P2O5 under an 
argon atmosphere) and N,N-dimethylaniline (DMA 3.16 ml, 25 mmol, pre-distilled 
from CaH2 under a nitrogen atmophere) were added under a stream of dry nitrogen. The 
solution was stirred for 2 min and phosphoryl chloride (13.7 ml, 15 mmol) were added 
dropwise at room temperature. The flask was placed in an oil bath preheated to 100 °C 
and the solution was stirred at reflux for 35 min until TLC showed the complete 
disappearance of 4.2 (eluent CH2Cl2/MeOH 9.5:0.5, Rf product = 0.45). 
Volatiles were evaporated immediately under reduced pressure. The resulting yellow 
foam was dissolved in CHCl3 (150 ml) and stirred vigorously with crushed ice for 15 
min. The layers were separated and the aqueous phase was extracted with CHCl3 (4 x 
50 ml). The combined organic phase was washed with cold water (3 x 60ml), 
5% NaHCO3/H2O up to pH 7 (3 x 50 ml) and brine (2 x 50 ml), dried over Na2SO4, 
filtered, and concentrated to 1/2 of the starting volume. 2-Propanol (60 ml) was added 
and the solution was slowly concentrated under reduced pressure to 40 ml. The mixture 
was stored at 4 °C overnight. The crystalline product was filtered and washed with 
2-propanol to give crude 4.3 (8.50 g, 19.9 mmol, 79%). This product was recrystallized 
with 2-propanol to give purified 4.3 (8.10 g, 19 mmol) as a white crystalline solid. 
 
Yield = 76 % 
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1H NMR (400 MHz, CDCl3): 
δ 2.11-2.12-2.17 (3s, 9H, -COCH3); 4.36-4.51 (m, 2H, CH25’a/b); 4.36 (m, 1H, CH4’); 
5.25 (br s, 2H, NH2); 5.77 (dd, J = 5.00 Hz, 1H, CH3’); 5.98 (dd, J = 5.2 Hz, 1H, CH2’); 
6.03 (d, J = 5.2 Hz, 1H, CH1’); 7.90 (s, 1H, CH8). 
 
13C NMR (100 MHz, CDCl3): 
δ 20.38-20.49-20.66 (3 -CacetylH3) ; 62.91 (C5’); 70,53 (C3’); 72.78 (C2’); 80.06 (C4’); 
86.66 (C1’); 125.88 (C5); 140.67 (C8); 151.95 (C6); 153.11 (C4); 159.12 (C2); 169.29-
169.51-170.42 (3 -COacetyl). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 428.2 [M+H]+; 450.4 [M+Na]+; 259.2 [M+-nitrogen base].  
 
[Robins et al., 1981] 
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7.6. Synthesis of 2-iodo-6-chloro-9-(2’,3’,5’-tri-O-acetyl-β-d-ribofuranosyl)-purine 
(4.4) 
 
 
 
In an anhydrous three-necked flask to a suspension of 6-chloro-2’,3’,5’-O-
triacetylguanosine 4.3 (855 mg, 2 mmol) in dried acetonitrile (2.5 ml, distilled from 
P2O5 under an argon atmosphere) CH2I2(0.8 ml, 10 mmol) was added under a stream of 
dry nitrogen. The solution was stirred for 2 min and t-butyl nitrite (0.36 ml, 3 mmol) 
were added dropwise at room temperature. The flask was placed in an oil bath preheated 
to 100 °C and the solution was stirred at reflux for 20 min, until TLC showed the 
complete disappearance of 4.3 (eluent AcOEt/n-hexane 6.5:3.5, Rf product = 0.4).  
Volatiles were evaporated immediately under reduced pressure. The resulting deep red 
residue was dissolved in AcOEt (50 ml) and stirred vigorously with an aqueous 
saturated NaS2O3 solution (50 ml) for some minutes. The layers were separated and the 
aqueous phase was extracted with AcOEt (3 x 50 ml). The combined organic phase was 
washed with brine (4 x 50ml), dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash chromatography (eluent AcOEt/n-
hexane = 6.5:3.5). The yellow crude was taken up in AcOEt (8 ml) and precipitated 
with cold n-hexane to give 2-iodo-6-chloro-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)-
purine 4.4 as a white solid (625 mg, 1.16 mmol). 
 
Yield = 58 % 
 
1H NMR (400 MHz, CDCl3): 
δ 2.13 (s, 3H, 3’-COCH3); 2.16 (s, 3H, 5’-COCH3); 2.20 (s, 3H, 2’-COCH3); 4.40 (m, 
2H, H5’); 4.49 (m, 1H, H4’); 5.61 (dd, J = 5.6 Hz, 1H, H3’); 5.80 (dd, J = 5.6 Hz, 1H, 
H2’); 6.22 (d, J = 5.2 Hz, 1H, H1’); 8.22 (s, 1H, H8). 
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13C NMR (100 MHz, CDCl3): 
δ 20.38 (2’-CacetylH3); 20.52 (5’-CacetylH3); 20.82 (3’-CacetylH3); 62.92 (C5’); 70.61(C3’); 
73.38 (C2’); 80.91 (C4’); 86.69 (C1’); 116.97 (C2); 132.27 (C5); 143.07 (C8); 151.06 (C6); 
151.96 (C4); 169.34 (2’-COacetyl); 169.50 (3’-COacetyl); 170.15 (5’-COacetyl). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 561.2, 562.2 [M+Na]+ (relative peak height ratio = 3:1) 
 
[Ohno et al., 2004] 
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7.7. Synthesis of 2-iodo-6-methoxy-9-(β-D-ribofuranosyl)-purine (4.5a) 
 
 
 
In a two-necked, round-bottom flask dry methanol (24 ml) was charged. Under a stream 
of dry nitrogen, sodium (214 mg, 9.3 mmol) was added slowly in pieces. After the 
complete dissolution of the metal, the solution was allowed to cool to room temperature 
and 2-iodo-6-chloro-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)-purine 4.4 (500 mg, 
0.93 mmol) was added. The mixture was stirred for 20 min at room temperature until 
TLC showed the complete disappearance of 4.4 (eluent CH2Cl2/MeOH 6:1, Rf product 
= 0.5). 
The reaction was quenched with NH4Cl (498 mg, 9.3 mmol) and the resulting mixture 
was stirred for some minutes. After vacuum filtration the solution was mildly 
concentrated under reduced pressure to obtain a white solid, which was dissolved in 
distilled water and adsorbed on Amberlite XAD-4 resin 20-50 Mesh (1 g of product: 30 
g of resin) at room temperature over night. The mixture was vacuum filtered, and the 
product was desorbed from the resin with methanol. Finally methanol was evaporated 
under reduced pressure to give 2-iodo-6-methoxy-9-(β-D-ribofuranosyl)-purine 4.5a as a 
white solid (374 mg, 0.92 mmol).  
 
Yield = 99 % 
 
1H NMR (400 MHz, CD3OD): 
δ 3.79 (dd, J1 = 12.3, J2 = 3.4 Hz, 1H, CH5’); 3.91 (dd, J1 = 12.3, J2 = 3.0 Hz, 1H, CH5’); 
4.14-4.20 (m, 1H, CH4’); 4.18 (s, 3H, -OCH3); 4.36 (dd, J1 = 4.9, J2 = 3.9 Hz, 1H, 
CH3’); 4.68 (dd, J1 = 5.3 Hz, J2 = 5.3 Hz,1H, CH2’); 6.04 (d, J = 5.5 Hz, 1H, CH1’); 
8.48 (s, 1H, CH8).  
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13C NMR (100 MHz, CD3OD): 
δ 54.42 (-OCH3); 61.53 (C5’); 70.67  (C3’); 74.36 (C2’); 86.15 (C4’); 89.41 (C1’); 117.04 
(C2); 121.23 (C5); 142.18 (C8); 151.85 (C4); 159.61 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 431.4 [M+Na]+. 
ESI-MS negative mode, m/z: 275.7 [M-ribose moiety]; 815.7 [2M-H+] 
 
[Robins et al., 1981]  
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7.8. Synthesis of 2-iodo-6-benzyloxy-9-(β-D-ribofuranosyl)-purine (4.5b) 
 
 
 
In a two-necked, round-bottom flask dry benzyl alcohol (4 mL) was charged. Under a 
stream of dry nitrogen, sodium (184 mg, 4 mmol) was added slowly in pieces. After the 
complete dissolution of the metal, the solution was allowed to cool to room temperature. 
The obtained solution was then added under stirring to a cooled (0 °C) mixture of 2-
iodo-6-chloro-9-(2',3',5'-tri-O -acetyl-β-D-ribofuranosyl)-purine 4.4 (1.077 g, 
2.00 mmol) in dry DMF (8.5 ml), under an argon atmosphere. The mixture was stirred 
at 0 °C monitoring the progress of the reaction by TLC analysis (eluent CH2Cl2/MeOH 
9.5:0.5, Rf product = 0.32). 
After 40 minutes the reaction was quenched with NH4Cl (498 mg, 6 mmol) and was 
stirred for 10 minutes. The resulting mixture was diluited with water (10 ml) and 
extracted with ethyl acetate (4 x 10 ml). The combined organic phase were washed with 
brine (15 ml), dried on sodium sulfate, and concentrated under reduced pressure. The 
residue was purified by flash chromatography (CH2Cl2/MeOH 9.5:0.5) to give 2-iodo-6-
benzyloxy-9-(β-D-ribofuranosyl)-purine 4.5b as a white crystalline solid(720 mg, 1.49 
mmol).  
 
Yield = 75% 
 
1H NMR (400 MHz, CD3OD): 
δ 3.78 (dd, J1 = 12.3, J2 = 3.4 Hz, 1H, CH5’); 3.90 (dd, J1 = 12.3, J2 = 3.0 Hz, 1H, CH5’); 
4.16 (dd, J1 = 6.7, J2 = 3.3 Hz, 1H, CH4’); 4.35 (dd, J1 = 5.0, J2 = 3.7 Hz, 1H, CH3’); 
4.67 (dd, J1 = 5.3 Hz, J2 = 5.3 Hz,1H, CH2’); 5.63 (s, 2H, -CH2Ph); 6.04 (d, J = 5.5 Hz, 
1H, CH1’);  7.38-7.59 (m, 5H); 8.48 (s, 1H, CH8).  
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13C NMR (100 MHz, CD3OD): 
δ 62.16 (C5’); 70.08 (CH2Ph); 71.31  (C3’); 75.04 (C2’); 86.79 (C4’); 90.08 (C1’); 117.49 
(C2); 121.92 (C5); 128.20-128.31-128.60-128.81-129.15-136.26 (-C6H5); 142.18 (C8); 
152.75 (C4);  159.61 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 507.4 [M+Na]+; 991.3 [2M+Na]+, 375 [M-ribofuranosyl 
moiety]+. 
 
[Casu et al., 2012] 
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7.9. Synthesis of 2-iodo-6-methoxy-9-(β-D-2’,3’-O-isopropyliden)-purine (4.7a) 
 
 
 
To a suspension of 2-iodo-6-methoxy-9-(β-D-ribofuranosyl)-purine 4.5a (1.22 g, 3 
mmol) in acetone (30 ml), p-toluensulphonic acid (285 mg, 1.5 mmol) and 2,2-
dimethoxypronane (4.00 ml, 30 mmol) were added, under an argon atmosphere. The 
mixture was stirred at room temperature until TLC showed the complete disappearance 
of 4.5a (eluent AcOEt2/n-hexane = 7:3). After 6 hn-hexane was added in order to obtain 
a white precipitate. The mixture was stored at 4 °C overnight and filtered. Compound 
4.7a was obtained as a white solid (1.062 g, 2.37 mmol). 
 
Yield: 79% 
 
1H NMR (400 MHz, DMSO-d6): 
δ 1.35 (s, 3H, C(CH3)); 1.56 (s, 3H, C(CH3)); 3.54 (td, J1 = 5.2 Hz, J2 = 1.4 Hz, 2H, 
CH25’a/b); 4.09 (s, 3H, -OCH3); 4.24 (dd,  J1 = 7.5 Hz, J2 = 4.8 Hz, 1H, CH4’); 4.96 (dd, 
J1 = 6.1 Hz, J2 = 2.7 Hz, 1H, CH3’); 5.06(t, J = 5.3 Hz, 1H, -OH5’);  5.33 (dd, J1 = 6.1 
Hz, J2 = 2.5 Hz, 1H, CH2’); 6.17 (d, J = 2.4 Hz, 1H, CH1’); 8.52 (s, 1H, CH8). 
 
13C NMR (100 MHz, DMSO-d6): 
δ 25.69 (C(CH3)2); 27.48 (C(CH3)2); 55.30 (-OCH3); 61.90 (C5’); 81.77 (C3’); 84.14 
(C2’); 87.68 (C4’); 90.06 (C1’); 113.58 (C(CH3)2); 118.97 (C2); 121.51 (C5); 142.68 (C8); 
152.65 (C4);  159.92 (C6). 
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Mass spectrum 
ESI-MS positive mode, m/z: 277.2 [M+-nitrogen base]; 449.1 [M+H+]; 471.2 [M+Na+]. 
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7.10. Synthesis of 2-iodo-6-benzyloxy-9-(β-D-2’,3’-O-isopropyliden)-purine (4.7b) 
 
 
 
To a suspension of 2-iodo-6-benzyloxy-9-(β-D-ribofuranosyl)-purine 4.5b (660 mg, 
1.36 mmol) in acetone (15 ml), p-toluensulphonic acid (258 mg, 1.36 mmol) and 2,2-
dimethoxypronane (1.67 ml, 13.60 mmol) were added, under an argon atmosphere. The  
mixture was stirred at room temperature until complete dissolution of 4.5b (about 30 
minutes) monitoring the reaction progress by TLC (CH2Cl2/MeOH 9.6:0.4, Rf product = 
0.4). The solvent was evaporated under reduced pressure. The yellow foam residue was 
taken up in ethyl acetate (10 ml), washed with NaHCO3 (2 x 5ml) and brine (5 ml). The 
organic phase was dried on Na2SO4, concentrated under reduced pressure to 1/3 of the 
starting volume and n-hexane (1 ml) was added in order to obtain compound 4.7b as a 
white foam solid (510 mg, 1.36 mmol). 
 
Yield: 100% 
 
1H NMR (400 MHz, CDCl3): 
δ 1.40 (s, 3H, CH3);1.66 (s, 3H, CH3);3.84 (dd, J1 = 12.8, J2 = 2.0 Hz, 1H, CH5’); 4.02 
(dd, J1 = 12.8, J2 = 1.6 Hz, 1H, CH5’); 4.54 (d, J = 1.4 Hz, 1H, CH4’); 5.14 (dd, J1 = 6.0 
Hz, J2 = 1.3 Hz, 1H, CH3’); 5.17-5.22 (m, 1H, CH2’); 5.66 (d, J = 2.0 Hz, 2H, -CH2Ph); 
5.86 (d, J = 4.9 Hz, 1H, CH1’); 7.33-7.58 (m, 5H, -C6H5); 7.90 (s, 1H, CH8).  
 
13C NMR (100 MHz, CDCl3): 
δ 25.91-28.29 (2 –C(CH3) 2); 64.03 (C5’); 70.53 (CH2Ph); 82.18 (C3’); 83.45 (C2’); 86.58 
(C4’); 94.63 (C1’); 115.00 (-C(CH3)2); 117.85 (C2); 123.79 (C5); 129.20-129.28-129.75-
135.71 (-C6H5); 142.52 (C8); 152.16 (C4);  160.30 (C6). 
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Mass spectrum 
ESI-MS positive mode, m/z: 547.2 [M+Na]+; 1070.9 [2M+Na]+. 
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7.11. Synthesis of 2-(1,6-diaminohexane)-6-methoxy-9-(β-D-2’,3’-O-isopropyliden)-
purine (4.8a) 
 
 
 
To a solution of 2-iodo-6-methoxy-9-(β-d-2’,3’-O-isopropyliden)-purine 4.7a (224 mg, 
0.5 mmol) in DMF (2 ml), 1,6-diaminohexane (291 mg, 2.5 mmol) dissolved in DMF 
(1.0 ml) was added under an argon atmosphere. The reaction mixture was stirred at 
70 °C until TLC showed the complete disappearance of 4.7a (eluent CH2Cl2/MeOH 
9:1). After 17 h the solution was allowed to cool to room temperature and AcOEt (5 ml) 
was added. The mixture was washed with distilled water (3 x 3ml),an aqueous saturated 
NaS2O3 solution (4 ml) and brine (3 ml), dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was purified by flash chromatography (eluent 
CH2Cl2/MeOH 9.5:0.5) to give 2-(1,6-diaminohexane)-6-methoxy-9-(β-D-2’,3’-O-
isopropyliden)-purine 4.8a as a yellow oil (30 mg, 0.06 mmol).  
 
Yield = 14% 
 
1H NMR (400 MHz, CD3OD): 
δ 1.43 (s, 3H, C(CH3)); 1.45-1.54 (m, 4H, CH212,13); 1.58 (dd, J1 = 13.7, J2 = 6.9 Hz, 
2H, CH214); 1.64 (s, 3H, C(CH3)); 1.73 (dd, J1 = 14.0 Hz, J2 = 6.9 Hz, 2H, CH211); 3.26 
(t, J = 7.0 Hz, 2H, CH215-NH2); 3.57 (t, J = 6.5 Hz, 2H, CH210); 3.75 (qd, J1 = 11.6 Hz, 
J2 = 5.2 Hz, 2H, CH25’a/b); 4.06 (s, 3H, -OCH3); 4.30 (dd,  J1 = 8.0 Hz, J2 = 5.0 Hz, 1H, 
CH4’); 5.11 (dd, J1 = 6.1 Hz, J2 = 2.9 Hz, 1H, CH3’);5.58 (dd, J1 = 6.2 Hz, J2 = 2.4 Hz, 
1H, CH2’); 6.10 (d, J = 2.4 Hz, 1H, CH1’); 7.88 (s, 1H, CH8).  
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13C NMR (100 MHz, CH3OD): 
δ24.17 (C(CH3)); 26.15 (C(CH3));26.25-26.26 (C12,13); 29.10 (C11); 30.71 (C14); 37.51 
(CH215); 39.72 (C10); 52.61 (-OCH3); 62.12 (CH25’a/b); 81.66 (CH23’); 83.69 (CH22’); 
87.03 (CH24’); 90.51 (CH21’); 113.71 (C(CH3)2); 113.72 (C5); 138.54 (C8); 152.93 (C4); 
159.59 (C2); 161.04 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 437.2 [M+H+]; 459.4 [M+Na+]; 895.5 [2M+Na+]. 
 
[Bressiet al., 2000]. 
 
 
  
 217 
 
7.12. Synthesis of 2-(1,6-diamino-N-tert-butyloxycarbonylhexane)-6-methoxy-9-(β-
D-2’,3’-O-isopropyliden)-purine (4.8b) 
 
 
 
To a solution of 2-(1,6-diaminohexane)-6-methoxy-9-(β-D-2’,3’-O-isopropyliden)-
purine 4.7a (224 mg, 0.5 mmol) in DMF (1 ml), 1,6-diamino-N-tert-
butyloxycarbonylhexane A1 (216 mg, 1mmol) dissolved in DMF (1.0 ml) and 
triethylamine (TEA, 0.139 ml, 1 mmol) were added under an argon atmosphere.The 
reaction mixture was stirred at 80 °C monitoring the progress by TLC analysis 
(eluent CH2Cl2/MeOH 9:1, Rf product = 0.5).  
After 36 h the solution was allowed to cool to room temperature and AcOEt (5 ml) was 
added. The mixture was washed with 0.5 M HCl (3 x 2 ml), distilled water (1 x 3ml),an 
aqueous saturated NaS2O3 solution (3 ml) and brine (3 x 3 ml), dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The orange oil residue (205 mg) was 
purified by preparative TLC (eluent CH2Cl2/MeOH 9.5:0.5) to give the desired product 
4.8b as a yellow oil (41 mg, 0.08 mmol).  
 
Yield = 16% 
 
1H NMR (400 MHz, DMSO-d6): 
δ 1.20-1.42 (m, 4H, CH212,13); 1.49-1.60 (m, 4H, CH211,14);1.32 (s, 3H, C(CH3)2); 1.36 
(s, 9H, -OC(CH3)3); 1.53 (s, 3H, C(CH3)2);2.89 (dt, 2H, CH215); 3.26 (m, 2H, CH210); 
3.50 (m, 2H, CH25’); 3.97 (s, 3H, -OCH3); 4.13 (m, 1H, CH4’);4.96-5.01 (m, 2H, CH3’, 
N2H); 5.39 (m, 1H, CH2’); 6.06 (m, 2H, CH1’); 6.75 (s, 1H, OH); 7.08 (br s, 1H, 
-NHBoc); 8.04 (s, 1H, CH8). 
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13C NMR (100 MHz, DMSO-d6): 
δ 26.23 (-C(CH3)2); 27.28-27.46 (CH212,13); 28.11 (-COOC(CH3)3); 29.37 (-C(CH3)2); 
30.09 (CH214); 30.65 (CH211); 40.00 (CH215); 42.27 (CH210);54.23 (-OCH3); 62.72 (C5’); 
78.40 (C(CH3)3); 82.51 (C3’); 84.23 (C2’); 87.84 (C4’); 89.81 (C1’);114.05 (C(CH3)2); 
114.96 (C5);139.83 (C8); 154.36 (C4); 156.69 (-COOC(CH3)3); 159.95 (C2); 161.70 
(C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 459.4 [M+–Boc+Na+]; 559.3 [M+Na+]; 1095.1 [2M+Na+]. 
 
[Bressi et al., 2000] 
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7.13. Synthesis of 2-iodo-6-benzyloxy-9-(β-D-5’-tertbutyldimethylsilyl-2’,3’-O-
isopropyliden)-purine (4.9) 
 
 
To a solution of 2-iodo-6-benzyloxy-9-(β-D-2’,3’-O-isopropyliden)-purine 4.7b (721 
mg, 1.38 mmol) in DMF (2.5 mL)at room temperature under an argon atmosphere, 
imidazole (206 mg, 3.31 mmol) and tert-butyldimethylsilylchloride (250 mg, 1.66 
mmol) were added. The reaction mixture was stirred until TLC showed the complete 
disappearance of 4.7b (eluent AcOEt/n-hexane = 3:7, Rf product = 0.37).  
After 1 h AcOEt (20 ml) was added and the solution was washed with 0.5 M HCl 
(2 x 10 ml), water (2 x 10 ml) and brine (10 ml). The organic phase was dried on 
Na2SO4 and concentrated at reduced pressure. The residue was purified by flash 
chromatography (AcOEt/n-hexane = 3:7) to afford 2-iodo-6-benzyloxy-9-(β-D-5’-
tert-butyldimethylsilyl-2’,3’-O-isopropyliden)-purine 4.9 as a white foam solid (869 
mg, 1.36 mmol). 
 
Yield: 98% 
 
1H NMR (400 MHz, CDCl3): 
δ 0.11 (s, 6H, Si(CH3)2); 0.90 (s, 9H, -C(CH3) 3); 1.41 (s, 3H, -C(CH3) 2); 1.65 (s, 3H,  -C(CH3) 
2);3.81 (dd, J1 = 11.2, J2 = 4.3 Hz, 1H, CH5’); 3.90 (dd, J1 = 11.2, J2 = 3.8 Hz, 1H, 
CH5’); 4.39 (dd, J1 = 6.9, J2 = 3.8 Hz, 1H, CH4’); 4.97 (dd, J1 = 6.1 Hz, J2 = 2.8 Hz, 1H, 
CH3’); 5.14 (dd, J1 = 6.1 Hz, J2 = 2.6 Hz, 1H, CH2’); 5.64 (s, 2H, -CH2Ph); 6.19 (d, J = 
2.6 Hz, 1H, CH1’); 7.31-7.65 (m, 5H, -C6H5); 8.10 (s, 1H, CH8).  
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13C NMR (100 MHz, CDCl3): 
δ -5.41 (Si(CH3)2); -5.32 (Si(CH3)2);18.42 (SiC(CH3)3); 25.49 (C(CH3)2); 25.95 
(C(CH3)3); 27.32 (C(CH3)2); 63.52 (C5’); 69.52 (CH2Ph); 81.27 (C3’); 84.86 (C2’); 
87.28 (C4’); 90.64 (C1’); 114.33 (-C(CH3)2); 117.35 (C2); 121.95 (C5); 128.45-129.01-
135.44 (-C6H5); 140.92 (C8); 152.21 (C4);  159.32 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 639.5 [M+H]+; 661.5 [M+Na]+; 662.5 [M+H+Na]+; 663.6 
[M+2H+Na]+; 664 [M+3H+Na]+; 1299.2 [2M+Na]+; 1300.3 [2M+H+Na]+; 1301.4 
[2M+2H+Na]+; 1302.4[2M+3H+Na]+. 
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7.14. Synthesis of 2-(1,6-diaminohexane)-6-methoxy-9-(β-D-2’,3’-O-isopropyliden)-
purine (4.10) 
 
 
 
To a solution of 2-iodo-6-benzyloxy-9-(β-D-5’-tertbutyldimethylsilyl-2’,3’-O-
isopropyliden)-purine 4.9 (255 mg, 0.43 mmol) in 2-ethoxyethanol (2.5 ml), 
1,6-diaminohexane (139 mg, 1.2 mmol) was added under an argon atmosphere. The 
reaction mixture was stirred at 80 °C until TLC showed the complete disappearance of 
4.9 (eluent ammonia-saturated CH2Cl2/MeOH 9.5:0.5 Rf product = 0.55). 
After 17 h the solution was allowed to cool to room temperature and concentrated under 
reduced pressure. The residue was purified by flash chromatography (eluent ammonia-
saturated CH2Cl2/MeOH 9.5:0.5) to give the desidered product 4.10 (67 mg, 0.108 
mmol) as a yellow oil. 
 
Yield = 25% 
 
1H NMR (400 MHz, CDCl3): 
δ 0.09 (s, 6H, Si(CH3)2); 0.88 (s, 9H, -C(CH3) 3);1.34-1.54 (m, 4H, CH212,13); 1.54-1.80 (m, 
4H, CH211,14); 1.41 (s, 3H, C(CH3)2); 1.64 (s, 3H, C(CH3)2);2.72 (t, J = 6.8 Hz, 2H, 
CH215); 3.42 (dt, J1 = 12.7, J2= 6.5 Hz 2H, CH210); 3.73-3.83 (m, 2H,CH5’); 4.33 (dd, 
J1= 7.7, J2= 4.5 Hz 1H, CH4’); 4.94-5.03 (m, 1H, CH3’); 5.30 (d, J =2.7 Hz, 1H, CH2’); 
5.57 (s, 2H, -CH2Ph); 6.07 (d, J = 1.9 Hz, 1H, CH1’); 7.30-7.56 (m, 5H, -C6H5); 
7.76 (s, 1H, CH8).  
 
13C NMR (100 MHz, CDCl3): 
δ -4.75 (Si(CH3)2);1.67 (Si(CH3)2); 19.03 (SiC(CH3)3); 26.14 (C(CH3)2); 26.57 
(C(CH3)3); 27.39-27.64 (CH212,13); 27.92 (-C(CH3)2); 30.36 (CH214); 34.06 (CH211); 
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42.65 (CH215); 42.75 (CH210); 64.15 (C5’); 68.40 (CH2Ph); 82.11 (C3’); 85.03 (C2’); 
87.61 (C4’); 90.71 (C1’); 114.53 (C(CH3)2); 115.99 (C5); 128.52-128.80-128.99-129.19-
129.39-137.39 (-C6H5); 138.30 (C8); 154.24 (C4); 159.75 (C2); 161.39 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 627.6 [M+H+]; 649.5 [M+Na+]; 1253.4 [2M+H+]; 1275.5 
[2M+H+Na+] 
 
[Bressi, 2000]. 
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7.15. Synthesis of compound 4.11 
 
 
To a solution of product 4.10 (118 mg, 0.19 mmol) in AcOEt (1.5 ml), Z-Glu-O-tBu-
γOH (64 mg, 0.19 mmol) and DCC (39 mg, 0.19 mmol) were added under an argon 
atmosphere.The mixture was stirred at room temperature overnight monitoring the 
progress of the reaction by TLC analysis (eluent ammonia-saturated CH2Cl2/MeOH 
9.6:0.4, Rf  product = 0.32). 
The mixture was filtered under vacuumand concentrated under reduced 
pressure.Finally, the residue was purified by flash chromatography (eluent  AcOEt/n-
hexane = 9.6:0.4) to give the desidered product 4.11 (67 mg, 0.108 mmol) as a yellow 
oil. 
 
Yield = 50% 
 
1H NMR (400 MHz, CDCl3): 
δ 0.02 (s, 3H, Si(CH3)); 0.03 (s, 3H, Si(CH3)); 0.09 (s, 9H, SiC(CH3)3); 1.01-1.22 (m, 
2H, CH213); 1.30-1.42 (m, 2H, CH212);1.40 (s, 3H, C(CH3)2); 1.46 (OC(CH3)3); 1.49-
1.56 (m, 2H, CH214); 1.63 (s, 3H, C(CH3)2); 1.70 (dt, J1 = 13.5 Hz, J2 4.04 = Hz, 2H, 
CH211); 1.88-1.99 (m, 2H, CH217); 2.11-2.30 (m, 2H, CH216); 3.24 (dd, J1 = 11.85 Hz, J2 
= 5.8 Hz, 2H, CH215);3.36-3.45 (m, 2H, CH210); 3.79 (qd, J1 = 11.0 Hz, J2 = 4.7 Hz, 2H, 
CH25’a/b); 4.17-4.25 (m, 1H, CHGlu); 4.32 (dd, J1 = 7.5 Hz, J2 = 4.4 Hz, 1H, CH4’); 4.97 
(dd, J1 = 6.1 Hz, J2 = 2.8 Hz, 1H, CH3’); 5.04 (br t, J = 5.2 Hz, 1H, N2H); 5.11 (s, 2H, -
OCH2Ph); 5.28 (d, J = 4.5 Hz, 1H, CH2’); 5.56 (s, 2H, COOCH2Ph); 6.07 (d, J = 2.2 Hz, 
1H, CH1’); 5.64 (br d, J = 7.7 Hz, 1H, HNCOOCH2Ph); 6.09 (br s, 1H, NHCOGlu); 
7.26-7.53 (m, 10H, 2 -C6H5); 7.76 (s, 1H, H8). 
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13C NMR (100 MHz, CDCl3): 
δ-6.46 (Si(CH3)); 0.00 (Si(CH3)); 17.35 (SiC(CH3)3);24.89 (C(CH3)2); 24.61 (CH213); 
24.83 (CH211);25.72 (SiC(CH3)3); 26.24 (C(CH3)2); 26.55 (CH212); 26.94 (OC(CH3)2); 
29.24 (CH216); 29.56 (CH214); 32.92 (CH217); 38.52 (CH215); 40.90 (CH210); 53.01 
(CHGlu); 62.46 (C5’); 65.96, 66.72 (2 CH2Ph); 80.39 (C3’);81.46 (OC(CH3)3); 83.40 
(C2’); 85.89 (C4’); 88.98 (C1’); 114.25 (C5); 126.85, 127.03, 127.10, 127.15, 127.32, 
127.50, 127.83, 127.94, 128.02, 135.22, 135.68 (2 -C6H5); 136.58 (C8); 152.54 
(C4);155.40 (NHCOOCH2Ph); 158.05 (C2); 159.69 (C6);170.05 (COOC(CH3)3); 170.88 
(NHCOGlu). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 946.7 [M+H+]; 968.6 [M+Na+]; 1913.3 [2M+Na+] 
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7.16. Synthesis of 2-iodo-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)-purine (4.12) 
 
 
 
Under argon atmosphere, to a suspension of 2’,3’,5’-tri-O-acetylguanosine 4.2 (0.204 g, 
0.5 mmol) in 1,2-dichloroethane (4 ml) CH3I (0.787 g, 2.0 mmol) and isoamyl nitrite 
(0.67 ml, 5.0 mmol), both dried before use, were added at room temperature. The 
reaction mixture stirred at 65°C for 2 h. The reaction was monitored by TLC (eluent 
CH2Cl2/MeOH 9.5:0.5). After completion, the solvent was removed under reduced 
pressure and the resulting residue, dissolved in CH2Cl2, was purified by column 
chromatography (eluent CH2Cl2/MeOH 9.5:0.5) to afford 2-iodo-9-(2’,3’,5’-tri-O-
acetyl-β-d-ribofuranosyl)-purine 4.12 (0.08 g, 0.15 mmol) as a yellow solid. 
 
Yield: 30% 
 
1H NMR (400 MHz, DMSO-d6): 
δ 
1H NMR (400 MHz, DMSO): δ 2.06 – 2.04 – 2.21 (s, 9H, -OCOCH3); 4.26 (m, 2H, 
CH25’a/b); 4.38 (dd, J = 5.6 Hz, 1H, CH4’); 5.57 (dd, J = 5.6 Hz, 1H, CH3’); 5.81 (dd, J = 
5.6 Hz, 1H, CH2’); 6.13 (d, J = 5.6 Hz, 1H, CH1’); 8.24 (s, 1H, CH8); 13.09 (s, 1H, 
NH1). 
13C NMR (100 MHz, DMSO-d6): 
δ 20.70 – 20.84 – 21.03 (-OCH3) ; 63.16 (C5’); 70,77 (C3’); 72.86 (C2’); 80.14 (C4’); 
86.05 (C1’); 124.79 (C5); 138.00 (C8); 148.45 (C4); 157.31 (C2-C6); 169.46 (OCOCH32’); 
169.84 (OCOCH33’); 169.70 (OCOCH35’). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 543.2 [M+Na]+; 1063.1 [2M+Na]+. 
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7.17. Synthesis of 2-N-acetyl-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)-purine 
(4.13) 
 
Under an argon atmosphere and in anhydrous conditions, to a solution of 2’,3’,5’-tri-O-
acetylguanosine 4.2 (0.41 g, 1.0 mmol) in CH3CN (15 ml) CH2I2 (1.57 g, 4.0 mmol) and 
isoamyl nitrite (1.33 ml, 10.02 mmol), both dried before use, were added at 0°C. After 
30 minutes the reaction mixture was allowed to come to room temperature and stirred at 
95°C for 2 h. The reaction was monitored by TLC (eluent CH2Cl2/MeOH 9.5:0.5). After 
completion, the solvent was removed under reduced pressure and the resulting residue, 
dissolved in CH2Cl2, was purified by column chromatography (eluent CH2Cl2/MeOH 
9.5:0.5) to afford 2-N-acetyl-9-(2’,3’,5’-tri-O-acetyl-β-d-ribofuranosyl)-purine 4.13 
(0.207 g, 0.46 mmol) as a yellow solid. Product 4.12 was not purified. 
 
Yield: 47% 
 
1H NMR (400 MHz, DMSO-d6) product 4.13: 
δ 2.04 (s, 9H, -OCOCH3); 3.33 (s, 3H, -NHCOCH3), 4.28 (m, 2H, CH25’a/b); 4.36 (dd, J 
= 3.7 Hz, 1H, CH4’); 5.49 (dd, J = 6 Hz, 1H, CH3’); 5.78 (dd, J = 6 Hz, 1H, CH2’); 6.13 
(d, J = 6.13 Hz, 1H, CH1’); 8.24 (s, 1H, CH8); 13.09 (s, 1H, NH1). 
 
13C NMR (100 MHz, DMSO-d6) product 4.13: 
δ 21.35 – 21.50 – 21.69 (-OCH3) ; 63.82 (C5’); 71,04 (C3’); 73.62 (C2’); 80.79 (C4’); 
86.68 (C1’); 111.37 (C5); 125.44 (C8); 149.11 (C4); 155.94 (C2); 157.97 (C6); 171.12 – 
170.50 – 170.36 (OCOCH3); 174.66 (NHCOCH3). 
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Mass spectrum 
ESI-MS positive mode, m/z: 452.3 [M+H]+, 474.4 [M+Na]+, 925.5 [2Mx2+Na]+ 
(product 4.13); 543.3 [M+Na]+, 1063.2 [2M+Na]+ (product 4.12 as impurity). 
 
[Nair et al.,2007] 
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7.18. Synthesis of 5’-tert-butyldimethylsilyl-2’,3’-O-isopropylidene-2-bromo-
guanosine (4.14) 
 
NH
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2’,3’-O-isopropylidenguanosine 1a. To a suspension of guanosine 4.1 (7.3 g, 
25.78 mmol) in acetone (250 ml), p-toluenesulfonic acid (5.35 g, 28.12 mmol) and 
2,2-dimethoxypronane (25 ml, 204.03 mmol) were added under inert atmosphere. The  
mixture was stirred overnight at room temperature. The solvent was removed under 
reduced pressure and the crude was dissolved in H2O (150 ml) and NH3 (15 ml). The 
solution was kept overnight at 4 °C. The resulting precipitate was filtered to afford 
2’,3’-O-isopropylidenguanosine 1a as a white solid (6.7 g, 20.73 mmol). 
 
Yield: 80% 
 
1H NMR (400 MHz, DMSO-d6): 
δ(ppm): 1.31 (s, 3H, CH3); 1.51 (s, 3H, CH3); 3.53 (m, 2H, CH25'); 4.12 (m 1H, CH4'); 
4.96 (dd, J= 5.0, 6.2 Hz, 1H, CH3'); 5.11 (t, J= 5.4 Hz, 1H, OH); 5.18 (dd, J = 2.8, 6.4 
Hz, 1H, CH2'); 5.92 (d, J=2.8 Hz, 1H, CH1'); 6.52 (s, 2H, NH2); 7.91 (s, 1H, CH8); 
10.71 (s, 1H, NH1). 
 
13C NMR (100 MHz, DMSO-d6): 
δ(ppm): 25.6, 27.5 (CH3); 62.0 (C5'); 81.6 (C3') 84.0.0 (C2'); 87.1 (C4'); 88.9 (C1'); 113.6 ((CH3)2C); 
117.1 (C5); 136.5 (C8); 151.2 (C4); 154.1 (C2); 157.3 (C6). 
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Mass spectrum 
ESI-MS positive mode, m/z: 324.0 [M+H]+; 347.4 [M+Na]+; 324.0 [M+H]+; 647.1 
[2M]+; 669.2 [2M+Na]+; 969.4 [3M]+; 992.1 [3M+Na]+; 1315.3 [4M+Na]+; 1616.8 
[5M]+; 1638.0 [5M+Na]+. 
 
2’,3’-O-isopropyliden-5’-tert-butyldimethylsilylguanosine 4.14. Under nitrogen 
atmosphere, to a suspension of 2',3'-O-isopropylidenguanosine 1a (1.09 g, 3.37 mmol) 
in DMF (10 ml), imidazole (0.51 g, 7.56 mmol) and tert-butyldimethylsilylchloride 
(0.60 g, 3.98 mmol) were added at room temperature. The reaction was monitored by 
TLC (eluent CH2Cl2/MeOH 12.5:1, Rf product = 0.38). After 4h the reaction mixture 
was extracted with CH2Cl2 (50 mL), washed with H2O (2x40 ml) and brine. The organic 
layer was dried over Na2SO4 and the solvent was removed under reduced pressure. The 
crude was purified by flash chromatography (eluent CH2Cl2/MeOH 12.5:1) to afford the 
desired compound 4.14 as a white solid (1.39 g, 3.20 mmol). 
 
Yield: 95% 
 
1H NMR (400 MHz, CDCl3): 
δ 0.12 (s, 6H, Si(CH3)2); 0.89 (s, 9H, C(CH3)3); 1.42 (s, 3H, C(CH3)2); 1.66 (s, 3H, 
C(CH3)2); 3.78-3.88 (m, 2H, CH25’a/b); 4.37 (dd, J = 3.7 Hz, 1H, CH4’); 4.95 (dd, J = 
3.0, 6.2 Hz, 1H, CH3’); 5.32 (dd, J = 2.2, 6.2 Hz, 1H, CH2’); 6.02 (d, J = 2.4 Hz, 1H, 
CH1’); 6.29 (s, 2H, NH2); 7.79 (s, 1H, CH8); 12.05 (s, 1H, NH1). 
 
13C NMR (100 MHz, CDCl3): 
δ -5.45 (Si(CH3)2); -5.35 (Si(CH3)2); 18.38 (SiC(CH3)3); 25.63 (C(CH3)2); 25.92 
(C(CH3)3); 27.28 (C(CH3)2); 63.48 (C5’); 81.25 (C3’); 84.71 (CH2’); 87.01 (C4’); 90.34 
(C1’); 114.10 (C(CH3)2); 117.36 (C5); 136.0 (C8); 151.3 (C4); 153.60 (C2); 159.05 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 438.3 [M+H]+; 874.4 [2M]+; 897.4 [2M+Na]+; 1312.4 
[3M]+; 1771.8 [4M+Na]+. 
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7.19. Synthesis of 2-iodo-9-(β-D-2’,3’-O-isopropyliden-5’-tert-
butyldimethylsilyl)purine (4.15) 
 
 
 
Under argon atmosphere, to a suspension of 2’,3’-O-isopropyliden-5’-tert-
butyldimethylsilylguanosine 4.14 (0.219 g, 0.5 mmol) in 1,4-dichloroethane (4 ml) 
CH3I (0.787 g, 2.0 mmol) and isoamyl nitrite (0.67 ml, 5.0 mmol), both dried before 
use, were added at room temperature. The reaction mixture was stirred for 30’ at room 
temperature and at 95°C for 5 h. Progress of the reaction was monitored by TLC (eluent 
CH2Cl2/MeOH 9.5:0.5, Rf product = 0.24). Volatiles were removed under reduced 
pressure.Product 4.15 was not isolated. 
 
Mass spectrum 
ESI-MS positive mode, m/z: 549.1 [M+H]+; 571.3 [M+Na]+; 1119.1 [2M+Na]+. 
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7.20. Synthesis of 2-bromo-9-(β-D-2’,3’-O-isopropyliden-5’-tert-
butyldimethylsilyl)purine (4.18) 
 
Method A 
 
 
2’,3’-O-isopropyliden-5’-tert-butyldimethylsilylguanosine 4.14 (0.437 g, 1.0 mmol) and 
SbBr3 (0.506 g, 1.4 mmol) were suspended in dry CH2Cl2 (10 ml) at 0 °C. After cooling 
the mixture to 0 °C, tert-butylnitrite (0.42 ml, 3.5 mmol) was added dropwise. The 
reaction was stirred at -10°C for 1 h and then diluted with a mixture of crushed ice, 
water (32.5 ml) and NaHCO3 (1.32 g). The resulting precipitate was filtered and the 
filtrate was extracted with CH2Cl2. The organic phase was dried over Na2SO4, the 
solvent was removed under reduced pressure and the crude yellow oil was purified by 
flash chromatography (eluent CH2Cl2/MeOH 9.5:0.5, Rf product = 0.38) to obtain 2-
bromo-9-(β-D-2’,3’-O-isopropyliden-5’-tert-butyldimethylsilyl)purine 4.18 as a pale 
yellow solid (0.3 g, 0.6 mmol). 
 
Yield: 60% 
 
[Quian & Glaser, 2005] 
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Method B 
 
To a stirred solution of 5’-tert-butyldimethylsilyl-2’,3’-O-isopropylidene guanosine 
4.14 (438 mg, 1 mmol) in CH2Br2 (7 mL), cooled at -10 °C under argon atmosphere, 
trimethylbromosilane (1.2 mL, 1.38 g, 9 mmol) and tert-butylnitrite, (2.4 mL, 2.06 g, 20 
mmol) were added dropwise . The dark brown solution was stirred at -10 °C for 2 h and 
at 0-10 °C (TLC control, CH2Cl2/MeOH=9.5:0.5, Rf  product = 0.42).  
After 5 h the solution was added dropwise to a cold, vigorously stirred mixture of 
saturated NaHCO3:H2O (150 mL)//CH2Cl2(150 mL). The aqueous layer was extracted 
with CH2Cl2 (70 mL), and the combined organic phase was washed with H2O (70 mL) 
and brine (70 mL) and then dried on Na2SO4. Volatiles were evaporated in vacuo, and 
the yellow oil was purified by flash chromatography on silica gel (CH2Cl2/MeOH 
9.5/0.5) to give 5’-tert-butyldimethylsilyl-2’,3’-O-isopropylidene-2-bromo-guanosine 
4.18 (350 mg, 70%) as yellow crystalline solid.  
 
Yield = 70% 
 
1H NMR (400 MHz, CDCl3): 
δ 0.09 (s, 6H, Si(CH3)2); 0.91 (s, 9H, SiC(CH3)3); 1.41 (s, 3H, C(CH3)2); 1.67 (s, 3H, 
C(CH3)2); 3.83-3.91 (dd, J = 3.6, 3.2, 2H, CH25’a/b); 4.40 (dd, J = 3.2 Hz, 1H, CH4’); 
4.94 (dd, J = 2.8, 6.2 Hz, 1H, CH3’); 5.07 (dd, J = 2.8, 6.2 Hz, 1H, CH2’); 6.15 (d, J = 
2.8 Hz, 1H, CH1’); 8.08 (s, 1H, CH8); 12.85 (br s, 1H, NH1). 
 
13C NMR (100 MHz, CDCl3): 
δ -5.46 (Si(CH3)2); -5.35 (Si(CH3)2); 18.42 (SiC(CH3)3); 25.45 (C(CH3)2); 25.96 
(SiC(CH3)3);  27.31 (C(CH3)2); 63.51 (C5’); 81.13 (C3’); 85.22 (CH2’); 86.91 (C4’); 
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90.71 (C1’); 114.42 (C(CH3)2); 123.85 (C5); 137.60 (C8); 148.35 (C4); 133.15 (C2); 
158.91 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 523.4 [M 79Br +Na]+; 525.4 [M 81Br +Na]+; 1023.3 [Mx2 
79Br +Na]+; 1025.3 [Mx2 81Br+Na]+ 
 
[Francom & Robins, 2003]. 
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7.21. Synthesis of 2-chloro-9-(β-D-2’,3’-O-isopropyliden-5’-tert-
butyldimethylsilyl)purine (4.19) 
 
 
 
2’,3’-O-isopropyliden-5’-tert-butyldimethylsilylguanosine 4.14 (0.144 g, 0.33 mmol) 
and SbCl3 (0.105 g, 0.46 mmol) were suspended in dry CH2Cl2 (10 ml) at 0°C. After 
cooling the mixture to 0 °C, tert-butylnitrite (0.14 ml, 1.15 mmol) was added dropwise. 
The reaction was stirred at -10 °C for 1 h and then diluted with a mixture of crushed ice, 
water (32.5 ml) and NaHCO3 (1.32 g). The resulting precipitate was filtered and the 
filtrate was extracted with CH2Cl2. The organic phase was dried over Na2SO4, the 
solvent was removed under reduced pressure and the crude was purified by flash 
chromatography (eluent CH2Cl2/MeOH 9.5:0.5, Rf product = 0.38) to obtain 2-chloro-9-
(β-D-2’,3’-O-isopropyliden-5’-tert-butyldimethylsilyl)purine 4.19 as a pale yellow solid 
(0.048 g, 0.10 mmol). 
 
Yield: 31% 
 
1H NMR (400 MHz, CDCl3) 
δ 0.09 (s, 6H, Si(CH3)2); 0.91 (s, 9H, SiC(CH3)3); 1.41 (s, 3H, C(CH3)2); 1.65 (s, 3H, 
C(CH3)2); 3.83 – 3.91 (dd, J = 3.6, 3.2, 2H, CH25’a/b); 4.42 (dd, J = 3.2 Hz, 1H, 
CH4’); 4.95 (dd, J = 2.8, 6.2 Hz, 1H, CH3’); 5.06 (dd, J = 2.8, 6.2 Hz, 1H, CH2’); 
6.14 (d, J = 2.8 Hz, 1H, CH1’); 8.10 (s, 1H, CH8); 12.85 (br s, 1H, NH1). 
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13C NMR (100 MHz, CDCl3) 
δ -4.71 (Si(CH3)2); -4.82 (Si(CH3)2); 19.09 (SiC(CH3)3); 26.10 (C(CH3)2); 26.61 
(SiC(CH3)3);  27.98 (C(CH3)2); 64.18 (C5’); 81.78 (C3’); 85.94 (CH2’); 87.69 (C4’); 
91.47 (C1’); 115.07 (C(CH3)2); 124.12 (C5); 137.60 (C8); 148.85 (C4); 144.83 (C2); 
159.51 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 457.3 [M+H]+; 479.5 [M+Na]+; 495.5 [M+K]+; 935.4 
[2M+Na]+. 
 
[Quian & Glaser, 2005] 
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7.22. Synthesis of 2-(1,4-diaminobutane)-9-(2’,3’,5-tri-O-acetyl-β-D-
ribofuranosyl)purine (4.21) 
 
 
 
2-iodo-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)-purine 4.12 (0.10g, 0.19 mmol) and 
1,4-diaminobutane (0.14 ml, 1.4 mmol) were dissolved in MeOH (2 ml) and the 
resulting solution was refluxed for 2 h. Progress of the reaction was monitored by TLC 
(eluent CH2Cl2/MeOH 9:1 or AcOH:nBuOH:H2O = 1:4:1). Volatiles were removed 
under reduced pressure. 
2-(1,4-diaminobutane)-9-(2’,3’,5-tri-O-acetyl-β-D-ribofuranosyl)purine 4.21 was not 
isolated. 
 
Mass spectrum 
ESI-MS positive mode, m/z: 355.3 [M+H]+; 377.5 [M+Na]+. 
 
[Bressi, 2000]. 
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7.23. Synthesis of 2-(1,4-diaminobutane)-9-(β-D-2’,3’-O-isopropyliden-5’-tert-
butyldimethylsilyl)purine (4.22) 
 
 
 
2-iodo-2’,3’-O-isopropyliden-5’-tert-butyldimethylsilylguanosine 4.15 (0.44 g, 0.79 
mmol) and 1,4-diaminobutane (0.16 ml, 1.6 mmol) were dissolved in MeOH (4 ml) and 
the resulting solution was refluxed for two days. Progress of the reaction was monitored 
by TLC (eluent CH2Cl2/MeOH 9:1 or AcOH/nBuOH/H2O 1:4:1). 2-(1,4-
diaminobutane)-9-(β-D-2’,3’-O-isopropyliden-5’-tert-butyldimethylsilyl)purine 4.22 
was not isolated. 
 
Mass spectrum 
ESI-MS positive mode, m/z: 509.4 [M+H]+; 531.5 [M+Na]+; 1017.5 [2M+H]+. 
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7.24. Synthesis of 2-N,N-dimethyl-9-(β-D-2’,3’-O-isopropyliden-5’-tert-
butyldimethylsilyl)purine (4.23) 
 
 
 
2-iodo-2’,3’-O-isopropyliden-5’-tert-butyldimethylsilylguanosine 4.15 (0.07 g, 0.13 
mmol) and 1,4-diaminobutane (0.04 ml, 0.38 mmol) were dissolved in DMF (3 ml) and 
the resulting solution was refluxed for one day. Progress of the reaction was monitored 
by TLC (eluent CH2Cl2/MeOH 9:1 or AcOH/nBuOH/H2O 1:4:1). The reaction mixture 
was diluted in AcOEt (5 ml) and washed with H2O (2 x 2.5 ml). The organic phase was 
dried over Na2SO4 and the solvent was removed under reduced pressure to obtain 2-
N,N-dimethyl-9-(β-D-2’,3’-O-isopropyliden-5’-tert-butyldimethylsilyl)purine 4.23 as a 
yellow solid (0.018 g, 0.04 mmol). 
 
Yield: 30% 
 
1H NMR (400 MHz, DMSO-d6) 
δ -0.03 (s, 6H, Si(CH3)2); 0.81 (s, 9H, C(CH3)3); 1.32 (s, 3H, C(CH3)2); 1.52 (s, 3H, 
C(CH3)2); 3.07 (s, 6H, C(CH3)2); 3.67-3.69 (m, 2H, CH25’a/b); 4.12 (dd, J = 3.2, 6 Hz, 
1H, CH4’); 4.93 (dd, J = 2.8, 6 Hz, 1H, CH3’); 5.39 (dd, J = 2, 6 Hz, 1H, CH2’); 6.04 (d, 
J = 2 Hz, 1H, CH1’); 7.97 (s, 1H, CH8); 11.05 (s, 1H, NH1). 
 
13C NMR (100 MHz, DMSO-d6) 
δ -5.45 (Si(CH3)2); -5.35 (Si(CH3)2); 19.11 (SiC(CH3)3); 26.27 (C(CH3)2); 26.85 (C(CH3)3); 28.04 
(C(CH3)2); 38.95 (N(CH3)2); 64.26 (C5’); 82.21 (C3’); 84.26 (CH2’); 87.73 (C4’); 89.83 (C1’); 114.07 
(C(CH3)2); 117.41 (C5); 137.3 (C8); 151.08 (C4); 154.22 (C2); 158.64 (C6). 
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Mass spectrum 
ESI-MS positive mode, m/z: 466.3 [M+H]+; 953.3 [2M+Na]+. 
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7.25. Synthesis of 2-(1,2-diaminoethane)-9-(β-D-2’,3’-O-isopropyliden-5’-tert-
butyldimethylsilyl)purine (4.24), 2-(1,4-diaminobutane)-9-(β-D-2’,3’-O-
isopropyliden-5’-tert-butyldimethylsilyl)purine (4.22) and 2-(1,6-diaminohexane)-
9-(β-D-2’,3’-O-isopropyliden-5’-tert-butyldimethylsilyl)purine (4.25) 
 
 
 
Substrate 4.18 or 4.19 (1 mmol) and the proper diamine (5 mmol) were dissolved in 2-
methoxyethanol (5 ml) and the resulting solution was stirred at 85°C for four-six days. 
The reaction was monitored by TLC (eluent CH2Cl2/MeOH 9.5:0.5 or 
AcOH/nBuOH/H2O 1:4:1). The mixture was then diluted in AcOEt (10 ml) and washed 
with H2O (2 x 5 ml). The organic phase was dried over Na2SO4 and the solvent was 
removed under reduced pressure to obtain 4.24, 4.22 or 4.25 as a crude product, which 
was not further purified. 
 
Mass spectrum 
ESI-MS positive mode, m/z: 
4.24)481.3 [M+H]+; 504.3 [M+Na]+; 519.3 [M+K]+, 961.6 [2M]+, 983.6 [2M+Na]+. 
4.22)509.7 [M+H]+; 531.7 [M+Na]+; 1017.7 [2M]+, 1039.9 [2M+Na]+, 1325.9 [3M]+. 
4.23)537.3 [M+H]+; 559.3 [M+Na]+. 
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7.26. Synthesis of 2-(1,4-diamino-N6-tert-buthoxycarbonylbutane)-9-(β-D-2’,3’-O-
isopropyliden-5’-tert-butyl dimethylsilyl)purine (4.26) 
 
Method A 
 
 
To a solution of 2-(1,6-diaminobutane)-9-(β-D-2’,3’-O-isopropyliden-5’-tert-
butyldimethylsilyl-2’,3’-O-isopropyliden)purine 4.22 in CH2Cl2 (2 ml) Boc2O (0.07 g, 
0.33 mmol) was added dropwise. The reaction was monitored by TLC (eluent 
CH2Cl2/MeOH 9.5:0.5, Rf product = 0.46), then the solvent was removed under reduced 
pressure. The crude was purified by flash chromatography (eluent  CH2Cl2/MeOH 19:1) 
to afford 2-(1,6-diamino-N6-tert-buthoxycarbonylbutane)-9-(β-D-2’,3’-O-isopropyliden-
5’-tert-butyldimethylsilyl-2’,3’-O-isopropyliden) purine 4.26 as a pale yellow solid 
(0.06 g, 0.098 mmol). 
 
Yield: 30% 
 
 
Method B 
 
 
Substrate 4.18 or 4.19 (0.28 mmol) and 1,4-diamino-N-tert-buthoxycarbonylbutane E 
(1.32 mmol) were dissolved in 2-methoxyethanol (2 ml) and the resulting solution was 
stirred at 85 °C for four-six days. The reaction was monitored by TLC (eluent 
CH2Cl2/MeOH 9.5:0.5, Rf product = 0.46, or AcOH/nBuOH/H2O 1:4:1). The mixture 
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was then diluted in AcOEt (5 ml) and washed with H2O (2 x 2 ml). The organic phase 
was dried over Na2SO4 and the solvent was removed under reduced pressure a crude 
which was purified by flash chromatography (eluent CH2Cl2/MeOH 9.5:0.5) to afford 2-
(1,4-diamino-N6-tert-buthoxycarbonylbutane)-9-(β-D-2’,3’-O-isopropyliden-5’-tert-
butyl dimethylsilyl)purine 4.26 as a pale yellow solid. 
 
Yield: 
from 18) 82% 
from 19) 63% 
 
1H NMR (400 MHz, CDCl3) 
δ 0.14 (s, 6H, Si(CH3)2); 0.89 (s, 9H, SiC(CH3)3); 1.45 (s, 9H, OC(CH3)3); 1.41 (s, 3H, C(CH3)2); 1.66 
(s, 3H, C(CH3)2); 1.76 – 1.64 (m, 4H, CH211,12); 3.49 – 3.21 (m, 4H, CH210,13); 3.78-3.87 (m, 2H, 
CH25’a/b); 4.34 (dd, J = 3.2, 6 Hz, 1H, CH4’); 4.95 (dd, J = 2.8, 6 Hz, 1H, CH3’); 5.28 (dd, J = 2, 6 Hz, 
1H, CH2’); 6.04 (d, J = 2 Hz, 1H, CH1’); 7.77 (s, 1H, CH8); 11.60 (br s, 1H, NH1). 
 
13C NMR (100 MHz, CDCl3) 
δ -5.38 (Si(CH3)2); -5.38 (Si(CH3)2); 18.37 (SiC(CH3)3); 25.46 (C(CH3)2); 25.90 (SiC(CH3)3); 27.25 
(C(CH3)2); 27.34 (OC(CH3)3); 28.48 (OC(CH3)3); 26.38 – 29.70 (CH211,12); 40.29 – 41.02 (CH210,13); 
63.57 (C5’); 78.93 (C3’); 84.57 (CH2’); 87.01 (C4’); 90.26 (C1’); 113.96 (C(CH3)2); 117.04 (C5); 138.0 
(C8); 151.50 (C4); 152.81 (C2); 156.13 (COO(CH3)3); 159.16 (C6). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 609.5 [M+H]+; 631.5 [M+Na]+; 1239.6 [2M+Na]+; ms/ms 
509.2 (M-Boc). 
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7.27. Synthesis of compounds 4.27, 4.28, 4.29 
 
 
To a solution of substrate 4.24, 4.22 or 4.25 (0.39 mmol) in AcOEt (2 ml), Nα-
benzyloxycarbonyl-γ-L-glutamic acid Oα-tert-butyl ester (0.51 mmol) and DCC (0.39 
mmol) were added. Progress of the reaction was monitored by TLC (eluent 
CH2Cl2/MeOH 9.5:0.5).  
Then the mixture was filtered under vacuum, and washed with HCl 0.5 M (2 ml), 
NaHCO3 (2 ml), and brine (2 ml). The combined organic phases were dried over 
Na2SO4 and concentrated under reduced pressure. The crude was purified by flash 
chromatography (eluent CH2Cl2/MeOH 9.5:0.5) to afford 4.27, 4.28 or 4.29 as pale 
yellow solids. 
 
 
Compound 4.27 
Yield = 64 %    
 
1H NMR (400 MHz, CDCl3) 
δ 0.05 (s, 3H, Si(CH3)2); 0.06 (s, 3H, Si(CH3)2); 0.89 (s, 9H, SiC(CH3)3); 0.91 (s, 3H, 
C(CH3)2); 1.41 (s, 9H, OC(CH3)3); 1.64 (s, 3H, C(CH3)2); 1.95 – 2.04 (m, 1H, CH213a); 
2.12 – 2.20 (m, 1H, CH213b); 2.24 – 2.37 (m, 2H, CH212); 3.45 – 3.66 (m, 4H, CH210,11); 
3.78 – 3.90 (m, 2H, CH25’a/b); 4.15 – 4.20 (m, 1H, CHGlu); 4.33 – 4.36 (dd, 1H, CH4’); 
4.93 – 4.95 (dd, 1H, CH3’); 5.02 – 5.12 (m, 2H, CH2Ph); 5.24 – 5.25 (dd, 1H, CH2’); 
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5.67 – 5.69 (br d, 1H, NHCHGlu); 6.06 (d, 1H, CH1’); 7.29 – 7.31 (m, 5H, Ph); 7.51 (br 
s, 1H, NHCOCH2CH2); 8.08 (s, 1H, CH8); 11.05 (br s, 1H, NH1). 
 
13C NMR (100 MHz, CDCl3) 
δ -5.42 (Si(CH3)2); 1.00 (Si(CH3)2); 18.35 (SiC(CH3)3); 25.57 (C(CH3)2); 25.88 
(SiC(CH3)3); 27.33 (C(CH3)2); 24.93 (OC(CH3)3); 27.91 (OC(CH3)3); 28.33 (CH213); 
32.01 (CH212); 41.15 – 38.59 (CH210,11); 54.41 (CHGlu); 63.55 (C5’); 66.70 (CH2Ph); 
81.16 (C3’); 81.29 (CqPh); 84.54 (CH2’); 87.10 (C4’); 90.40 (C1’); 114.12 (C(CH3)2); 
116.74 (C5); 128.40 – 128.18 – 127.94 (Ph); 136.41 (C8); 151.63 (C4); 152.96 (C2); 
156.20 (COOCH2Ph);158.31 (C6); 171.12 (COO(CH3)3); 173.20 (NHCOGlu). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 800.7 [M+H]+; 822.9 [M+Na]+; 1622.1 [2M+Na]+. 
 
 
Compound 4.28 
Yield = 47 %    
 
1H NMR (400 MHz, CDCl3) 
δ0.01 (s, 3H, Si(CH3)2); 0.02 (s, 3H, Si(CH3)2); 0.83 (s, 9H, SiC(CH3)3); 1.26 – 1.29 (m, 
2H, CH211); 1.37 (s, 3H, C(CH3)2); 1.42 (s, 9H, OC(CH3)3); 1.60 (s, 3H, C(CH3)2); 1.68 
– 1.72 (m, 2H, CH212); 1.91 – 1.95 (m, 1H, CH215a); 2.12 – 2.17 (m, 1H, CH215b); 2.24 – 
2.26 (m, 2H, CH214); 3.27 – 3.28 (m, 2H, CH213); 3.44 – 3.92 (m, 2H, CH210); 3.83 – 
3.73 (m, 2H, CH25’a/b); 4.15 – 4.20 (m, 1H, CHGlu); 4.30 (dd, 1H, CH4’); 4.91 (dd, 1H, 
CH3’); 5.07 (dd, 2H, CH2Ph); 5.20 (dd, 1H, CH2’); 5.83 (br d, 1H, NHCHGlu); 6.02 (d, 
1H, CH1’); 6.84 (br s, 1H, NHCOCH2CH2); 7.28 – 7.31 (m, 5H, Ph); 7.73 (s, 1H, CH8); 
11.35 (br s, 1H, NH1). 
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13C NMR (100 MHz, CDCl3) 
δ-5.29 (Si(CH3)2 ); -5.25 (Si(CH3)2); 18.47 (SiC(CH3)3); 25.57 (C(CH3)2); 26.00 
(SiC(CH3)3); 26.33 (CH212); 26.93 (OC(CH3)3); 27.38 (C(CH3)2); 28.05 (OC(CH3)3); 
28.89 (CH215); 31.69 (CH211); 32.64 (CH214); 39.15 (CH213); 40.98 (CH210); 54.35 
(CHGlu); 63.64 (C5’); 67.00 (CH2Ph); 81.46 (C3’); 82.36 (CqPh); 84.66 (CH2’); 86.96 
(C4’); 90.11 (C1’); 114.08 (C(CH3)2); 117.10 (C5); 128.56 – 128.16 – 128.05 (Ph); 
136.41 (C8); 151.50 (C4); 152.81 (C2); 156.49 (NHCOCH2Ph); 159.13 (C6); 171.26 
(COO(CH3)3); 172.31 (NHCOGlu). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 850.9 [M+Na]+; 826.4 [M-H]+; 1653.0 [2M-H]+; 1679.0 
[2M+Na]+. 
 
 
Compound 4.29 
Yield = 50 %    
 
1H NMR (400 MHz, CDCl3) 
δ0.01 (s, 3H, Si(CH3)2); 0.02 (s, 3H, Si(CH3)2); 0.86 (s, 9H, SiC(CH3)3); 1.26 – 1.29 (m, 
2H, CH211); 1.37 (s, 3H, C(CH3)2); 1.43 (s, 9H, OC(CH3)3); 1.53 – 1.47 (m, 2H, CH212); 
1.66 (s, 3H, C(CH3)2); 1.61 – 1.65 (m, 2H, CH210-15); 1.89 – 1.97 (m, 2H, CH215-10); 
.1.89 – 1. 97 (m, 1H, CH217a); 2.14 – 2.25 (m, 1H, CH217b); 2.21 – 2.28 (m, 2H, CH216); 
3.20 – 3.24 (m, 2H, CH213); 3.34 – 3.45 (m, 2H, CH210); 3.83 – 3.74 (m, 2H, CH25’a/b); 
4.17 – 4.22 (m, 1H, CHGlu); 4.29 (dd, 1H, CH4’); 4.92 (dd, 1H, CH3’); 5.08 (dd, 2H, 
CH2Ph); 5.21 (dd, 1H, CH2’); 5.80 (br d, 1H, NHCHGlu); 6.02 (d, 1H, CH1’); 6.53 (br s, 
1H, NHCOCH2CH2); 7.30 – 7.33 (m, 5H, Ph); 7.73 (s, 1H, CH8); 11.74 (br s, 1H, NH1). 
 
 
 246 
 
13C NMR (100 MHz, CDCl3) 
δ -6.39 (Si(CH3)2 ); -6.39 (Si(CH3)2); 17.37 (SiC(CH3)3); 24.46 (C(CH3)2); 24.90 
(SiC(CH3)3); 26.33 (CH212); 26.93 (OC(CH3)3); 26.26 (C(CH3)2); 26.95 (OC(CH3)3); 
28.89 (CH215); 31.69 (CH211); 32.64 (CH214); 39.15 (CH213); 40.98 (CH210); 53.13 
(CHGlu); 62.56 (C5’); 65.94 (CH2Ph); 80.43  (C3’); 83.48 (CH2’); 85.92 (C4’); 88.89 
(C1’); 112.88 (C(CH3)2); 116.18 (C5); 126.98 – 127.11 – 127.47 (Ph); 135.25 (C8); 
150.20 (C4); 151.75 (C2); 155.45 (NHCOCH2Ph); 158.09 (C6); 170.09 (COO(CH3)3); 
171.26 (NHCOGlu). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 878.4 [M+Na]+. 
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7.28. Synthesis of compounds 4.30, 4.31, 4.32 
 
 
 
To a solution of substrate 4.27, 4.28 or 4.29 (0.17 mmol) in THF (2 ml), TBAF·3H2O 
(0.34 mmol) was added. Progress of the reaction was monitored by TLC (eluent 
CH2Cl2/MeOH 1:1). After 6 h, the mixture was diluted in CH2Cl2(3 ml) and washed 
with H2O (2 x 2 ml). The combined organic phases were dried over Na2SO4 and 
concentrated under reduced pressure. The crude was purified by flash chromatography 
(eluent CH2Cl2/MeOH 9:1) to afford 4.30, 4.31 or 4.32 as pale yellow solids. 
 
 
Compound 4.30 
Yield =  84 %    
 
1H NMR (400 MHz, CDCl3) 
δ 1.32 (s, 3H, C(CH3)2); 1.38 (s, 9H, OC(CH3)3); 1.52 (s, 3H, C(CH3)2); 1.70 – 1.79 (m, 
2H, CH213a); 1.89 – 1.98 (m, 1H, CH213b); 2.14 – 2.18 (m, 2H, CH212); 3.86 – 3.91 (m, 
2H, CH210); 3.86 – 3.91 (m, 2H, CH211); 3.47 – 3.56 (m, 2H, CH25’a/b); 3.89 (br s, 1H, 
CHGlu); 4.12 (dd, 1H, CH4’); 4.91 (m, 1H, CH3’); 5.02 (m, 2H, CH2Ph); 5.29 (dd, 1H, 
CH2’);5.98 (d, 1H, CH1’); 6.48 (br d, 1H, NHCHGlu); 7.32 (m, 5H, Ph); 7.58 (br s, 1H, 
NHCOCH2); 7.92 (s, 1H, CH8); 11.72 (br s, 1H, NH1). 
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13C NMR (100 MHz, CDCl3) 
δ 25.63 (C(CH3)2); 27.10 (CH213); 27.51 (C(CH3)2); 27.52 (OC(CH3)3); 28.10 
(OC(CH3)3); 32.05 (CH212); 38.45 (CH211); 41.06 (CH210); 54.69 (CHGlu); 62.02 (C5’); 
65.90 (CH2Ph); 81.74 (C3’); 81.03 (CqPh); 83.66 (CH2’); 86.87 (C4’); 89.12 (C1’); 113.50 
(C(CH3)2); 117.38 (C5); 128.21 – 128.29 – 128.80 (Ph); 137.46 (C8); 151.59 (C4); 
153.07 (C2); 156.55 (COOCH2Ph);157.11 (C6); 171.80 (COO(CH3)3); 172.05 
(NHCOOGlu). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 686.8 [M+H]+; 708.9 [M+Na]+; 724.0 [M+K]+; 1393.8 
[2M+Na]+. 
 
 
Compound 4.31 
Yield = 82 %    
 
1H NMR (400 MHz, CDCl3) 
δ 1.27 (m, 2H, CH211); 1.39 (s, 3H, C(CH3)2); 1.44 (s, 9H, OC(CH3)3); 1.63 (s, 3H, 
C(CH3)2); 1.69 (m, 2H, CH212); 1.91 – 2.00 (m, 1H, CH215a); 2.13 – 2.21 (m, 1H, 
CH215b); 2.27 – 2.29 (m, 2H, CH214); 3.23 – 3.33 (m, 2H, CH213); 3.37 – 3.46 (m, 2H, 
CH210); 3.77 – 3.92 (m, 2H, CH25’a/b); 4.19 (br s, 1H, CHGlu); 4.39 (dd, 1H, CH4’); 5.05 
(m, 1H, CH3’); 5.05 (m, 2H, CH2Ph); 5.29 (dd, 1H, CH2’); 5.92 (d, 1H, CH1’); 6.93 (br 
d, 1H, NHCHGlu); 7.08 (br s, 1H, NHCOCH2CH2); 7.32 (m, 5H, Ph); 7.84 (s, 1H, 
CH8); 11.41 (br s, 1H, NH1). 
 
13C NMR (100 MHz, CDCl3) 
δ 25.41 (C(CH3)2); 26.25 (CH212); 26.62 (OC(CH3)3); 27.44 (C(CH3)2); 27.94 
(OC(CH3)3); 28.79 (CH215); 32.60 (CH211); 32.64 (CH214); 39.14 (CH213); 41.06 
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(CH210); 54.31 (CHGlu); 62.58 (C5’); 66.94 (CH2Ph); 81.20 (C3’); 82.37 (CqPh); 83.49 
(CH2’); 86.07 (C4’); 91.32 (C1’); 114.12 (C(CH3)2); 117.37 (C5); 127.97 – 128.11 – 
128.48 (Ph); 136.25 (C8); 151.07 (C4); 153.02 (C2); 156.47 (COOCH2Ph);158.59 (C6); 
171.23 (COO(CH3)3); 172.51 (NHCOGlu). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 714.4 [M+H]+; 736.4 [M+Na]+. 
 
 
Compound 4.32 
Yield = 58 %    
 
1H NMR (400 MHz, CDCl3) 
δ 1.26 – 1.29 (m, 2H, CH211); 1.37 (s, 3H, C(CH3)2); 1.43 (s, 9H, OC(CH3)3); 1.53 – 
1.47 (m, 2H, CH212); 1.66 (s, 3H, C(CH3)2); 1.61 – 1.65 (m, 2H, CH210-15); 1.89 – 1.97 
(m, 2H, CH215-10); .1.89 – 1. 97 (m, 1H, CH217a); 2.14 – 2.25 (m, 1H, CH217b); 2.21 – 
2.28 (m, 2H, CH216); 3.20 – 3.24 (m, 2H, CH213); 3.34 – 3.45 (m, 2H, CH210); 3.83 – 
3.74 (m, 2H, CH25’a/b); 4.17 – 4.22 (m, 1H, CHGlu); 4.29 (dd, 1H, CH4’); 4.92 (dd, 1H, 
CH3’); 5.08 (dd, 2H, CH2Ph); 5.21 (dd, 1H, CH2’); 5.80 (br d, 1H, NHCHGlu); 6.02 (d, 
1H, CH1’); 6.53 (br s, 1H, NHCOCH2CH2); 7.30 – 7.33 (m, 5H, Ph); 7.73 (s, 1H, CH8); 
11.74 (br s, 1H, NH1). 
 
13C NMR (100 MHz, CDCl3) 
δ 24.46 (C(CH3)2); 26.33 (CH212); 26.93 (OC(CH3)3); 26.26 (C(CH3)2); 26.95 
(OC(CH3)3); 28.89 (CH215); 31.69 (CH211); 32.64 (CH214); 39.15 (CH213); 40.98 
(CH210); 53.13 (CHGlu); 62.56 (C5’); 65.94 (CH2Ph); 80.43  (C3’); 83.48 (CH2’); 85.92 
(C4’); 88.89 (C1’); 112.88 (C(CH3)2); 116.18 (C5); 126.98 – 127.11 – 127.47 (Ph); 
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135.25 (C8); 150.20 (C4); 151.75 (C2); 155.45 (NHCOCH2Ph); 158.09 (C6); 170.09 
(COO(CH3)3); 171.26 (NHCOGlu). 
 
Mass spectrum 
ESI-MS positive mode, m/z: 742.4 [M+H]+; 764.4 [M+Na]+; 780.4 [M+K]+. 
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7.29. Synthesis of compounds 4.36a, 4.36b, 4.36c 
 
 
Under inert atmosphere, to a stirred solution of compound 4.31 (0.13 mmol) in TEP (1.5 
ml), POCl3 (0.65 mmol) was added dropwise at 0°C. The mixture was then stirred at 
0°C, monitoring progress of the reaction by reverse phase TLC (eluent MeOH/H2O 
4:1). After 3 h, the mixture was diluted with H2O (2 ml) and NaOH 2N was carefully 
added to pH 2. The resulting solution was stirred for 4 h at 70°C, then pH was adjusted 
to 7.0. The solvent was removed by lyophilization and products 4.36a, 4.36b and 4.36c 
were afforded isolated by reverse phase HPLC. 
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Compound 4.36a 
Yield =  41 %    
 
 
1H NMR (400 MHz, D2O) 
δ 1.13 (s, 9H, OC(CH3)3); 1.29 (m, 2H, CH211); 1.45 (m, 2H, CH212); 1.71 – 1.83 (m, 
1H, CH215a); 1.99 – 2.04 (m, 1H, CH215b); 2.15 – 2.22 (m, 2H, CH214); 2.99 – 3.07 (m, 
2H, CH213); 3.15 – 3.19 (m, 2H, CH210); 3.80 – 3.89 (m, 2H, CH25’a/b); 3.80 – 3.89 (br s, 
1H, CHGlu); 4.09 (dd, 1H, CH4’); 4.17 (m, 1H, CH3’); 4.47 (dd, 1H, CH2’); 4.91 – 5.02 
(m, 2H, CH2Ph); 5.72 (d, 1H, CH1’); 7.18 – 7.25 (m, 5H, Ph); 7.90 (s, 1H, CH8). 
 
13C NMR (100 MHz, D2O) 
δ 25.78 (CH212); 26.35 (CH211); 27.84 (OC(CH3)3); 27.74 (CH215); 29.58 (OC(CH3)3); 
32.54 (CH214); 39.22 (CH213); 41.10 (CH210); 55.98 (CHGlu); 64.18 (C5’); 66.88 
(CH2Ph); 71.41 (C3’); 82.37 (CqPh); 75.28 (CH2’); 84.31 (C4’); 87.13 (C1’); 117.09 (C5); 
127.59 – 128.23 – 128.64 (Ph); 136.31 (C8); 152.09 (C4); 157.71 (C2); 161.37 
(COOCH2Ph);168.22 (C6); 175.37 (COO(CH3)3); 179.07 (NHCOGlu). 
 
31P NMR (161.98 MHz, D2O) 
δ 0.45 
 
Mass spectrum 
ESI-MS positive mode, m/z: 754.3 [M+H]+; 776.3 [M+Na]+; 792.3 [M+K]+. 
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Compound 4.36b 
Yield =  28 %    
 
1H NMR (400 MHz, D2O) 
δ 1.43 – 1.46 (m, 4H, CH211-12); 1.71 – 1.77 (m, 1H, CH215a); 1.98 – 2.06 (m, 1H, 
CH215b); 2.15 – 2.19 (m, 2H, CH214); 2.99 – 3.09 (m, 2H, CH213); 3.15 – 3.21 (m, 2H, 
CH210); 3.79 – 3.90 (m, 2H, CH25’a/b); 3.79 – 3.90 (br s, 1H, CHGlu); 4.11 (dd, 1H, 
CH4’); 4.19 (m, 1H, CH3’); 4.48 (dd, 1H, CH2’); 4.92 – 5.03 (m, 2H, CH2Ph); 5.73 (d, 
1H, CH1’); 7.20 – 7.26 (m, 5H, Ph); 7.91 (s, 1H, CH8). 
 
13C NMR (100 MHz, D2O) 
δ 25.78 (CH211-12); 26.35 (CH211-12); 27.84 (CH215); 32.56 (CH214); 39.23 (CH213); 41.11 
(CH210); 55.99 (CHGlu); 64.18 (C5’); 64.15 (CqPh); 66.89 (CH2Ph); 71.40 (C3’); 75.26 
(CH2’); 84.32 (C4’); 87.12 (C1’); 117.10 (C5); 128.23 – 128.65 – 128.74 (Ph); 136.31 
(C8); 152.09 (C4); 157.71 (C2); 161.37 (COOCH2Ph);168.23 (C6); 175.37 
(COO(CH3)3); 179.07 (NHCOGlu). 
 
31P NMR (161.98 MHz, D2O) 
δ 0.34 
 
Mass spectrum 
ESI-MS positive mode, m/z: 698.3 [M+H]+; 720.4 [M+Na]+; 736.4 [M+K]+. 
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Compound 4.36c 
Yield =  28 %    
 
1H NMR (400 MHz, D2O): 
δ 1.61 (m, 4H, CH211-12); 2.96 (m, 2H, CH213); 3.30 (m, 2H, CH210); 3. 96 – 4.05 (m, 
2H, CH25’a/b); 4.24 (dd, 1H, CH4’); 4.43 (m, 1H, CH3’); 4.74 (dd, 1H, CH2’); 5.88 (d, 1H, 
CH1’); 7.96 (s, 1H, CH8). 
 
13C NMR (100 MHz, D2O): 
δ 24.19 (CH211-12); 25.51 (CH211-12); 39.29 (CH213); 40.22 (CH210); 64.69 (C5’); 70.60 
(C3’); 73.43 (CH2’); 83.79 (C4’); 87.46 (C1’); 115.99 (C5); 136.31 (C8); 152.89 (C4); 
159.36 (C2); 180.71 (C6). 
 
31P NMR (161.98 MHz, D2O): 
δ 0.64 
 
Mass spectrum 
ESI-MS positive mode, m/z: 435.2 [M+H]+; 869.3 [2M]+. 
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7.30. Synthesis of compounds 4.38a, 4.38b, 4.38c 
 
 
Under inert atmosphere, to a stirred solution of compound 4.32 (0.13 mmol) in TEP 
(1.5 ml), POCl3 (0.65 mmol) was added dropwise at 0 °C. The mixture was then stirred 
at 0 °C, monitoring progress of the reaction by reverse phase TLC (eluent MeOH/H2O 
4:1). After 3 h, the mixture was diluted with H2O (2 ml) and NaOH 2N was carefully 
added to pH 2. The resulting solution was stirred for 4 h at 70 °C, then pH was adjusted 
to 7.00. The solvent was removed by lyophilization and products 4.38a, 4.38b and 4.38c 
were afforded isolated by reverse phase HPLC. 
 
 
Compound 4.38a 
Yield =  60 %    
 
1H NMR (400 MHz, D2O): 
δ 1.43 (s, 9H, OC(CH3)3); 1.26 – 1.29 (m, 4H, CH212-13); 1.53 – 1.47 (m, 2H, CH211-14); 
1.42 – 1.47 (m, 2H, CH211-14); 1.72 – 1. 79 (m, 1H, CH217a); 1.98 – 2.06 (m, 1H, 
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CH217b); 2.14 – 2.17 (m, 2H, CH216); 2.92 – 3.06 (m, 2H, CH210); 3.12 – 3.23 (m, 2H, 
CH215); 3.90 – 3.78 (m, 2H, CH25’a/b); 3.90 – 3.78 (m, 1H, CHGlu); 4.06 (dd, 1H, CH4’); 
4.11 (dd, 1H, CH3’); 4.45 (dd, 1H, CH2’); 4.93 – 5.04 (dd, 2H, CH2Ph); 5.70 (d, 1H, 
CH1’); 7.23 – 7.28 (m, 5H, Ph); 7.90 (s, 1H, CH8). 
 
13C NMR (100 MHz, D2O): 
δ 26.93 (OC(CH3)3); 25.85 – 27.87 – 28.13 – 28.84 (CH211-12-13-14); 28.85 (CH216); 35.53 
(CH217); 39.38 (CH215); 41.53 (CH210); 55.93 (CHGlu); 64.43 (C5’); 66.88 (CH2Ph); 
71.67 (C3’); 75.78 (CH2’); 84.46 (C4’); 87.49 (C1’); 112.88 (C(CH3)2); 117.08 (C5); 
127.61 – 128.26 – 127.61 (Ph); 136.34 (C8); 152.16 (C4); 157.68 (C2); 161.50 
(NHCOCH2Ph); 168.24 (C6); 175.27 (COO(CH3)3); 179.05 (NHCOGlu). 
 
31P NMR (161.98 MHz, D2O): 
δ -0.42 
 
Mass spectrum  
ESI-MS positive mode, m/z: 782.3 [M+H]+; 804.3 [M+Na]+; 820.4 [M+K]+. 
 
 
Compound 4.38b 
Yield =  10 %    
 
1H NMR (400 MHz, D2O): 
δ 1.18 – 1.34 (m, 4H, CH212-13); 1.35 – 1.45 (m, 2H, CH211-14); 1.46 – 1.56 (m, 2H, 
CH211-14); 1.75 – 1.82 (m, 1H, CH217a); 2.00 – 2.11 (m, 1H, CH217b); 2.15 – 2.27 (m, 2H, 
CH216); 2.96 – 3.05 (m, 2H, CH210b); 3.05 – 3.15 (m, 2H, CH210a); 3.19 – 3.30 (m, 2H, 
CH215); 3.81 – 3.86 (m, 1H, CHGlu); 3.95 – 4.05 (m, 2H, CH25’a/b); 4.22 (dd, 1H, CH4’); 
4.41 (dd, 1H, CH3’); 4.64 (dd, 1H, CH2’); 4.90 – 5.02 (dd, 2H, CH2Ph); 5.87 (d, 1H, 
CH1’); 7.23 – 7.28 (m, 5H, Ph); 7.98 (s, 1H, CH8). 
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31P NMR (161.98 MHz, D2O): 
δ 1.03 
 
Mass spectrum 
ESI-MS positive mode, m/z: 726.3 [M+H]+; 748.4 [M+Na]+); 864.3[M+K]+ 
 
 
Compound 4.38c 
Yield =  10 %    
 
1H NMR (400 MHz, D2O): 
δ 1.23 – 1.33 (m, 6H, CH212-13); 1.45 – 1.50 (m, 2H, CH211-14); 2.44 – 2.49 (m, 2H, 
CH210); 3.14 – 3.22 (m, 2H, CH215); 3.78 – 3.88 (m, 2H, CH25’a/b); 4.09 (dd, 1H, CH4’); 
4.13 (dd, 1H, CH3’); 4.50 (dd, 1H, CH2’); 5.70 (d, 1H, CH1’); 7.92 (s, 1H, CH8). 
 
31P NMR (161.98 MHz, D2O): 
δ 3.96 
 
Mass spectrum 
ESI-MS positive mode, m/z: 463.2 [M+H]+; 531.6 [M+3Na]+ 
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7.31. Synthesis of compound 4.39 
 
 
Compound 4.38a (75 mg, 0.096 mmol) was dissolved in Trifluoroacetic acid (TFA, 1.5 
ml) at 0 °C. The solution was stirred at 0 °C for 15 minutes, monitoring the course of 
the reaction by inverse phase TLC (MeOH/H2O·0,1%TFA 1:1, Rf product = 0.46). 
TFA was removed under reduced pressure and the product was triturated with Et2O. 
The supernatant was removed and the solid was resuspended diethyl ether (5 ml) and 
collected by filtration. The white solid was washed with ether (3 x 5 ml) and dried under 
reduced pressure.  
 
Yield =  95 % 
 
1H NMR (400 MHz, D2O): 
δ 1.25 – 1.31 (m, 4H, CH212-13); 1.53 – 1.46 (m, 2H, CH211-14); 1.41 – 1.52 (m, 2H, 
CH211-14); 1.72 – 1. 79 (m, 1H, CH217a); 2.00 – 2.07 (m, 1H, CH217b); 2.14 – 2.17 (m, 
2H, CH216); 2.87 – 3.11 (m, 2H, CH210); 3.10 – 3.19 (m, 2H, CH215); 3.89 – 3.71 (m, 
2H, CH25’a/b); 3.90 – 3.81 (m, 1H, CHGlu); 4.07 (dd, 1H, CH4’); 4.13 (dd, 1H, CH3’); 
4.46 (dd, 1H, CH2’); 5.69 (d, 1H, CH1’); 7.92 (s, 1H, CH8). 
 
13C NMR (100 MHz, D2O): 
δ 25.86 – 28.23 – 28.53 – 28.84 (CH211-12-13-14); 29.12 (CH216); 24.12 (CH217); 39.31 
(CH215); 41.03 (CH210); 57.49 (CHGlu); 64.22 (C5’); 70.15 (C3’); 76.90 (CH2’); 85.16 
(C4’); 88.01 (C1’); 117.08 (C5’); 137.28 (C8); 152.22 (C4); 158.98 (C2); 167.23 (C6); 
176.98 (COOH); 181.69 (NHCOGlu). 
 
31P NMR (161.98 MHz, D2O): 
δ -0.47 
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Mass spectrum  
ESI-MS positive mode, m/z: 536.2 [M+H]+; 558.1 [M+Na]+; 574.1 [M+K]+ 
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7.32. Synthesis of compound 4.40 
 
 
Under inert atmosphere, to a stirred solution of compound 4.30 (154.5 mg, 0.225 mmol) 
in TEP (1.5 ml), POCl3 (0.1 ml, 1.125 mmol) was added dropwise at 0 °C. The mixture 
was then stirred at 0 °C, monitoring the progress of the reaction by reverse phase TLC 
(eluent MeOH/H2O 4:1, Rf product = 0.5). After 3 h, the mixture was diluted with H2O 
(2 ml) and the pH was adjusted to 2.0 by careful addition of 2 N NaOH. The resulting 
solution was stirred for 4 h at 70 °C, then pH was adjusted to 7.0 with 2 N NaOH. The 
solvent was removed by lyophilisation; the residue was taken up in water and added to a 
suspension of XAD-4 resin (1 g of resin/20 mg of crude) in acidic water at pH ca 2 
(HCl). The suspension was stirred until disappearance of the product in the supernatant 
(RP TLC monitoring). The resin was then charged into a glass column, and washed with 
water until negative assay for chloride ion (1% AgNO3). The resin pad was then eluted 
with methanol and the eluate was collected in fractions. Fractions containing the 
product (RP TLC) were combined and evaporated under reduced pressure. The residue 
was re-dissolved with water and lyophilized. White solid (132 mg, 0.196 mmol). 
 
Yield =  87 % 
 
1H NMR (400 MHz, D2O): 
δ 1.41 (s, 9H, OC(CH3)3); 1.71 – 1. 84 (m, 1H, CH213a); 2.01 – 2.11 (m, 1H, CH213b); 
2.14 – 2.17 (m, 2H, CH212); 2.88 – 3.16 (m, 2H, CH210); 3.88 – 3.77 (m, 2H, CH25’a/b); 
3.88 – 3.75 (m, 1H, CHGlu); 4.06 (dd, 1H, CH4’); 4.12 (dd, 1H, CH3’); 4.51 (dd, 1H, 
CH2’); 4.96 (dd, 2H, CH2Ph); 5.81 (d, 1H, CH1’); 7.21 – 7.32 (m, 5H, Ph); 7.92 (s, 1H, 
CH8). 
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13C NMR (100 MHz, D2O): 
δ 27.94 (OC(CH3)3); 28.84 (CH211); 28.85 (CH212); 35.53 (CH213); 43.00 (CH210); 57.03 
(CHGlu); 65.55 (C5’); 67.75 (CH2Ph); 72.36 (C3’); 79.97 (CH2’); 85.54 (C4’); 91.94 
(C1’); 113.77 (C(CH3)2); 119.09 (C5); 127.60 – 129.78 – 131.61 (Ph); 139.64 (C8); 
151.83 (C4); 158.98 (C2); 162.48 (NHCOCH2Ph); 169.28 (C6); 175.29 (COO(CH3)3); 
183.09 (NHCOGlu). 
 
31P NMR (161.98 MHz, D2O): 
δ -0.39 
 
Mass spectrum  
ESI-MS positive mode, m/z: 726.3 [M+H]+; 748.2 [M+Na]+; 764.7 [M+K]+ 
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7.33. Synthesis of compound 4.41 
 
 
The crude compound 4.40 (132 mg, 0.196 mmol) was dissolved in Trifluoroacetic acid 
(TFA, 1.5 ml) in presence of a trace amount of trifluoromethanesulfonic acid (TFMS) at 
0 °C. The solution was stirred at 0 °C for 15 minutes, monitoring the course of the 
reaction by inverse phase TLC (MeOH/H2O·0,1%TFA 1:1). 
TFA was removed under reduced pressure and the product was triturated with Et2O. 
The supernatant was removed and the solid was resuspended diethyl ether (5 ml) and 
collected by filtration. The white solid was washed with ether (3 x 5 ml) and dried under 
reduced pressure.  
 
Yield =  95 % crude product (to be purified by HPLC) 
 
1H NMR (400 MHz, D2O): 
δ 1.67 – 1. 83 (m, 1H, CH213a); 2.02 – 2.09 (m, 1H, CH213b); 2.14 – 2.17 (m, 2H, CH212); 
2.89 – 3.21 (m, 2H, CH210); 3.89 – 3.77 (m, 2H, CH25’a/b); 3.90 – 3.76 (m, 1H, CHGlu); 
4.06 (dd, 1H, CH4’); 4.12 (dd, 1H, CH3’); 4.53 (dd, 1H, CH2’); 5.80 (d, 1H, CH1’); 7.92 
(s, 1H, CH8). 
 
13C NMR (100 MHz, D2O): 
δ 27.19 (CH211); 28.79 (CH212); 33.21 (CH213); 46.02 (CH210); 57.05 (CHGlu); 66.97 
(C5’); 72.36 (C3’); 79.97 (CH2’); 85.55 (C4’); 92.36 (C1’); 121.01 (C5); 141.89 (C8); 
151.55 (C4); 159.00 (C2); 168.54 (C6); 176.98 (COOH); 183.11 (NHCOGlu). 
 
31P NMR (161.98 MHz, D2O): 
δ -0.39 
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Mass spectrum  
ESI-MS positive mode, m/z: 535.2 [M+H]+; 558.1 [M+Na]+); 574.2 [M+K]+. 
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